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RNA helicases comprise a large family of ubiquitously expressed enzymes that remodel 
RNA structures and RNA-protein complexes in an NTP-dependent manner. These proteins 
are essential regulators of every RNA-related process, including pre-mRNA splicing and 
ribosome biogenesis, where they are suggested to perform various activities, such as 
unwinding RNA duplexes and displacing proteins from RNA. RNA helicases require a 
complex regulation due to the lack of specificity of their conserved helicase core, their 
generally low intrinsic activity and the involvement of individual helicases in multiple cellular 
functions. The activity of these enzymes can be modulated in diverse ways, including 
through interactions with effector proteins termed helicase cofactors. Several helicase 
cofactors identified so far share a conserved glycine-rich domain known as a G-patch 
domain. In yeast, the role of these G-patch proteins as RNA helicase regulators has been 
established. However, a larger number of G-patch proteins are expressed in human cells 
and much less is known about their functions and interactions with RNA helicases. 
In this study, a comprehensive analysis of the human G-patch protein family was performed 
in order to assess their functions and potential role as cofactors of RNA helicases. Our 
results show that all 22 human G-patch proteins interact with an RNA helicase and, in most 
cases, they enhance the RNA binding affinity and/or the ATPase activity of their helicase 
partner. Only three human DEAH/RHA helicases associate with G-patch proteins, among 
which DHX15 is regulated by approximately 20 G-patch cofactors, suggesting that this 
helicase could have a central role in the cell. Our transcriptome analyses indicate that 
DHX15 and the majority of G-patch proteins are involved in alternative splicing, where they 
regulate specific genes but also have common targets. We confirm the role in alternative 
splicing for several proteins and propose that DHX15 functions together with its G-patch 
cofactors in this pathway. Our results further suggest that G-patch proteins and DHX15 
could potentially regulate alternative splicing by direct binding to pre-mRNAs as well as in 
an indirect manner. In addition to its role in splicing, DHX15 also functions in ribosome 
biogenesis together with its G-patch cofactor NKRF and with the exonuclease XRN2. These 
proteins associate into a nucleolar complex that is involved in the efficient processing of the 
pre-rRNA transcript at a specific site. The catalytic activity of DHX15 is required for this 
function, implying that the helicase might remodel structures in this region to facilitate the 
cleavage event. Taken together, our data provide essential insights into the role of human 
G-patch proteins as cofactors of RNA helicases and also reveal functions for DHX15 in 
alternative splicing and ribosome biogenesis together with its G-patch cofactors. Therefore, 
the findings of this study provide the basis for further understanding the function and 




1.1 General aspects of RNA and RNA-binding proteins 
RNA is a highly versatile molecule that plays a central role in almost every cellular process 
and is capable of a wide range of functions, such as mediating the transfer of genetic 
information from DNA to proteins, catalyzing biochemical reactions and regulating gene 
expression at the transcriptional, post-transcriptional and translational levels (Cech, 2012). 
A typical cell contains a multitude of RNA molecules that can be broadly classified into 
protein-coding RNA (or messenger RNA) and non-coding RNA, with the latter including, 
among others, ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), 
small nucleolar RNA (snoRNA) and the related small Cajal body-associated RNA (scaRNA) 
(Cech and Steitz, 2014; Morris and Mattick, 2014). Messenger RNAs (mRNAs) are 
intermediaries in the gene expression pathway that transmit information from genes to 
proteins and their splicing requires the action of snRNAs, which are essential components 
of the spliceosome. Protein synthesis is catalyzed by rRNA in the context of the ribosome 
and involves decoding of the three-nucleotide code of the mRNA sequence into the 
corresponding amino acids, which is accomplished with the help of tRNAs. Ribose 
methylation at 2′-OH groups and the isomerization of uridine into pseudouridine in rRNAs 
and snRNAs are guided by snoRNAs and scaRNAs, which act together with proteins that 
install these modifications. 
The functions of RNAs are brought about by their ability to fold into unique and complex 
structures, which involve local secondary structure elements that contribute to higher-order 
tertiary arrangements (Russell, 2008). In addition, many non-coding RNAs establish  
base-pairing interactions with other RNAs to carry out their activity. This includes, for 
example, the association of snRNAs with pre-mRNAs in splicing and of snoRNAs and 
scaRNAs with their target RNAs for directing modifications. However, RNA molecules are 
rarely found alone in the cell but instead they are bound by proteins to form RNA-protein 
(RNP) complexes. These RNA-binding proteins (RBPs) are suggested to regulate the fate 
or function of RNAs by stabilizing or remodeling their structure, mediating interactions with 
other macromolecules, assisting in their transport or installing modifications (Cusack, 1999; 
Hentze et al., 2018). In general, RBPs recognize either sequence motifs, structural 
elements or both and bind short stretches (3-8 nucleotides) of RNA that have a low 
sequence complexity (Jankowsky and Harris, 2015; Dominguez et al., 2018). Classical 
RBPs interact with RNA through established RNA-binding domains, such as the RNA 
recognition motif (RRM) or the helicase core. In addition, a multitude of RBPs that use 
intrinsically disordered regions, protein-protein interaction interfaces and other 
unconventional modes to bind RNA have been recently described (Castello et al., 2016).  
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The structure and composition of RNPs are dynamically regulated throughout their lifetime 
and this has been suggested to take place mainly through the action of RNA helicases 
(Jarmoskaite and Russell, 2014; Hentze et al., 2018). The role of RNA helicases in RNP 
remodeling as well as their other biochemical activities, mode of action and regulation are 
discussed in detail below. 
 
1.2 RNA helicases: characteristics and mode of action 
RNA helicases comprise a large family of ubiquitously expressed RBPs that are involved in 
every aspect of RNA metabolism through their function in remodeling RNA-RNA and  
RNA-protein interactions using the energy of nucleoside triphosphate (NTP) hydrolysis. 
Originally designated as helicases based on the ability of some members of the family to 
unwind duplex structures, it is now widely accepted that RNA helicases display a broad 
range of activities and mechanisms of action, with their common characteristic being that 
they possess RNA-dependent NTPase activity (Jarmoskaite and Russell, 2014; Ozgur et 
al., 2015). 
1.2.1 Classification and conserved sequence elements 
RNA helicases and the related DNA helicases have been classified into six superfamilies 
(SF1-SF6) based on primary sequence and structural and functional analyses (Gorbalenya 
and Koonin, 1993; Singleton et al., 2007). Most helicases of SF1 and SF2 act as monomers, 
while SF3-SF6 helicases associate into hexameric ring-like structures. RNA helicases 
belong almost exclusively to SF1 and SF2 and are further subdivided into five SF2 families 
(DEAD-box, DEAH/RHA, RIG-I-like, Ski2-like, NS3/NPH-II) and the Upf1-like family that is 
part of SF1 (Fairman-Williams et al., 2010; Byrd and Raney, 2012). More than 70 RNA 
helicases have been identified in human cells and the majority are either DEAD-box or 
DEAH/RHA proteins. Consequently, much of our mechanistic understanding of RNA 
helicases stems from studies of these two families. 
The hallmark of SF1 and SF2 helicases is the presence of a conserved helicase core 
consisting of two globular domains connected by a flexible linker, which are designated as 
RecA-like domains based on homology to bacterial RecA (Bleichert and Baserga, 2007; 
Jankowsky and Fairman, 2007). Within the two RecA-like domains, a series of conserved 
sequence motifs have been described, with roles in RNA and NTP substrate binding, NTP 
hydrolysis and its coordination with remodeling events (Figure 1.1A). The Walker A motif 
(motif I) containing the characteristic glycine-lysine-threonine (GKT) sequence, the Walker 
B motif (motif II) with the aspartate-glutamate-alanine-glutamate/histidine (DEAD/H) 
signature that gives the name of the respective families, and motif VI, which contains an 
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essential ‘arginine finger’, are highly conserved and participate in NTP binding and 
hydrolysis (Walker et al., 1982; Caruthers and McKay, 2002). The Q motif confers specificity 
for ATP through interactions between the glutamine and the adenine base and is absent 
from certain families, such as the DEAH/RHA helicases, that are able to bind and hydrolyze 
other NTPs (Cordin et al., 2004). Other conserved regions include motifs implicated in the 
coordination of the RNA and NTP binding sites (III and Va) and motifs required for binding 
of the RNA substrate (Ia, Ib, Ic, IV, IVa, V) (Cordin et al., 2006; Banroques et al., 2010; 
Fitzgerald et al., 2017).  
Figure 1.1. Structural comparison of DEAD-box and DEAH/RHA RNA helicases. (A) Schematic 
representation of the primary sequence of DEAD-box and DEAH/RHA helicases depicting the two domains of 
the conserved core as well as the winged helix (WH), ratchet-like (Ratchet) and OB-fold domains that are 
specific for the DEAH/RHA family. Each core domain contains several conserved motifs that are colored in gray 
and labelled above. (B) Crystal structures of the DEAH/RHA helicase Prp43 in the open (left) and closed (right) 
conformations based on the PDB entries 5LTK and 5LTA. The different domains are colored as in (A) and the 
bound nucleotide is shown in red. The closed conformation also contains the RNA substrate, which is depicted 
in black. (C) Structures of the DEAD-box helicase Mss116 in the open (left) and closed (right) conformations. 
The open conformation is based on small-angle X-ray scattering data, while the closed conformation is obtained 
from the PDB entry 3I5X. The two helicase domains are colored as in (A) and the C-terminal extension that is 
found only in some DEAD-box proteins is shown in magenta. The nucleotide and the RNA substrate, which are 
only present in the closed conformation, are colored in red and black respectively. This figure was adapted from 
Gilman et al., 2017. 
The conserved core of RNA helicases is flanked in most cases by N-terminal and C-terminal 
auxiliary regions, which are in general highly variable between, and also within, the different 
families and can encompass specific domains or folds (Fairman-Williams et al., 2010). In 
DEAD-box proteins, the N- and C-terminal extensions adopt a variety of conformations and 
are not conserved between the different helicases. For example, the bacterial helicase 
DbpA contains an RRM domain at its C-terminus, while the yeast helicase Mss116 has a 
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positively charged C-tail, and both features are important for their regulation. In some cases, 
DEAD-box proteins can be represented exclusively by the helicase core as is the case for 
eIF4A, which is defined as a minimal helicase (Rudolph and Klostermeier, 2015). On the 
other hand, while the N-terminal extension of DEAH/RHA helicases is specific for each 
individual protein, this family is characterized by the presence of a highly-conserved  
C-terminus that has an essential role in their function and regulation and is composed of a 
winged helix (WH) domain, a ratchet-like domain and an oligonucleotide/oligosaccharide-
binding (OB)-fold (He et al., 2010; Walbott et al., 2010). Interestingly, OB-folds are versatile 
domains composed of a five-stranded b-barrel structure that are found in a wide range of 
proteins where they are involved in binding nucleic acids, proteins or other molecules 
(Arcus, 2002; Theobald et al., 2003). In general, it has been suggested that the auxiliary 
domains regulate the activity of RNA helicases by different mechanisms that involve 
interactions with proteins or RNA and some of these regulatory mechanisms are discussed 
in the following sections. 
1.2.2 Structure and mechanism of action 
In three-dimensional structure, the two helicase domains form a cleft where the motifs 
involved in NTP binding and hydrolysis cluster, while the RNA-binding motifs are located 
on the surface of the two domains, opposite the NTP binding site (Jankowsky and Fairman, 
2007; Pyle, 2008). Structural and biochemical studies of RNA helicases in different 
functional conformations have provided insight into how these enzymes couple NTP binding 
and hydrolysis to RNA unwinding and have revealed major differences in the mode of action 
of DEAD-box and DEAH/RHA helicases (Yang et al., 2007; Walbott et al., 2010; Mallam et 
al., 2012; He et al., 2017; Tauchert et al., 2017). 
DEAH/RHA helicases are generally defined as processive enzymes that unwind duplexes 
by directional translocation powered by cycles of NTP hydrolysis. These helicases load onto 
single-stranded RNA overhangs adjacent to a duplex region and have been suggested to 
translocate preferentially in the 3′-5′ direction, leading to the displacement of the 
complementary strand (Pyle, 2008). An important feature of DEAH/RHA helicases is the 
presence of a highly-conserved C-terminal region consisting of a WH domain, a ratchet-like 
domain and an OB-fold (He et al., 2010; Walbott et al., 2010). These C-terminal domains 
establish essential interactions with both RecA-like domains that contribute to the formation 
of an RNA-binding channel located inside the core. Binding of NTP triggers rearrangements 
of the C-terminal region, which leads to an open conformation that allows access of the 
RNA substrate to the binding channel (Tauchert et al., 2017; Figure 1.1B). The RNA is 
bound in a specific configuration with its 5′ end located in domain 2 and its 3′ end contacting 
domain 1, thus providing a basis for the 3′-5′ polarity exhibited by these enzymes (Pyle, 
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2008; Tauchert et al., 2017). Only four RNA bases are stacked in the helicase binding 
channel and relatively few contacts are formed, involving almost exclusively the sugar-
phosphate backbone of the nucleic acid, which suggests a transient and unspecific 
interaction of these helicases with their substrate. RNA binding triggers further 
rearrangements of the helicase core, mostly in domain 2, and this leads to a closed 
conformation that is favorable for NTP hydrolysis (He et al., 2017; Tauchert et al., 2017). 
Translocation along the RNA substrate is driven by changes in the interactions between the 
RNA and the two helicase core domains during the NTP hydrolysis cycle. More specifically, 
two b-hairpin regions in each helicase domain contact the RNA, acting as ‘bookends’ for a 
region of four nucleotides (nt), and their movement relative to each other by a stepping 
mechanism leads to translocation by one nucleotide (He et al., 2017). How the actual 
unwinding takes place is still not fully understood, but it has been suggested to involve a 
combination of active disruption of the duplex during translocation and passive, 
spontaneous dissociation of base-pairs at the duplex termini followed by translocation to 
prevent re-annealing (Pyle, 2008). In the cell, helicases act on highly structured substrates, 
raising the question of how DEAH/RHA proteins access and remodel their RNA targets, 
which are generally buried inside large RNPs. For this, a winching mechanism was 
proposed that involves loading of the helicase onto an exposed single-stranded RNA region 
and, if its translocation is physically blocked, pulling onto the complementary RNA strand, 
thereby disrupting the base-pairing interactions (Gilman et al., 2017). 
In contrast to DEAH/RHA helicases, DEAD-box proteins are generally considered to be 
non-processive enzymes that unwind short duplex regions by a local strand separation 
mechanism (Yang et al., 2007). Due to the absence of the specific C-terminal region found 
in DEAH/RHA helicases, the two RecA-like domains in DEAD-box proteins are more flexible 
and unwinding takes place through switching of the helicase core between an open and a 
closed conformation during one cycle of ATP hydrolysis (Ozgur et al., 2015; Figure 1.1C). 
In the unbound state, the two RecA-like domains are spatially separated and inter-domain 
contacts are lacking. The cooperative binding of ATP and RNA to conserved sites located 
in both domains leads to the formation of an intricate network of interactions and triggers 
the conversion to a closed conformation (Hilbert et al., 2009; Mallam et al., 2012). Similar 
to DEAH/RHA helicases, DEAD-box proteins contact exclusively the sugar-phosphate 
backbone of RNA, demonstrating the intrinsic lack of specificity of the helicase core. 
Interestingly, while DEAD-box proteins can dock directly onto double-stranded RNA, their 
binding can be stabilized in some cases by the presence of nearby single-stranded RNA 




The closed conformation with ATP and RNA bound induces a kink in the RNA that distorts 
the duplex structure and further stochastic dissociation of base-pairs next to the unwound 
region leads to the release of one strand (Yang et al., 2007; Hilbert et al., 2009; Gilman et 
al., 2017). ATP hydrolysis and inorganic phosphate (Pi) release induce the transition to an 
open conformation, dissociating the second RNA strand and recycling the helicase for more 
catalytic cycles (Liu et al., 2008). In the cellular context, most RNAs and RNPs likely contain 
relatively short duplex regions and would therefore be appropriate targets for unwinding by 
a local strand separation mechanism (Linder and Jankowsky, 2011). Putative physiological 
unwinding substrates that have been suggested to require the action of DEAD-box 
helicases include snoRNA-rRNA interactions and the base-pairing of U1 snRNA to the  
pre-mRNA 5′ splice site (Staley and Guthrie, 1999; Kos and Tollervey, 2005; Srivastava et 
al., 2010). 
1.2.3 Biochemical activities 
In addition to the NTP-dependent unwinding of RNA duplexes described above, RNA 
helicases can perform other activities, such as acting as RNA chaperones to facilitate RNA 
folding, displacing proteins from RNA, nucleating the assembly of RNP complexes 
(clamping) or annealing RNA strands (Pyle, 2008; Linder and Jankowsky, 2011). RNA 
structures have a strong tendency to adopt misfolded or non-functional conformations and 
were suggested to require the action of RNA chaperones, such as RNA helicases, to 
achieve their native configuration (Herschlag, 1995). This RNA chaperoning activity has 
been shown for a few DEAD-box proteins, which bind RNA non-specifically and either assist 
directly in their folding or resolve non-native structures that would then facilitate their proper 
folding (Russell, 2008; Pan and Russell, 2010). On the other hand, protein displacement 
has been described both for translocating and non-translocating helicases and, although it 
was shown to be independent of duplex unwinding for specific helicases, the exact 
mechanism is not known (Fairman et al., 2004; Jankowsky and Bowers, 2006; Putnam and 
Jankowsky, 2013). Interestingly, in some cases, the diverse activities carried out by 
helicases are a result of their regulation by interacting proteins. For example, the exon 
junction complex RNA helicase eIF4A-III binds RNA in an ATP-dependent manner and 
arrest of its ATP hydrolysis cycle by the MAGOH-Y14 heterodimer leads to clamping of the 
helicase onto RNA and the formation of a stable RNP complex that serves as an assembly 
platform for other factors (Ballut et al., 2005; Nielsen et al., 2009). Furthermore, the RNA 
helicase Rok1 was shown to undergo conformational changes in the presence of Rrp5 that 
stimulate its ability to anneal RNA strands (Young et al., 2013). RNA annealing activity was 
also observed for Ded1 and Mss116 in addition to their unwinding function and, 
interestingly, it was found to be ATP-independent, suggesting that these enzymes can 
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catalyze complex rearrangements of RNA structures depending on their nucleotide status 
(Linder and Jankowsky, 2011).  
 
1.3 Cellular pathways involving RNA helicases 
The diverse ways in which RNA helicases express their function in remodeling RNAs and 
RNPs is also reflected in the wide range of activities that they perform in the cell. These 
enzymes are essential effectors of all RNA-related processes and are involved in pathways 
such as ribosome biogenesis, splicing, transcription, mRNA export, translation, mRNA 
decay and innate immunity (Jankowsky, 2011). The function of RNA helicases has been 
described mostly in the context of two large and highly complex RNPs, the ribosome and 
the spliceosome, which undergo extensive remodeling during their assembly and functional 
cycle (Jarmoskaite and Russell, 2014). 
1.3.1 Ribosome biogenesis 
Ribosomes are essential ribonucleoprotein complexes that are responsible for protein 
synthesis in all three domains of life. The eukaryotic ribosome sediments at 80S and is 
composed of four rRNAs and approximately 80 ribosomal proteins (RPs) that are 
assembled into two asymmetric subunits. In human cells, the 40S small subunit (SSU) 
contains the 18S rRNA and 33 RPs, while the 60S large subunit (LSU) is composed of the 
5S, 5.8S and 28S rRNAs together with 47 RPs. During translation, decoding of the mRNA 
sequence takes place in the SSU and peptide bond formation is accomplished in a catalytic 
center consisting of rRNA that is located in the LSU. The functional core of the ribosome is 
highly conserved in all organisms, but eukaryotic ribosomes have an increased size and 
complexity compared to their bacterial counterparts due to the presence of rRNA expansion 
segments, additional RPs and RP extensions (Melnikov et al., 2012; Wilson and Doudna 
Cate, 2012; Yusupova and Yusupov, 2014). 
The production of eukaryotic ribosomes starts with the transcription of ribosomal RNA 
precursors (pre-rRNAs), which undergo processing, folding and modification and are 
concurrently assembled with RPs to generate the mature ribosomal subunits. This requires 
the assistance of hundreds of assembly factors, which bind transiently and in a defined 
order and generally perform irreversible reactions that drive the process forward (Strunk 
and Karbstein, 2009; Kressler et al., 2010). Thus, ribosome biogenesis is a highly regulated 
and energy-consuming process. The pathway of ribosome assembly is best studied in 
Saccharomyces cerevisiae (S. cerevisiae) and, while most features are conserved across 
eukaryotes, in human cells there are specific differences in pre-rRNA processing as well as 
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a larger number of assembly factors (Tafforeau et al., 2013; Henras et al., 2015; Tomecki 
et al., 2017). 
Figure 1.2. Overview of ribosome biogenesis in human cells. (A) Schematic representation of the 47S  
pre-rRNA transcript, which contains the sequences of the mature 18S, 5.8S and 28S rRNAs flanked by external 
transcribed spacer (5′ETS and 3′ETS) and separated by internal transcribed spacer (ITS1 and ITS2) regions. 
This precursor is processed by endonucleolytic cleavage at sites that are marked above. The position of the 
first and last nucleotide of the mature rRNAs within the precursor are indicated below. This panel is based on 
Mullineux and Lafontaine, 2012 and Henras et al., 2015. (B) During ribosome assembly, a multitude of factors 
associate with the nascent transcript to generate the 90S pre-ribosome, which undergoes a pre-rRNA cleavage 
event that separates the precursors of the two ribosomal subunits. These pre-ribosomal complexes are further 
processed in the nucleus and cytoplasm to produce the mature 40S and 60S subunits. This panel was adapted 
from Martin, 2014.  
In human cells, the 18S, 5.8S and 28S rRNAs are co-transcribed in the nucleolus by RNA 
polymerase I to generate the 47S pre-rRNA transcript, in which the sequences of the mature 
rRNAs are interspersed with external transcribed spacer (5′ETS and 3′ETS) and internal 
transcribed spacer (ITS1 and ITS2) regions (Figure 1.2A). Multiple assembly factors and 
several RPs are recruited co-transcriptionally to the nascent pre-rRNA, leading to the 
formation of the earliest biogenesis precursor, the 90S pre-ribosome, which contains the 
full-length transcript and predominantly proteins required for SSU maturation (Grandi et al., 
2002; Phipps et al., 2011; Figure 1.2B). Structures of 90S pre-ribosomes from S. cerevisiae 
and Chaetomium thermophilum have revealed that this macromolecular complex 
assembles as a scaffold around the pre-rRNA and ensures that its maturation takes place 
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in a coordinated and sequential manner (Kornprobst et al., 2016; Kressler et al., 2017; Sun 
et al., 2017a). The processing pathways of the SSU and LSU diverge after an 
endonucleolytic cleavage in ITS1. The precursors of the two subunits undergo additional 
maturation steps that involve the dynamic association and release of assembly factors, the 
incorporation of RPs and further pre-rRNA processing and structural rearrangement events. 
These pre-ribosomal complexes transition through the nucleolus and nucleoplasm and are 
then exported to the cytoplasm, where final maturation occurs and the two subunits 
associate for translation (Kressler et al., 2017; Pena et al., 2017; Chaker-Margot, 2018). 
The 5S rRNA precursor is transcribed separately by RNA polymerase III at sites adjacent 
to the nucleolus and joins the assembly pathway at an early stage (Ciganda and Williams, 
2011). 
The processing of the 47S pre-rRNA transcript into the mature 18S, 5.8S and 28S rRNAs 
involves sequential endonucleolytic cleavages that take place at defined sites in the spacer 
regions and are followed by exonucleolytic trimming (Henras et al., 2015; Aubert et al., 
2018; Figure 1.2A). The initial precursor is processed first at sites A′ in the 5′ETS and 02 in 
the 3′ETS to produce the 45S pre-rRNA. The cleavage at site A′ was shown to not be 
required for the downstream steps and, while its role is not known, it is interesting to note 
that this site is only present in metazoans (Sloan et al., 2014). Two parallel pathways exist 
for processing of the 45S precursor that differ in the relative order of the 5′ETS removal and 
ITS1 cleavage events and give rise to different pre-rRNA species. Cleavage of the 45S  
pre-rRNA at site 2 in ITS1 prior to 5′ETS excision generates the 30S and 32.5S precursors. 
The 5′ETS region of the 30S pre-rRNA is subsequently removed by coordinated cleavages 
at sites A0 and 1, giving rise to the 21S intermediate, which is then processed at its 3′ 
terminus through the combined action of endo- and exonucleases to produce the 18SE  
pre-rRNA. This precursor is exported to the cytoplasm where a final cleavage at site 3 in 
ITS1 generates the mature 18S rRNA (Henras et al., 2015; Aubert et al., 2018). 
Alternatively, excision of the 5′ETS region in the 45S pre-rRNA leads to the formation of the 
41S intermediate, which can be further processed via two pathways. In the major pathway, 
cleavage takes place at site 2 in ITS1 and creates the 21S and 32.5S precursors, while in 
the minor pathway processing occurs instead at site E in ITS1 and produces the 18SE and 
36S pre-rRNAs (Preti et al., 2013; Sloan et al., 2013). The 21S and 18SE precursors of the 
small ribosomal subunit are matured as described above. The 36S pre-rRNA is trimmed at 
its 5′ end by the 5′-3′ exonuclease XRN2 to produce the 32.5S intermediate, which is the 
common LSU biogenesis precursor for all the alternative pathways. The 5′ end of the 32.5S 
pre-rRNA is further digested by XRN2 to generate the abundant 32S intermediate, which 
contains the sequences of the 5.8S and 28S rRNAs. Cleavage at site 4 in ITS2 followed by 
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exonucleolytic digestion releases the mature forms of these rRNAs (Henras et al., 2015; 
Aubert et al., 2018). Interestingly, a second ITS2 cleavage has been reported at site 4a, 
which leads to the excision of a fragment corresponding to the 4a-4 region that is degraded 
by XRN2 (Schillewaert et al., 2012). Other pre-rRNA spacer regions are released during 
processing and XRN2 has also been linked to the turnover of the 5′-A′, A0-1 and E-2 
fragments (Wang and Pestov, 2011; Sloan et al., 2013; Sloan et al., 2014). 
In addition to nucleases that participate directly in pre-rRNA processing, the ribosome 
assembly pathway requires the action of a multitude of other factors, such as RNA 
helicases, GTPases, kinases, structural proteins and snoRNAs that associate with proteins 
into snoRNPs. These assembly factors are essential for a wide range of processes, which 
include, among others, folding and modification of pre-rRNAs, remodeling and export of 
pre-ribosomal complexes, acting as structural scaffolds within pre-ribosomes or 
chaperoning and assisting the integration of RPs (Strunk and Karbstein, 2009; Kressler et 
al., 2010; Watkins and Bohnsack, 2012; Konikkat and Woolford, 2017; Pillet et al., 2017). 
The role of RNA helicases in ribosome biogenesis has been mainly characterized in yeast, 
where 21 helicases participate in this process. These enzymes were suggested to remodel 
RNA-RNA and protein-RNA interactions within pre-ribosomes and were recently shown to 
also mediate the export of pre-ribosomal complexes and the acetylation of pre-rRNA (Martin 
et al., 2013; Rodriguez-Galan et al., 2013; Neumann et al., 2016; Sharma et al., 2017). The 
RNA/RNP remodeling function of RNA helicases is exerted in diverse ways during ribosome 
biogenesis. For example, multiple RNA helicases were suggested to mediate the release 
of snoRNPs from pre-ribosomes by unwinding snoRNA-rRNA interactions. This includes 
Dbp4, Rok1, Has1, Dhr1 and Prp43, whose depletion or inactivation led to the accumulation 
of specific snoRNPs in pre-ribosomal particles (Kos and Tollervey, 2005; Liang and 
Fournier, 2006; Bohnsack et al., 2008; Bohnsack et al., 2009; Sardana et al., 2015). RNA 
helicases can also unwind secondary structures in pre-rRNAs that facilitate the binding of 
snoRNPs to their target sites as has been suggested for Prp43. Another role proposed for 
Prp43 is the remodeling of late pre-ribosomal complexes to enable access of the 
endonuclease Nob1 to its cleavage site (Lebaron et al., 2009; Pertschy et al., 2009). 
Therefore, in addition to snoRNPs, RNA helicases might also regulate the binding or 
dissociation of ribosome assembly proteins either in a direct or indirect manner. A 
remodeling function was also described for the RNA helicase Mtr4, which is required to 
unfold structured pre-rRNA substrates and facilitate their processing or degradation by the 
nuclear exosome (Thoms et al., 2015; Schuller et al., 2018; Weick et al., 2018). 
RNA helicases in higher eukaryotes are expected to perform similar functions in ribosome 
biogenesis as their yeast counterparts (Martin et al., 2013; Rodriguez-Galan et al., 2013). 
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Consistent with this, some mammalian helicases have already been implicated in snoRNA 
release/association within pre-ribosomes (Srivastava et al., 2010; Sloan et al., 2015). 
However, the function of most RNA helicases in human ribosome biogenesis is poorly 
characterized and, given the increased complexity of this pathway compared to yeast, 
additional roles might be revealed. 
1.3.2 Pre-mRNA splicing 
The transcription of protein-coding genes yields precursor mRNAs (pre-mRNAs) that 
require processing by splicing to remove the non-coding segments (introns) and join the 
coding sequences (exons). Pre-mRNA splicing takes place within the spliceosome, a large 
RNP complex that assembles de novo on each intron from five snRNPs, composed of the 
U1, U2, U4, U5 and U6 snRNAs and their associated proteins, and numerous additional 
non-snRNP proteins. Introns are defined by conserved sequence elements, namely the 5′ 
splice site, the branch point and the 3′ splice site, and are removed in two sequential 
transesterification reactions. First, the 2′-OH group of a conserved adenosine in the branch 
point initiates a nucleophilic attack on the phosphodiester bond at the 5′ splice site that 
releases the 5′ exon and generates an intron lariat-3′ exon intermediate. In the next step, 
the phosphodiester bond at the 3′ splice site is attacked by the 3′-OH group of the first exon, 
leading to ligation of the exons and release of the excised intron lariat (Wahl et al., 2009; 
Will and Lührmann, 2011). Both reactions take place in an RNA-based catalytic core, in 
which the splice sites are brought into proximity by a network of base-pairing interactions 
and the U6 snRNA coordinates metal ions that are directly involved in catalysis (Fica et al., 
2013; Fica and Nagai, 2017; Shi, 2017). 
During its assembly and functional cycle, the spliceosome undergoes extensive structural 
and compositional rearrangements that involve the dynamic exchange of proteins as well 
as restructuring of RNA-RNA interactions (Figure 1.3). In S. cerevisiae, these remodeling 
events are driven by eight conserved RNA helicases that belong to the DEAD-box, 
DEAH/RHA and Ski2-like families (Cordin and Beggs, 2013). While DEAD-box proteins act 
in the early steps of spliceosome assembly, DEAH/RHA helicases are implicated at the later 
stages, possibly reflecting the requirement for different types of helicase activity at the pre-
catalytic and catalytic phases (Gilman et al., 2017). Following the association of U1 snRNP 
with the 5′ splice site, the U2 snRNP is stably recruited at the branch point in a process that 
requires the action of the RNA helicases Sub2 and Prp5. Next, joining of the pre-assembled 
U4/U6.U5 tri-snRNP complex generates the pre-B complex, which undergoes major 
rearrangements driven by Prp28 and Brr2 to form the activated spliceosome complex (Bact 
complex). Prp28 removes the U1 snRNP from the 5′ splice site, while Brr2 unwinds the 
U4/U6 duplex, enabling the base-pairing of U6 snRNA to the 5′ splice site and the formation 
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of U6-U2 snRNA interactions. The final transition step to the catalytic spliceosome (B* 
complex) requires the action of Prp2, which remodels the branch point region, exposing the 
adenosine for the nucleophilic attack. After the first transesterification reaction, the resulting 
C complex is remodeled by Prp16 to position the reactive groups for the second catalytic 
step. Following exon ligation, Prp22 releases the mRNA, while Prp43 disassembles the 
spliceosome, recycling the snRNPs and releasing the intron lariat (Cordin and Beggs, 2013; 
Fica and Nagai, 2017; Shi, 2017). In addition to their remodeling function, several RNA 
helicases ensure the fidelity of the splicing process by discriminating against suboptimal 
splice sites. At the assembly stage, Prp5 was suggested to check the accuracy of the 
branch point-U2 snRNA pairing, while Prp28 proofreads the 5′ splice site. During the 
catalytic steps, proofreading at the 5′ and 3′ splice sites is carried out by Prp16 and Prp22 
respectively. Subsequently, the suboptimal spliceosomal complexes are directed to Prp43 





Although the core aspects of the splicing pathway are conserved between yeast and 
human, specific differences and the presence of additional factors lead to a more complex 
spliceosome machinery in human cells. In yeast, the splice site sequences are highly 
conserved and this correlates with the prevalence of constitutive splicing compared to 
alternative splicing (Will and Lührmann, 2011). In contrast, these sites are more degenerate 
in humans, where it is estimated that 95-100% of genes undergo alternative splicing, which 
Figure 1.3. Overview of the splicing cycle. 
A model pre-mRNA containing the 5′ splice 
site, the branch point (BP) and the 3′ splice site 
conserved sequences is depicted with exons 
as rectangles and the intron as a line. The 
spliceosome assembles on this substrate in a 
step-wise manner with the U1 and U2 snRNPs 
binding first, followed by the U4/U6.U5  
tri-snRNP, the NineTeen Complex (NTC) and 
additional splicing factors. During assembly, 
the spliceosome undergoes structural and 
compositional changes that are necessary for 
the two transesterification reactions (branching 
and exon ligation), which lead to joining of the 
two exons and the release of the intron lariat. 
These remodeling events are driven by eight 
conserved RNA helicases that are indicated in 
blue. This figure was originally published in 
Fica and Nagai, 2017 and is reprinted here 
with permission from Springer Nature. 
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expands the proteome significantly and contributes to the complexity of higher organisms 
(Lee and Rio, 2015). The regulation of alternative splicing is enabled by the presence of 
cis-acting regulatory elements in metazoan pre-mRNAs, which serve as binding sites for 
proteins that can either promote or inhibit spliceosome assembly. It has been suggested 
that the combined action of multiple such trans-acting splicing factors determines the choice 
of splice sites both at the early and late stages of the splicing cycle (Will and Lührmann, 
2011; Fu and Ares, 2014). Furthermore, the regulation of alternative splicing is also linked 
to transcription, chromatin organization and signal transduction mechanisms (Wahl and 
Lührmann, 2015). 
1.3.3. Other pathways 
Splicing is tightly connected to mRNA export and several RNA helicases are implicated in 
this process as well. For example, Sub2/UAP56 mediates the recruitment of specific 
adaptor proteins to mRNAs to form export-competent complexes, while on the cytoplasmic 
side of the nuclear pore, Dbp5/DDX19 displaces export factors from mRNPs to ensure 
directionality (Tieg and Krebber, 2013; Jarmoskaite and Russell, 2014; Bourgeois et al., 
2016). Similarly, multiple RNA helicases are involved at different stages during translation. 
In the early steps of cap-dependent translation initiation, eIF4A-I/DDX2A, eIF4A-II/DDX2B 
and Ded1/DDX3 are required to unwind structures in the 5′ untranslated regions (UTR) of 
the mRNA, thereby facilitating the loading of the pre-initiation complex and scanning for the 
start codon. These helicases have complementary but distinct activities, with eIF4A-I/II 
being suggested to disrupt weak structures and promote translation of all mRNAs, while 
mRNAs that contain strong secondary structures in the 5′ UTR are more dependent on 
Ded1 (Sen et al., 2015; Yourik et al., 2017; Gupta et al., 2018). The translation of mRNAs 
with highly structured 5′ UTRs is also assisted by DHX29, which interacts with the 40S 
ribosomal subunit near the mRNA entry channel and was proposed to act by remodeling 
ribosomal complexes (Dhote et al., 2012). Other RNA helicases function at later stages of 
translation. This includes DHX33, which has a role in the formation of elongation-competent 
80S ribosomes, and Dbp5/DDX19, which is involved in translation termination (Gross et al., 
2007; Tieg and Krebber, 2013; Zhang et al., 2015; Mikhailova et al., 2017). Multiple other 
cellular processes involving RNA helicases have been described, including mRNA storage 
and decay, miRNA-induced silencing and viral RNA recognition in the immune response 






1.4 Regulation of RNA helicases 
1.4.1 General regulatory mechanisms 
RNA helicases are essential for all RNA-related processes through their function in 
remodeling RNA and RNA-protein complexes. Furthermore, many multifunctional RNA 
helicases that regulate several aspects of RNA metabolism have been identified, indicating 
that these enzymes have a central role in the coordination of different cellular events 
(Jankowsky, 2011; Bourgeois et al., 2016). On the other hand, structural studies have 
revealed that the conserved core of RNA helicases binds the RNA substrate in a  
non-sequence specific manner and biochemical analyses have shown that some of these 
enzymes have a low activity in vitro (Ozgur et al., 2015; Gilman et al., 2017). 
These features indicate the need for a complex regulation of RNA helicases, which can be 
achieved in cis through the influence of auxiliary domains flanking the helicase core, as well 
as in trans through the action of accessory proteins termed RNA helicase cofactors (Ozgur 
et al., 2015). Furthermore, other regulatory mechanisms, such as post-translational 
modifications and interactions with long non-coding RNAs (lncRNAs), have been suggested 
(Sloan and Bohnsack, 2018). These diverse modes of RNA helicase regulation can result 
in the stimulation or inhibition of their activity, enable their recruitment and/or confer 
specificity for certain RNA targets, as well as expand the repertoire of the biochemical 
activities that they perform. 
1.4.2 Protein cofactor-independent regulation 
The N-terminal and C-terminal auxiliary regions present in the majority of RNA helicases 
generally establish interactions with RNA and/or proteins and can influence helicase 
function in multiple ways. For example, DHX36 contains a characteristic motif in its  
N-terminal extension that contributes to specific recognition of G-quadruplex structures 
(Lattmann et al., 2010). Some DEAD-box proteins such as Mss116 possess a positively-
charged C-tail region that binds adjacent to the target site and anchors the helicase core to 
the substrate in a non-sequence specific manner (Russell et al., 2013). On the other hand, 
the RRM domain present in the C-terminus of the Escherichia coli (E. coli) RNA helicase 
DbpA and of its Bacillus subtilis orthologue YxiN was found to recruit the helicase to rRNA 
by specifically binding to a region of 23S rRNA (Diges and Uhlenbeck, 2001; Kossen et al., 
2002). Interestingly, this is also linked to the stimulation of the ATPase and unwinding 
activities, at least in the case of YxiN (Samatanga et al., 2017). A different role has been 
attributed to the C-terminal region of Ded1, which is involved both in the oligomerization of 
the helicase and in the interaction with the translation initiation factor eIF4G. Due to the 
mutually exclusive nature of these processes, it has been suggested that the helicase might 
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be targeted to distinct functions depending on the interactions that its C-terminus 
establishes (Putnam et al., 2015). Furthermore, the C-terminal OB-fold domain that is 
specific for DEAH/RHA helicases contributes to RNA binding and also serves as a platform 
for interaction with protein cofactors, indicating that it represents an essential hub for the 
regulation of helicase activity (He et al., 2010; Walbott et al., 2010). Auxiliary domains can 
also function to keep the helicase inactive in the absence of the RNA substrate, preventing 
futile ATP hydrolysis. For example, DDX19 contains an N-terminal segment wedged 
between its two RecA-like domains that is displaced upon RNA binding to allow formation 
of the active, closed conformation (Collins et al., 2009). In addition to the effects exerted by 
auxiliary domains, RNA helicases can be regulated by post-translational modifications that 
either directly influence their catalytic activity or presumably modulate their interactions with 
other factors. Furthermore, several lncRNAs were found to impact the function of RNA 
helicases and the mechanisms proposed include competition with the cognate RNA 
substrate or acting as acceptors for the unwound products (Sloan and Bohnsack, 2018). 
These examples of cofactor-independent regulatory mechanisms highlight the complex 
control of RNA helicase function. An additional layer of regulation is provided by RNA 
helicase protein cofactors, which are discussed in the next section. 
1.4.3 Regulation by protein cofactors 
In addition to the mechanisms described above, a growing number of RNA helicases whose 
functions are modulated by trans-acting proteins, termed cofactors, have been identified. 
Overall, the helicase cofactors characterized so far comprise a heterogeneous group of 
proteins that interact with RNA helicases either in the conserved core or in the auxiliary 
domains and can influence every aspect of their catalytic cycle, including substrate binding 
and release, ATP hydrolysis and unwinding activity (Young and Karbstein, 2012; Sloan and 
Bohnsack, 2018). Interestingly, a significant number of these effector proteins don’t share 
any obvious similarity with other cofactors, implying that they represent individual proteins 
that have evolved to regulate RNA helicases. This includes, for example, the ribosome 
biogenesis factors Utp14 and Esf2, which were shown to stimulate the activity of Dhr1 and 
Dbp8 respectively (Granneman et al., 2006; Zhu et al., 2016). Some cofactors can have 
other defined functions in the cell that are independent of their role as RNA helicase 
regulators as is the case for NUP98, which is a component of the nuclear pore complex but 
also interacts in the nucleoplasm with DHX9 and was suggested to activate this helicase 
for its functions in transcription and splicing (Capitanio et al., 2017). 
On the other hand, the identification of effector proteins that modulate the activity of RNA 
helicases through a common domain has revealed the existence of dedicated families of 
helicase cofactors. This includes proteins that contain an MIF4G (middle domain of eIF4G) 
Introduction 
 16 
or a G-patch domain, several of which have been shown to act as helicase regulators. 
Interestingly, MIF4G domain-containing proteins regulate DEAD-box helicases, while  
G-patch proteins are cofactors of DEAH/RHA helicases (Ozgur et al., 2015; Robert-Paganin 
et al., 2015; Sloan and Bohnsack, 2018). 
Structural studies of various MIF4G cofactors in complex with their cognate helicase have 
revealed that they act mainly by modulating the transition between the open and closed 
conformation of the helicase core and can either stimulate or repress the activity of the RNA 
helicase. The MIF4G domain consists of five antiparallel a-helices termed HEAT repeats 
that are assembled into a crescent-shaped configuration, with the N-terminal and C-terminal 
sides contacting the helicase domains 2 and 1 respectively. In the case of activating 
cofactors, such as eIF4G, Gle1 and CNOT1, these interactions bring the RecA-like domains 
together, leading to a ‘half-open’ conformation that enhances activity (Schutz et al., 2008; 
Montpetit et al., 2011; Mathys et al., 2014; Ozgur et al., 2015). Intriguingly, the MIF4G 
domain of CWC22 does not have a stimulatory role but instead inhibits the activity of  
eIF4A-III. This is due to a different binding mode of the C-terminus of the MIF4G module to 
domain 1 of the helicase core, which leads to an inactive conformation in which the ATP 
and RNA binding sites located in the two RecA-like domains of the helicase are distant 
(Buchwald et al., 2013). Therefore, despite having a similar architecture, MIF4G domains 
can induce opposing effects depending on a few key intermolecular contacts that stabilize 
the helicase core either in an active or inactive conformation. Similarly, subtle variations in 
the MIF4G domains have been suggested to control their binding specificity, allowing the 
discrimination of the cognate DEAD-box helicase based on a few favorable or unfavorable 
interactions (Buchwald et al., 2013; Ozgur et al., 2015). The regulation of DEAH/RHA 
helicases by G-patch proteins is discussed separately in the next section. 
 
1.5 G-patch proteins as regulators of DEAH/RHA helicases 
1.5.1 General characteristics and regulatory mechanisms 
In addition to the MIF4G domain proteins and the other cofactors described above, several 
yeast and human proteins containing a G-patch domain have been shown to regulate the 
activity of RNA helicases (Robert-Paganin et al., 2015; Sloan and Bohnsack, 2018).  
G-patch proteins are found in eukaryotes as well as in some viruses and are characterized 
by a common glycine-rich region of approximately 50 amino acids that constitutes the  
G-patch domain. The consensus sequence of the G-patch domain was defined as 
HHX3GAX2GXGHGX4G (H - hydrophobic, A - aromatic, X - non-conserved amino acid) and 
includes five highly conserved glycine residues, an invariant aromatic amino acid following 
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the first conserved glycine and several conserved hydrophobic residues. In addition, a sixth 
glycine can be found downstream in most proteins (Aravind and Koonin, 1999; Robert-
Paganin et al., 2015). 
Most of our knowledge of the regulation of DEAH/RHA helicases by G-patch cofactors is 
based on studies in S. cerevisiae, where five G-patch proteins have been identified. These 
include Spp382 (Ntr1), Pxr1 (Gno1), Sqs1 (Pfa1) and Cmg1, which were shown to act as 
positive regulators of the multifunctional RNA helicase Prp43, as well as Spp2, which is a 
cofactor of Prp2 (Robert-Paganin et al., 2015; Sloan and Bohnsack, 2018). The best 
characterized G-patch cofactor is Spp382, which is required together with Prp43 for the 
disassembly of aberrant spliceosomes and of late-stage, intron lariat spliceosomes. The  
N-terminal region of Spp382 containing the G-patch domain enhances the activity of Prp43 
and enables coupling of ATP hydrolysis to its remodeling function, while the C-terminal 
region controls the timing of Prp43 activation through interactions with other proteins 
(Fourmann et al., 2016; Fourmann et al., 2017). On the other hand, Pxr1 and Sqs1 were 
suggested to stimulate the activity of Prp43 during ribosome biogenesis for its function in 
the release of a subset of snoRNAs from pre-rRNA and in the remodeling of pre-ribosomal 
complexes to facilitate final maturation of 18S rRNA respectively (Lebaron et al., 2009; 
Pertschy et al., 2009; Robert-Paganin et al., 2017). For the Cmg1-Prp43 complex, a role in 
the remodeling or disassembly of cytoplasmic RNPs has been proposed (Heininger et al., 
2016). Furthermore, Spp2 is essential for the remodeling activity of Prp2, which is required 
for the transition to a catalytically active spliceosome (Silverman et al., 2004; Warkocki et 
al., 2015). 
The above-mentioned interactions have provided valuable insight into the regulation of RNA 
helicases by G-patch cofactors. In all cases, G-patch proteins were shown to have a 
stimulatory role and enhance the ATPase and/or unwinding activity of their interacting 
helicase. In contrast to MIF4G cofactors, which bind in the helicase core and control its 
conformational transitions, G-patch proteins interact with the C-terminal auxiliary region of 
the RNA helicase. Protein-protein crosslinking experiments and interaction studies with 
helicase mutants have pinpointed the OB-fold domain as the main contact site for the  
G-patch motif (Silverman et al., 2004; Walbott et al., 2010; Christian et al., 2014; Heininger 
et al., 2016). Furthermore, the G-patch domain is the essential module for activating RNA 
helicases as no stimulation is observed in its absence, although in some cases other 
regions of the G-patch protein can bind the helicase (Lebaron et al., 2009; Christian et al., 
2014). In addition to mediating the interaction with the OB-fold region, the G-patch domain 
was shown to bind RNA in specific cases (Svec et al., 2004; Lebaron et al., 2009). However, 
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this characteristic is not shared by all G-patch domains, for example Spp382 being 
suggested to interact with RNA only in the presence of the helicase (Christian et al., 2014). 
Elucidating the mechanistic details of the G-patch protein-mediated regulation of RNA 
helicases would require structural information of the G-patch domain alone or in the 
presence of the helicase, which is currently limited. Circular dichroism spectroscopy studies 
have determined that the G-patch motif is unstructured in solution but has the capacity to 
adopt secondary structure elements and it was proposed that this would take place upon 
binding to the helicase (Frenal et al., 2006; Christian et al., 2014). In addition, based on 
structure probing and protein-RNA crosslinking experiments, it was suggested that binding 
of the G-patch protein induces structural rearrangements in the C-terminal region of the 
helicase that increase the availability of the RNA-binding channel (Christian et al., 2014). 
On the other hand, a recent study proposed that activation by G-patch proteins is required 
to disrupt a non-productive, auto-inhibited state of the RNA helicase, which is imposed by 
stacking of the nucleotide base between two residues found in each of the helicase domains 
(Robert-Paganin et al., 2017). 
An important aspect that remains to be elucidated is whether G-patch proteins act solely as 
enhancers of helicase activity or if they have other regulatory effects. Both Prp43 and Prp2 
were found to associate with their target RNPs in the absence of their cofactors, indicating 
that they are recruited to the spliceosome and pre-ribosome independently of G-patch 
proteins (Lebaron et al., 2009; Warkocki et al., 2015; Fourmann et al., 2016). In addition, 
swapping experiments have shown that in some cases G-patch domains can substitute for 
each other in activating the helicase (Banerjee et al., 2015; Fourmann et al., 2016). On the 
other hand, the effects exerted by G-patch proteins are likely to be more complex than 
simply acting as activators of RNA helicases, as demonstrated for Spp382, whose  
C-terminal region lacking the G-patch domain is also essential for the regulation of Prp43 
(Fourmann et al., 2017). This is further supported by the finding that overexpression of 
certain G-patch cofactors of Prp43 leads to a relocalization of the helicase and to its 
withdrawal from specific functions, indicating that G-patch proteins control the distribution 
of the RNA helicase between different pathways (Heininger et al., 2016). 
1.5.2 Human G-patch proteins 
The human genome encodes 22 proteins that have a G-patch domain in their sequence as 
indicated by the UniProt database (Apweiler et al., 2004). In addition, G-patch domains are 
found as part of endogenous retroviral elements, which are remnants of ancient retroviral 
infections that were preserved in the genome. However, the expression of these human 
endogenous retroviruses is suppressed in most cases and there is limited knowledge of 
their function (Hanke et al., 2016; Garcia-Montojo et al., 2018). The 22 human G-patch 
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proteins comprise a heterogeneous group of proteins, some of which contain additional 
defined domains, such as the RRM and R3H domains, which are involved in RNA binding 
(Figure 1.4A). Sequence alignment of the human G-patch domains revealed the presence 
of most of the conserved elements described originally for the G-patch motif, with the first 
and fourth glycine, as well as the aromatic amino acid and one hydrophobic residue, being 
found in all proteins (Figure 1.4B). 
Figure 1.4. Characteristics and sequence alignment of human G-patch proteins. (A) The human genome 
encodes 22 G-patch proteins that differ in size and, in some cases, contain additional domains apart from the 
G-patch domain. Abbreviations: FHA - forkhead-associated domain; SURP (SWAP) - suppressor-of-white-
apricot and PRP21 motif; CID - CTD (C-terminal domain of RNA polymerase II)-interaction domain; ANK - 
ankyrin repeat domain; KOW - Kyprides, Ouzounis, Woese motif; RRM - RNA recognition motif; ZNF - zinc 
finger motif; DRBM - double-stranded RNA-binding motif. The information in this panel is based on the UniProt 
database. (B) Primary sequence alignment of the G-patch domain regions corresponding to the 22 human G-
patch proteins indicated in (A). The conserved amino acids are marked below the panel and the residues that 
correspond to the consensus sequence of the G-patch domain are highlighted in blue. The symbols indicate 
fully conserved residues (*), conservation between residues of strongly similar properties (:) and conservation 
between residues of weakly similar properties (.). The alignment was generated using MUSCLE (Edgar, 2004). 
Compared to yeast G-patch proteins, much less is known about the role of human G-patch 
proteins as regulators of RNA helicases. Only CMTR1, GPATCH2, RBM5 and ZGPAT have 
been described as cofactors that stimulate the activity of the RNA helicase DHX15, which 
is the homologue of yeast Prp43 (Lin et al., 2009; Niu et al., 2012; Chen et al., 2017; Inesta-
Vaquera et al., 2018; Toczydlowska-Socha et al., 2018). Furthermore, the G-patch proteins 
TFIP11 and PINX1 were also shown to bind DHX15, whereas GPKOW associates with 
DHX16 (Yoshimoto et al., 2009; Chen et al., 2014; Zang et al., 2014). These interactions 
are conserved from yeast where their homologues Spp382, Pxr1 and Spp2 are known to 
bind and activate Prp43 and Prp2 respectively, implying that the stimulatory role of these 
cofactors is preserved as well. For the other human G-patch proteins, there is no information 
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regarding their action as helicase cofactors, and in most cases, there is also limited 
knowledge of their function. 
For AGGF1, multiple cellular functions have been proposed, including as an angiogenesis 
factor and as a transcriptional regulator (Tian et al., 2004; Major et al., 2008). The G-patch 
proteins CHERP and RBM17 were suggested to form a subcomplex with U2SURP that 
regulates the alternative splicing of a subset of genes, most of which encode  
RNA-processing factors (De Maio et al., 2018). Interestingly, CMTR1 is the only protein that 
contains a catalytic domain in combination with a G-patch domain and was shown to 
methylate the first transcribed nucleotide of mRNAs at the ribose 2′-OH position, thus 
contributing to the formation of the mRNA cap (Smietanski et al., 2014). CMTR1 was also 
described as a cofactor that stimulates the activity of the RNA helicase DHX15. Although 
the exact role of this complex was not determined, expression of a CMTR1 mutant that does 
not interact with DHX15 led to a more efficient translation of a subset of mRNAs, which in 
turn impaired cell growth (Inesta-Vaquera et al., 2018). Conversely, DHX15 might be 
required to facilitate the methylation activity of CMTR1 on highly structured RNA substrates 
(Toczydlowska-Socha et al., 2018). GPATCH1 was detected in the spliceosomal C complex 
and was also found to interact with centrosomal proteins, but it is not clear if these are 
related or separate functions (Agafonov et al., 2011; Gupta et al., 2015). GPATCH2 was 
shown to stimulate the ATPase activity of DHX15 and was suggested to participate in 
ribosome biogenesis similar to the related yeast G-patch protein Sqs1 (Lin et al., 2009; 
Robert-Paganin et al., 2015). GPATCH3 was recently described as a negative regulator of 
the antiviral immune response (Nie et al., 2017). GPKOW associates with the RNA helicase 
DHX16 and probably regulates its function in splicing similar to the interaction of their yeast 
homologues (Zang et al., 2014). Interestingly, it was suggested that the RNA binding affinity 
of GPKOW is regulated by phosphorylation (Aksaas et al., 2011). NKRF was originally 
described as a transcriptional repressor of NF-kB target genes (Nourbakhsh and Hauser, 
1999). During the course of this work, an independent study reported that NKRF acts as a 
regulator of nucleolar homeostasis and pre-rRNA processing in heat shock conditions 
(Coccia et al., 2017). These results are in accordance with some of the findings of the 
present study, which are presented in the following sections. PINX1 was shown to interact 
with DHX15 and to substitute the function of its yeast homologue Pxr1 in ribosome 
biogenesis, raising the possibility that it performs a similar role in human cells together with 
the RNA helicase (Chen et al., 2014). Furthermore, PINX1 was described as a telomerase 
inhibitor and was also suggested to regulate chromosome segregation, but it is not known 
if these functions involve DHX15 as well (Zhou and Lu, 2001; Yuan et al., 2009). The highly 
similar proteins RBM5, RBM6 and RBM10 were suggested to regulate the alternative 
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splicing of distinct sets of pre-mRNAs (Bechara et al., 2013). While RBM5 and RBM10 have 
been detected in spliceosome preparations, RBM6 was not found in any spliceosomal 
complex so far (Agafonov et al., 2011). Furthermore, RBM5 was shown to stimulate the 
activity of DHX15, leading to the suggestion that these two proteins function together in 
splicing (Niu et al., 2012). SON is a splicing factor that regulates both intron removal in 
constitutively spliced transcripts and the alternative splicing of specific genes involved in 
essential processes such as cell cycle regulation, apoptosis or pluripotency maintenance 
(Ahn et al., 2011; Lu et al., 2013; Hickey et al., 2014). In addition, SON was linked to 
transcriptional regulation at specific promoters. The two related proteins SUGP1 and 
SUGP2 are putative splicing factors (Utans and Kramer, 1990; Sampson and Hewitt, 2003; 
Agafonov et al., 2011). Likewise, TFIP11 is involved in splicing where it is suggested to act 
together with DHX15 in the disassembly of intron lariat spliceosomes similar to their yeast 
counterparts (Yoshimoto et al., 2009). ZGPAT was recently described as a component of a 
U4/U6.U5 tri-snRNP complex intermediate that also contains DHX15 and was shown to 
stimulate the activity of the helicase, which might be required for maturation of the tri-snRNP 
(Chen et al., 2017). For GPANK1, GPATCH4, GPATCH8 and GPATCH11 there is no 
information available about their cellular functions. 
1.5.3 G-patch proteins and RNA helicases in disease 
Due to their central role in fundamental cellular pathways, dysregulation of the activity of 
RNA helicases often leads to disease, and several RNA helicases have already been 
implicated in cancer as a result of altered expression levels or mutations (Fuller-Pace, 2013; 
Robert and Pelletier, 2013). In addition, the function of RNA helicases can be disrupted by 
alterations of their protein cofactors. For example, GPATCH2 was found to be 
overexpressed in breast cancer and, based on its role in stimulating the activity of DHX15, 
it was suggested that this would lead to hyperactivation of the helicase and promote cancer 
cell growth (Lin et al., 2009). Furthermore, a recurrent mutation in DHX15, which involves 
substitution of an arginine by a glycine residue (R222G), was detected in several cases of 
acute myeloid leukaemia. This mutant helicase showed reduced binding to the G-patch 
protein TFIP11 and its overexpression impaired splicing, implying that disruption of the 
DHX15-TFIP11 interaction might contribute to disease (Faber et al., 2016). Other diseases 
caused by mutations of RNA helicases or G-patch proteins were also identified (Tian et al., 
2004; Kaneko et al., 2011; Steimer and Klostermeier, 2012). For example, nonsense and 
frame-shift mutations in the RBM10 gene were shown to cause TARP syndrome (Talipes 
equinovarus, atrial septal defect, Robin sequence and persistent left superior vena cava) 
(Gripp et al., 2011). One such mutation in a patient led to the deletion of a segment of the 
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G-patch protein and induced changes in alternative splicing that might explain the molecular 
basis of the disorder (Wang et al., 2013). 
In addition to their implication in cancer and other diseases, RNA helicases play a role in 
viral infection, as most viruses do not encode their own RNA helicase but instead rely on 
host helicases for replication. Multiple cellular RNA helicases were found to be recruited by 
viruses to support various stages of their replication cycle, yet the mechanisms involved 
remain elusive (Ranji and Boris-Lawrie, 2010; Steimer and Klostermeier, 2012). 
Interestingly, some retroviruses encode a G-patch domain, raising the possibility that they 
use it to co-opt host RNA helicases for their purposes (Gifford et al., 2005; Jern et al., 2005). 
Furthermore, the G-patch domain expressed by the Mason-Pfizer monkey virus was found 
to be required for the activity of the reverse transcriptase and for viral infectivity, but it is not 
known if any RNA helicase is implicated in this function (Bauerova-Zabranska et al., 2005; 
Krizova et al., 2012). Overall, these findings highlight the importance of understanding the 





1.6 Scope of the thesis 
RNA helicases are essential regulators of the structure and function of RNA and  
RNA-protein complexes and participate in fundamental pathways such as ribosome 
biogenesis, splicing and translation. These enzymes share a conserved helicase core that 
binds RNA in a non-sequence specific manner, indicating that substrate recognition is 
regulated through other means. Furthermore, the majority of RNA helicases in higher 
eukaryotes are suggested to have more than one cellular role, but the mechanisms that 
determine their distribution between different functions are not known. 
In recent years, regulation by trans-acting proteins, termed cofactors, has emerged as a 
powerful means to control the activity of RNA helicases. Among the diverse helicase 
cofactors that have been identified so far, several of them belong to the G-patch protein 
family. These proteins contain a characteristic glycine-rich motif known as a G-patch 
domain that is essential for their function as helicase regulators. 
In order to understand the regulation of RNA helicases by G-patch protein cofactors, the 
complete inventory of such complexes needs to be identified. Furthermore, to decipher the 
functions of RNA helicases whose activities are modulated by interacting proteins, these 
enzymes have to be studied together with their cofactors. However, despite the large 
number of G-patch proteins expressed in human cells, only few of them have been 
functionally characterized and their role as RNA helicase cofactors has remained largely 
unexplored. 
In this context, the goals of the present study were to: 
• Identify the interacting RNA helicase(s) of the 22 human G-patch proteins; 
• Characterize the identified G-patch protein-RNA helicase interactions in vitro to 
assess the effects that the cofactors exert on the activity of the helicase; 
• Determine the subcellular localization of all human G-patch proteins; 
• Functionally characterize the G-patch protein-RNA helicase complexes in a global 
manner using genome-wide approaches; 
• Explore the function of selected G-patch protein-RNA helicase complexes in depth. 
Together, these complementary strategies aimed to establish the human G-patch protein 
family as regulators of RNA helicases and to provide key insights into the mode of 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and buffers 
Standard laboratory reagents were purchased from Sigma-Aldrich, Carl Roth and 
Applichem. All restriction enzymes used in this study were obtained from Thermo Fisher. 
Other specific reagents used in this study together with their supplier are listed in Table 2.1 
and the composition of standard solutions and buffers is given in Table 2.2. 
Table 2.1. Specific reagents used in this study 
Reagent Supplier 
[g-32P]-ATP and [32P]-orthophosphate PerkinElmer 
Anti-FLAG M2 Magnetic Beads Sigma-Aldrich 
Blasticidin S Hydrochloride Applichem 
cOmplete His-Tag Purification Resin Roche 
cOmplete Mini Protease Inhibitor Cocktail Roche 
Coomassie Plus (Bradford) assay kit Thermo Fisher 
Dulbecco’s Modified Eagle Medium Thermo Fisher 
Fetal Bovine Serum Superior Merck 
FLAG Peptide Sigma-Aldrich 
Hygromycin B Applichem 
Immobilon Western Chemiluminescent HRP Substrate Merck 
Isopropyl-b-D-thiogalactoside (IPTG) Sigma-Aldrich 
LightCycler 480 SYBR Green I Master kit Roche 
Lipofectamine RNAiMAX Thermo Fisher 
b-Nicotinamide adenine dinucleotide reduced (NADH) Sigma-Aldrich 
Ni-NTA Agarose Resin Qiagen 
Nuclease-free H2O Qiagen 
NuPAGE LDS Sample Buffer (4X) Thermo Fisher 
Opti-MEM Thermo Fisher 
Penicillin-Streptomycin Thermo Fisher 
PfuTurbo DNA polymerase Bohnsack lab 
Phosphoenolpyruvate Sigma-Aldrich 
Phusion High-Fidelity DNA polymerase Thermo Fisher 
Poly-L-lysine solution (0.1%) Sigma-Aldrich 
Protein G Sepharose GE Healthcare 
Proteinase K Roche 
Pyruvate kinase/lactic dehydrogenase Sigma-Aldrich 
RiboLock Ribonuclease Inhibitor Thermo Fisher 
(continued on next page) 
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(Table 2.1 continued) 
RNace-It Ribonuclease Cocktail Agilent 
RNase H NEB 
RNasin Ribonuclease Inhibitor Promega 
SuperScript III Reverse Transcriptase Thermo Fisher 
T4 DNA Ligase Thermo Fisher 
T4 Polynucleotide Kinase Thermo Fisher / NEB 
T4 RNA Ligase 1 NEB 
T4 RNA Ligase 2, Deletion Mutant Epicentre 
TaKaRa LA Taq DNA polymerase Clontech 
4-Thiouridine Sigma-Aldrich 
TRI Reagent Sigma-Aldrich 
Trypsin-EDTA (0.25%) Thermo Fisher 
TSAP Thermosensitive Alkaline Phosphatase Promega 
TURBO DNase Thermo Fisher 
VECTASHIELD Antifade Mounting Medium with DAPI Vector Labs 
X-tremeGENE 9 DNA transfection reagent Roche 
 
Table 2.2. Composition of standard solutions and buffers 
Solution / buffer Composition 
PBS 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4 
TBS 25 mM Tris-HCl pH 7.4, 137 mM NaCl, 2.7 mM KCl 
TBE 90 mM Tris, 90 mM boric acid, 2.55 mM EDTA 
SDS-PAGE resolving gel buffer 375 mM Tris-HCl pH 8.8, 3.5 mM SDS 
SDS-PAGE stacking gel buffer 125 mM Tris-HCl pH 6.8, 3.5 mM SDS 
SDS-PAGE running buffer 25 mM Tris, 0.19 M glycine, 0.05% SDS 
Western blotting transfer buffer 25 mM Tris, 0.19 M glycine, 20% methanol 
NuPAGE MES running buffer 50 mM MES, 50 mM Tris, 0.1% SDS, 1 mM EDTA 
NuPAGE western blotting transfer buffer 25 mM bicine, 25 mM Bis-Tris, 1 mM EDTA 
BTPE 10 mM PIPES, 30 mM Bis-Tris, 1 mM EDTA 
SSC 150 mM NaCl, 15 mM sodium citrate 
SES1 0.25 M sodium phosphate pH 7.0, 7 % SDS, 1 mM EDTA 
DNA loading dye (6X) 60% glycerol, 60 mM EDTA, 0.2% xylene cyanol, 0.2% bromophenol blue 
SDS loading dye (4X) 200 mM Tris-HCl pH 6.8, 8% SDS, 50 mM EDTA, 4% 2-mercaptoethanol, 0.08% bromophenol blue, 40% glycerol 
Formamide loading dye (2X) 80% formamide, 1 mM EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol 
Glyoxal loading dye 72 ml DMSO, 24 ml glyoxal, 14.4 ml BTPE (10X), 7.2 ml 80% glycerol, 20 µg/ml ethidium bromide 
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2.1.2 Plasmids 
Table 2.3. Mammalian expression plasmids used in this study 
Construct CDS Vector Source ID 
AGGF1-His6-2xFLAG NM_018046 pcDNA5/FRT/TO This study p1339 
CHERP-His6-2xFLAG NM_006387 pcDNA5/FRT/TO This study p1338 
CMTR1-His6-2xFLAG NM_015050 pcDNA5/FRT/TO This study p1302 
His6-2xFLAG-DHX15 NM_001358 pcDNA5/FRT/TO Bohnsack lab p420 
His6-2xFLAG-DHX151-698 NM_001358 pcDNA5/FRT/TO This study p1253 
His6-2xFLAG-DHX15-siRNA resistant NM_001358 pcDNA5/FRT/TO This study p1038 
His6-2xFLAG-DHX15E261Q-siRNA resistant NM_001358 pcDNA5/FRT/TO This study p1309 
DHX35-His6-2xFLAG NM_021931 pcDNA5/FRT/TO This study p1472 
DHX351-597-His6-2xFLAG NM_021931 pcDNA5/FRT/TO This study p1536 
His6-2xFLAG - pcDNA5/FRT/TO Bohnsack lab p187 
GPANK1-His6-2xFLAG NM_001199237 pcDNA5/FRT/TO This study p1326 
GPATCH1-His6-2xFLAG NM_018025 pcDNA5/FRT/TO This study p1327 
GPATCH1199-931-His6-2xFLAG NM_018025 pcDNA5/FRT/TO This study p1593 
GPATCH2-His6-2xFLAG NM_018040 pcDNA5/FRT/TO This study p1328 
GPATCH3-His6-2xFLAG NM_022078 pcDNA5/FRT/TO This study p1329 
GPATCH4-His6-2xFLAG KJ902705 pcDNA5/FRT/TO This study p1370 
GPATCH8-His6-2xFLAG NM_001002909 pcDNA5/FRT/TO This study p1487 
GPATCH11-His6-2xFLAG AK294697 pcDNA5/FRT/TO This study p1330 
GPKOW-His6-2xFLAG NM_015698 pcDNA5/FRT/TO This study p1332 
His6-2xFLAG-NKRF NM_001173487 pcDNA5/FRT/TO This study p1036 
His6-2xFLAG-NKRF110-705 NM_001173487 pcDNA5/FRT/TO This study p1169 
His6-2xFLAG-NKRFG1-6A NM_001173487 pcDNA5/FRT/TO This study p1248 
PINX1-His6-2xFLAG NM_017884 pcDNA5/FRT/TO This study p1258 
RBM5-His6-2xFLAG NM_005778 pcDNA5/FRT/TO This study p1340 
His6-2xFLAG-RBM6 NM_005777 pcDNA5/FRT/TO This study p1603 
RBM10-His6-2xFLAG NM_005676 pcDNA5/FRT/TO This study p1369 
RBM17-His6-2xFLAG NM_001145547 pcDNA5/FRT/TO This study p1334 
SON-His6-2xFLAG NM_138927 pcDNA5/FRT/TO This study p1371 
His6-2xFLAG-SUGP1 NM_172231 pcDNA5/FRT/TO This study p1372 
SUGP2-His6-2xFLAG NM_001017392 pcDNA5/FRT/TO This study p1337 
TFIP11-His6-2xFLAG NM_001008697 pcDNA5/FRT/TO This study p1335 
His6-2xFLAG-XRN2 NM_012255 pcDNA5/FRT/TO Bohnsack lab p810 
GFP-XRN2 NM_012255  pcDNA5/FRT/TO Bohnsack lab p811 
ZGPAT-His6-2xFLAG NM_001195653 pcDNA5/FRT/TO This study p1333 
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Table 2.4. Plasmids for recombinant protein expression used in this study 
Construct CDS Vector Source ID 
ZZ-AGGF1_619-665-His7 NM_018046 pQE-80 (A15) This study p1501 
ZZ-CHERP_841-891-His7 NM_006387 pQE-80 (A15) This study p1506 
ZZ-CMTR1_87-133-His7 NM_015050 pQE-80 (A15) This study p1505 
MBP-DHX15-His10 NM 001358 pQE-80 (A102) Bohnsack lab p1102 
MBP-DHX15E261Q-His10 NM 001358 pQE-80 (A102) This study p1310 
MBP-DHX16-His10 NM_003587 pQE-80 (A102) This study p1481 
ZZ-GPANK1_255-301-His7 NM_001199237 pQE-80 (A15) This study p1513 
ZZ-GPATCH1_152-198-His7 NM_018025 pQE-80 (A15) This study p1491 
ZZ-GPATCH2_467-513-His7 NM_018040 pQE-80 (A15) This study p1496 
ZZ-GPATCH3_410-458-His7 NM_022078 pQE-80 (A15) This study p1516 
ZZ-GPATCH4_11-57-His7 KJ902705 pQE-80 (A15) This study p1492 
ZZ-GPATCH8_40-86-His7 NM_001002909 pQE-80 (A15) This study p1503 
ZZ-GPATCH11_69-115-His7 AK294697 pQE-80 (A15) This study p1502 
ZZ-GPKOW_164-210-His7 NM_015698 pQE-80 (A15) This study p1495 
ZZ-GPKOW-His7 NM_015698 pQE-80 (A15) This study p1417 
ZZ-NKRF_551-596-His7 NM_001173487 pQE-80 (A15) This study p1517 
MBP-NKRF-His10 NM_001173487 pQE-80 (A102) This study p1040 
ZZ-PINX1_26-72-His7 NM_017884 pQE-80 (A15) This study p1489 
ZZ-RBM5_743-789-His7 NM_005778 pQE-80 (A15) This study p1499 
ZZ-RBM6_1051-1097-His7 NM_005777 pQE-80 (A15) This study p1497 
ZZ-RBM10_858-904-His7 NM_005676 pQE-80 (A15) This study p1514 
ZZ-RBM17_235-283-His7 NM_001145547 pQE-80 (A15) This study p1498 
ZZ-SON_2305-2351-His7 NM_138927 pQE-80 (A15) This study p1512 
ZZ-SUGP1_562-609-His7 NM_172231 pQE-80 (A15) This study p1490 
ZZ-SUGP2_1011-1057-His7 NM_001017392 pQE-80 (A15) This study p1504 
ZZ-TFIP11_149-195-His7 NM_001008697 pQE-80 (A15) This study p1515 
ZZ-ZGPAT_313-359-His7 NM_001195653 pQE-80 (A15) This study p1500 
 
2.1.3 Small interfering (si)RNAs 
Table 2.5. siRNAs used in this study 
Name / target gene Sense sequence (5′-3′) Reference 
siAGGF1 GUCGGAAGAUGUUGGAGAA(dTdT) Major et al., 2008 
siCHERP GGUUUAGGUCUAGAAAGAAGAAU(dAdC) Sasaki-Osugi et al., 2013 
siCMTR1 GUGAAGGAUUGGGUAAAUA(dTdT) Schuberth-Wagner et al., 2015 
siDHX15_1  GGUUAUAGUUAUGAGCGCUACUCUA(dTdT) Mosallanejad et al., 2014 
siDHX15_2 GAGAAGGAGUUGCGAGCUU(dTdT) Dharmacon 
(continued on next page) 
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(Table 2.5 continued) 
siGPANK1 GGACUUACAUGAACCUCGA(dTdT) Qiagen 
siGPATCH3 GCAUGAAGUUUCGGACAGA(dTdT) Qiagen 
siGPATCH8 CCGUGUCCUAGAAGUAGAA(dTdT) Qiagen 
siGPATCH11 GCUAUAUUGUGAUACGUGA(dTdT) Qiagen 
siGPKOW CGGCCGCACCUUCAAUCAA(dTdT) Qiagen 
siNKRF_1 GGCUAUGCUUGUGAAGUUA(dTdT) Tafforeau et al., 2013 
siNKRF_2 GUAUUGAAGUUAGAGUUGU(dTdT) Tafforeau et al., 2013 
siNT (non-target) UCGUAAGUAAGCGCAACCC(dTdT) Elbashir et al., 2001 
siRBM5 AACUCGCAAUACUACUAUA(dTdT) Qiagen 
siRBM6 GAGUCAUGUUUGCUCGAUA(dTdT) Qiagen 
siRBM10 CAACGUGCGCGUCAUAAAG(dTdT) This study 
siRBM17 GCGUAAAGACAGACAUGAA(dTdT) Qiagen 
siSON GCAUUUGGCCCAUCUGAGA(dTdT) Ahn et al., 2011 
siSUGP1 CGAUAAGAAUAGCAGGGAA(dTdT) Qiagen 
siSUGP2 GCGAGCAGAUCACAGGGUA(dTdT) Qiagen 
siTFIP11 GGAUUAGCAAGAAGCUCAC(dTdT) Stanek et al., 2008 
siXRN2_1 GGGAAGAAAUAUUGGCAAA(dTdT) West et al., 2004 
siXRN2_2 AAGAGUACAGAUGAUCAUG(dTdT) West et al., 2004 
siZGPAT CGUUCUUCCUGGAGGGAAA(dTdT) Qiagen 
 
2.1.4 RNA oligonucleotides 
Table 2.6. RNA oligonucleotides used in this study 
















2.1.5 Northern blotting probes 
Table 2.7. Northern blotting probes used in this study 
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U1 snRNA GGTCAGCACATCCGGAGTGC 
U2 snRNA CATTTAATATATTGTCCTCGG 
U4 snRNA CCAGTGCCGACTATATTGC 
U5 snRNA GACTCAGAGTTGTTCCTCTCC 
U6 snRNA GAACGCTTCACGAATTTGCGTGTC 
 
2.1.6 Antibodies 
Table 2.8. Primary antibodies used in this study 
Target Supplier 
DHX9 Bethyl (A300-854A) 
DHX15 Bethyl (A300-390A) 
DHX16 Bethyl (A301-537A) 
DDX21 Bethyl (A300-628A) 
DHX35 Abcam (ab179442) 
Fibrillarin Santa Cruz Biotechnology (sc-25397) 
FLAG M2 Sigma-Aldrich (F3165) 
NKRF Bethyl (A304-016A) 
NSUN5 Santa Cruz Biotechnology (sc-376147) 
Nucleophosmin Sigma-Aldrich (B0556) 
PCNA Santa Cruz Biotechnology (sc-56) 
PES1 Bethyl (A300-903A) 
PWP2 GeneTex (GTX105344) 
RPL15 Aviva Systems Bio (ARP65141) 
RPS3A ProteinTech (14123-1-AP) 
a-Tubulin Sigma-Aldrich (T6199) 
UTP14A ProteinTech (11474-1-AP) 
WBSCR22 Abgent (AP20254b) 
XRN2 Bethyl (A301-103A) 
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Table 2.9. Secondary antibodies used in this study 
Secondary antibody Supplier 
Goat anti-mouse - Alexa Fluor 488-conjugated Jackson ImmunoResearch 
Goat anti-rabbit - Alexa Fluor 488-conjugated Jackson ImmunoResearch 
Goat anti-mouse - Alexa Fluor 594-conjugated Jackson ImmunoResearch 
Goat anti-rabbit - Alexa Fluor 594-conjugated Jackson ImmunoResearch 
Goat anti-mouse - HRP-conjugated Jackson ImmunoResearch 
Goat anti-rabbit - HRP-conjugated Jackson ImmunoResearch 
 
2.2 Standard molecular biology methods 
2.2.1 Molecular cloning 
Cloning of the vector constructs used in this study was performed using standard molecular 
biology procedures (Sambrook and Russell, 2001). First, the coding sequences of the 
proteins of interest were amplified by PCR with Phusion polymerase (Thermo Fisher) either 
from existing plasmids or from HEK293 or HeLa cDNA. The general PCR reaction 
conditions and the primers used are listed in Table 2.10 and in Supplementary Table S1. 
Table 2.10. PCR parameters for cloning 
PCR reaction components (cloning) 
5X buffer 10 μl 
dNTP mix (10 mM) 1 μl 
Forward primer (10 μM) 1 μl 
Reverse primer (10 μM) 1 μl 
Template (cDNA or plasmid DNA) 2 μl 
H2O 34.5 μl 
Phusion polymerase 0.5 μl 
PCR reaction conditions (cloning) 
98°C (initial denaturation) 2 min x1 
98°C (denaturation) 30 sec 
x35 50-58°C (annealing) 40 sec 
72°C (elongation) 1 min/kb 
72°C (final elongation) 10 min x1 
 
Ten percent of the PCR reaction was checked by agarose gel electrophoresis for the correct 
product size and the remainder was purified with the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel) following manufacturer’s instructions. The vector backbones and the 
purified PCR products were digested with the corresponding restriction enzymes (Thermo 
Fisher) for 2 h at 37°C and gel-purified using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel). Ligation reactions containing 50 ng of digested vector and five-fold 
molar excess of the PCR insert were carried out with 5 U of T4 DNA Ligase (Thermo Fisher) 
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either at 22°C for 1 h or at 16°C overnight. Afterwards, the ligation mix was transformed into 
chemically competent E. coli cells as described in 2.2.3 and plasmid DNA was extracted 
from single colonies and analyzed by Sanger sequencing to confirm cloning of the correct 
construct (2.2.4). 
2.2.2 Site-directed mutagenesis 
Primers for site-directed mutagenesis were designed with approximately 20 bases 
surrounding the region containing the desired mutations on each side (Supplementary 
Table S2). PCR reactions consisting of 50 ng plasmid DNA template and 125 ng each of 
the forward and reverse primers were carried out using the parameters listed in Table 2.11. 
Afterwards, the parental wild-type methylated plasmids were digested with 10 U of DpnI for 
2 h at 37°C and the reactions were precipitated for 1 h at -80°C with 0.3 M sodium acetate 
pH 5.3 and 3 volumes of 100% ethanol. After centrifugation for 20 min at 20,000 g, the 
pellets were washed with 70% ethanol, resuspended in H2O and transformed in DH5a cells 
(2.2.3). Plasmid DNA extraction and verification of the mutagenesis by Sanger sequencing 
are described in 2.2.4.  
Table 2.11. PCR parameters for site-directed mutagenesis 
PCR reaction components (mutagenesis) 
10X buffer 5 μl 
dNTP mix (10 mM) 1 μl 
Forward primer 125 ng 
Reverse primer 125 ng 
Template (50 ng) 1 μl 
H2O up to 50 μl 
PfuTurbo polymerase 0.5 μl 
PCR reaction conditions (mutagenesis) 
95°C (initial denaturation) 5 min x1 
95°C (denaturation) 30 sec 
x12-18 55°C (annealing) 1 min 
68°C (elongation) 1 min/kb 
 
2.2.3 Transformation of E. coli 
Chemically competent E. coli strains were thawed on ice, incubated for 20 min on ice with 
the DNA sample and transformed by heat-shock for 1 min at 42°C. Afterwards, the cells 
were briefly chilled on ice, LB media was added and samples were incubated for 1 h at 
37°C with shaking. The bacteria were plated on agar plates containing the appropriate 
selection antibiotics (100 µg/ml ampicillin with or without 34 µg/ml chloramphenicol) and 
grown overnight at 37°C. E. coli strains used in this study were DH5a (Thermo Fisher) for 
cloning and plasmid propagation, and BL21 (DE3) pLysS (Novagen) and BL21 (DE3) 
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CodonPlus-RIL (Agilent) for recombinant protein expression. Cloning of GPATCH8-His6-
2xFLAG was done using CopyCutter EPI400 cells (Epicentre) due to the instability of the 
full-length GPATCH8 insert. 
2.2.4 Plasmid DNA extraction 
Plasmid DNA was extracted using the NucleoSpin Plasmid kit (Macherey-Nagel) following 
manufacturer’s protocol. Single colonies obtained after bacterial transformation were used 
to inoculate LB cultures containing selection antibiotics, which were grown overnight at 
37°C. The bacterial cultures were centrifuged at 20,000 g for 1 min and the cell pellet was 
resuspended in 250 µl of Solution A1. For alkaline cell lysis, 250 µl of Solution A2 were 
added, the samples were gently mixed and incubated for 5 min at room temperature. The 
reactions were neutralized with 300 µl Solution A3 and centrifuged at 20,000 g for 10 min. 
The soluble fraction containing plasmid DNA was added to a silica spin column and 
centrifuged for 1 min at 20,000 g. The column was washed with 700 µl Solution A4 and 
centrifuged as before, followed by another centrifugation at 20,000 g for 2 min to remove 
the residual ethanol. To elute the plasmid DNA, 30 µl H2O were added and the columns 
were incubated for 1 min at room temperature followed by centrifugation at 20,000 g for 1 
min. The purified plasmids were verified for the presence of the correct construct by Sanger 
sequencing (Eurofins Genomics) and the results were analyzed with the DNASTAR 
Lasergene 10 SeqMan software. 
 
2.3 Cell culture-based methods 
2.3.1 Cell culture growth conditions 
HeLa CCL-2 (ATCC) and HEK293 Flp-In T-REx (Thermo Fisher) cells were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM; Thermo Fisher) supplemented with 10% fetal 
bovine serum (FBS; Merck) and penicillin-streptomycin (1:100 dilution; Thermo Fisher) at 
37°C in a humidified atmosphere with 5% CO2. Cells were passaged every 2-3 days at a 
ratio of 1:5 or 1:10 using 0.25% Trypsin-EDTA (Thermo Fisher). Cell lines used in this study 
were checked for mycoplasma contamination with the Mycoplasmacheck service (Eurofins 
Genomics). 
2.3.2 Generation of inducible stable cell lines  
For generation of stable cell lines, HEK293 Flp-In T-REx cells (Thermo Fisher), which have 
an FRT site integrated into their genome, were plated in antibiotic-free media at a 
concentration of 350,000 cells/well in a 6-well plate. The following day, two wells for each 
construct were transfected with the pOG44 plasmid encoding the Flp recombinase and with 
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the appropriate pcDNA5/FRT/TO-derived plasmid (Table 2.3) to enable site-specific 
integration of the transgene at the FRT locus. Transfection was carried out with  
X-tremeGENE 9 DNA transfection reagent (Roche) and 100 µl of transfection mix 
containing 91 µl Opti-MEM (Thermo Fisher), 9 µl transfection reagent, 0.6 µg pcDNA5 
plasmid and 1.8 µg pOG44 plasmid were added to each well. The selection was started  
48 h after transfection with 82.4 µg/ml Hygromycin B (Applichem) and 10 µg/ml Blasticidin 
S Hydrochloride (Applichem), and was maintained for 2 weeks. Afterwards, cells were 
generally cultured in medium without hygromycin and blasticidin, and tested regularly for 
expression of the transgene. To confirm expression of the encoded proteins, cells were 
induced for 24 h with 1 µg/ml tetracycline, harvested with trypsin, lysed in 4X SDS loading 
dye and analyzed by SDS-PAGE and western blotting (2.4.1). 
2.3.3 Gene knockdown with siRNAs 
Knockdowns were carried out either in HeLa or HEK293 cells with Lipofectamine RNAiMAX 
(Thermo Fisher) following manufacturer’s protocol for reverse transfections. In general,  
20-50 nM siRNAs (Table 2.5) were mixed with 5 µl transfection reagent and 500 µl  
Opti-MEM (Thermo Fisher) in the well of a 6-well plate and incubated for 15 min. Afterwards, 
the appropriate number of cells diluted in antibiotic-free media (e.g. approximately 120,000 
HeLa cells or 275,000 HEK293 cells for a 3-day knockdown) were added to each well and 
knockdowns were carried out for 3-5 days as specified. The knockdowns were scaled up 
accordingly when required. 
2.3.4 Immunofluorescence microscopy 
Glass coverslips were coated with 0.01% poly-L-lysine (Sigma-Aldrich) for 15 min at room 
temperature, washed with H2O and sterilized with UV light. The coverslips were placed in 
wells of 24-well plates and 25,000-50,000 cells were plated per well depending on the 
experiment. Cells were generally grown on coverslips for 2 days, and in the case of HEK293 
stable cell lines, expression of the transgene was induced for 24 h with 1 µg/ml tetracycline. 
All sample preparation steps for microscopy were carried out at room temperature. First, 
cells were fixed with 2.5% paraformaldehyde in PBS for 15 min and then washed two times 
with PBS for 5 min. Permeabilization was done for 20 min with 0.1% Triton X-100 in PBS 
and afterwards, cells were blocked for 1.5 h with PBS containing 1% FBS (Merck) and 0.1% 
Triton X-100. Protein localization was determined by staining with antibodies against the 
respective target or against the FLAG tag. Antibodies against markers for different cellular 
structures (nucleoli - UTP14A/NSUN5, centrosome - PCM1) were used for counterstaining. 
After blocking, the cells were incubated with the primary antibodies for 2 h, washed three 
times for 10 min each with PBS and stained for 1.5 h with Alexa Fluor 488 and  
594-conjugated secondary antibodies (Table 2.9). The cells were then washed with PBS as 
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before and mounted on microscope slides using VECTASHIELD Antifade Mounting 
Medium with DAPI (Vector Labs) for visualization of nuclei. The slides were imaged using 
a ZEISS LSM 510 META laser scanning microscope. For the GFP-XRN2 localization 
studies, the seeding of the cells was coupled with setting up siRNA-mediated knockdowns 
and the cells were fixed and subjected to immunofluorescence detection with an UTP14A 
antibody as above, while the GFP signal was visualized directly. 
 
2.4 Protein analysis methods 
2.4.1 SDS-PAGE and western blotting 
For SDS-polyacrylamide gel electrophoresis (SDS-PAGE), protein samples were mixed 
with 4X SDS loading dye and denatured at 95°C for 10 min. Electrophoresis was carried 
out using 25 mA/gel in a discontinuous system with different composition and pH of the 
resolving and stacking gel buffers (Table 2.2). After the run, the gels were stained for 1 h 
with a Coomassie solution (0.1% Coomassie R-250, 10% acetic acid, 40% methanol) 
followed by destaining with a solution of 10% acetic acid and 20% methanol to enable direct 
protein visualization. 
Alternatively, the samples were transferred onto a Hybond P 0.45 PVDF blotting membrane 
(GE Healthcare) in a wet-transfer system. The membrane was first activated in 100% 
methanol for 2 min and the transfer was carried out for 75 min at 100 V in western blotting 
transfer buffer. For experiments involving detection of the G-patch protein SON, which has 
a molecular weight of more than 260 kDa, the buffer was supplemented with 0.05% SDS 
and the transfer was done for 16 h at 25 V. After transfer, the membrane was blocked for  
1 h at room temperature in 5% milk in TBS with 0.1% Tween-20 (TBS-T), followed by 
incubation with primary antibodies (Table 2.8) overnight at 4°C. Next, the membrane was 
washed three times for 10 min each in TBS-T and incubated with HRP-coupled secondary 
antibodies (Table 2.9) for 1 h at room temperature. After removal of the secondary antibody, 
washing steps with TBS-T were carried out as before and detection was done by exposure 
to X-ray films using Immobilon Western Chemiluminescent HRP Substrate (Merck). 
2.4.2 Immunoprecipitation (IP) of protein complexes 
For each sample, approximately 7x106 cells were plated in a 15 cm dish and the next day, 
expression of the FLAG-tagged proteins was induced with 1 µg/ml tetracycline. After 24 h, 
the cells were washed with PBS, harvested with 0.25% Trypsin-EDTA (Thermo Fisher) and 
centrifuged for 3 min at 1000 g. The cell pellet was resuspended in 1 ml IP buffer (20 mM 
HEPES-NaOH pH 7.5, 250 mM NaCl, 0.5% Triton X-100, 10% glycerol, 0.5 mM EDTA) 
supplemented with cOmplete Mini Protease Inhibitor Cocktail (Roche). Cells were lysed by 
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sonication (3 cycles of 15 sec with 0.3 sec on/0.7 off) using a Branson Digital Sonifier set 
to 20% amplitude, followed by centrifugation for 10 min at 20,000 g and 4°C to remove the 
insoluble material. The lysate was added to 30 µl slurry of pre-equilibrated anti-FLAG M2 
Magnetic Beads (Sigma-Aldrich) and binding was carried out for 2 h at 4°C in the presence 
of 50 µg/ml RNase A (Applichem). Afterwards, the beads were washed five times with the 
IP buffer and bound complexes were eluted with 250 µg/ml FLAG Peptide (Sigma-Aldrich) 
diluted in IP buffer for 30 min at 4°C. The eluates were precipitated with 20% trichloroacetic 
acid for 20 min on ice and centrifuged for 20 min at 20,000 g and 4°C. The pellets were 
then washed with ice-cold acetone and air-dried briefly. For mass spectrometry analysis 
(2.4.4), the samples were resuspended in 1X NuPAGE LDS Sample Buffer (Thermo Fisher) 
supplemented with 50 mM DTT and denatured at 70°C for 10 min. For SDS-PAGE and 
western blotting analysis (2.4.1), the pellets were resuspended first in 100 mM Tris-HCl  
pH 8.4, mixed with 4X SDS loading dye and boiled at 95°C for 10 min. 
To study the interactions between DHX15, NKRF and XRN2 (3.2.4), IPs using antibodies 
against the FLAG tag or against NKRF were performed as above with some modifications. 
The buffer for cell lysis consisted of 20 mM HEPES pH 8.0, 150 mM KCl and 0.5 mM EDTA. 
The cells were lysed by sonication and centrifuged to remove cell debris as described 
above. Afterwards, the lysates were supplemented with 10% glycerol, 1.5 mM MgCl2 and 
0.2% Triton X-100, and incubated with the pre-equilibrated beads for 2 h at 4°C. For IP with 
an anti-NKRF antibody, Protein G Sepharose beads (GE Healthcare) were prepared 
beforehand by an overnight incubation at 4°C with 5 µl antibody followed by washing with 
IP buffer (20 mM HEPES pH 8.0, 150 mM KCl, 10% glycerol, 1.5 mM MgCl2 and 0.2% Triton 
X-100). After binding, the beads were washed with the IP buffer and in the case of the  
anti-NKRF IP, the co-precipitated proteins were eluted at 95°C with 4X SDS loading dye. 
For the anti-FLAG IP, the bound proteins were eluted with 250 µg/ml FLAG Peptide (Sigma-
Aldrich) and precipitated with 20% trichloroacetic acid as above. The samples were then 
analyzed by SDS-PAGE and western blotting (2.4.1). In the case of the IP experiments 
coupled to siRNA-mediated knockdowns, the cells were treated for 96 h with 50 nM siRNAs 
and expression of the FLAG-tagged proteins was induced 24 h prior to harvesting. 
2.4.3 Purification of nucleoli and preparation of nucleolar lysates 
HEK293 cell lines expressing FLAG-tagged DHX15 or the FLAG tag only were induced for 
24 h with 1 µg/ml tetracycline and nucleoli were isolated based on Chamousset et al., 2010 
with a few changes. Cells (4x15 cm plates) were harvested with trypsin, washed twice with 
ice-cold PBS and lysed for 10 min on ice in 5 ml lysis buffer containing 20 mM Tris-HCl  
pH 7.4, 10 mM KCl, 3 mM MgCl2, 0.1% NP-40 and 10% glycerol. The released nuclei were 
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pelleted by centrifugation at 1350 g for 10 min, resuspended in 3 ml of solution S1 (0.25 M 
sucrose, 10 mM MgCl2) and layered on top of 3 ml solution S2 (0.35 M sucrose, 0.5 mM 
MgCl2). After centrifugation at 1430 g for 5 min, the nuclear pellet was resuspended in 3 ml 
solution S2 and sonicated six times for 10 sec each at 20% amplitude using a Branson 
Digital Sonifier. The lysed sample containing intact nucleoli was layered on top of 3 ml 
solution S3 (0.88 M sucrose, 0.5 mM MgCl2) and centrifuged at 3000 g for 10 min. The 
nucleolar pellet was resuspended in 500 µl solution S2 and centrifuged again at 1430 g for 
5 min to remove contaminants. The isolated nucleoli were disrupted by incubation for  
30 min on ice in 400 µl high-salt buffer (20 mM HEPES pH 8.0, 500 mM KCl, 0.5 mM EDTA, 
0.8% Triton X-100, 0.4% CHAPS) supplemented with 16 U TURBO DNase (Thermo 
Fisher), followed by sonication as described for the IP protocol. The nucleolar lysate was 
diluted 1:4 with a buffer containing 20 mM HEPES pH 8.0, 2 mM MgCl2 and 13.3% glycerol, 
and immunoprecipitation with anti-FLAG M2 beads (Sigma-Aldrich) was performed as 
detailed above.  
2.4.4 Liquid chromatography tandem mass spectrometry (LC-MS/MS) 
Protein IP samples obtained as described in 2.4.2 were separated on 4-12% NuPAGE Bis-
Tris gels (Thermo Fisher) and entire lanes were excised, divided into 12 fragments and 
digested with trypsin. The samples were analyzed on a mass spectrometer with two 
technical replicates for each. Proteins were identified with Mascot (Matrix Science) by 
searching against the UniProt human protein database. The results were further processed 
with Scaffold (Proteome Software) and proteins containing at least two detected peptides 
were identified at a false discovery rate of less than 1%. These steps were performed by 
the Proteomics Service Facility (University Medical Center Göttingen). For further data 
analysis, the proteins were ranked based on the total spectral counts and the fold change 
for each protein was calculated relative to the control sample. To enable calculations, a 
spectral count of 1 was added to proteins that had zero counts. The final results were 
expressed as the mean of two technical replicates or, when available, two biological 
replicates. 
2.4.5 Separation of (pre)-ribosomal complexes on sucrose gradients 
HeLa cells grown to 80% confluency in a 10 cm plate were detached with trypsin, 
centrifuged for 3 min at 1000 g and resuspended in 0.5 ml of lysis buffer (50 mM Tris-HCl 
pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT). The cells were lysed by sonication as 
described for the IP method (2.4.2) and the lysates were cleared by centrifugation for  
10 min at 20,000 g and 4°C. The obtained whole cell extracts (400 µl) were layered on top 
of 6 ml sucrose gradients (10-45%), which were prepared using a Gradient Master 
(BioComp). The separation of complexes was carried out for 16 h at 23,500 rpm and 4°C 
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in a SW40 Ti rotor (Beckman Coulter). After centrifugation, the gradient was fractionated 
into 530 µl samples that were precipitated with 20% trichloroacetic acid (2.4.2) and prepared 
for SDS-PAGE and western blotting analysis (2.4.1). When indicated, cells were treated 
with siRNAs for 96 h prior to the experiment.  
 
2.5 RNA analysis methods 
2.5.1 Total RNA extraction 
Total RNA was extracted using TRI Reagent (Sigma-Aldrich) according to manufacturer’s 
recommendations. Briefly, the media was removed, cells were washed once with PBS and 
the appropriate amount of TRI Reagent was added directly to the cells. The lysate was 
pipetted up and down several times to disrupt RNA-protein complexes and the samples 
were incubated for 5 min at room temperature. Next, chloroform (1/5 volume) was added 
and the samples were thoroughly mixed and incubated for 2-3 min at room temperature 
before centrifuging for 20 min at 20,000 g and 4°C. The upper aqueous phase containing 
RNA was transferred to a fresh tube and 1 volume isopropanol was added. Samples were 
incubated for 5 min and then centrifuged for 15 min at 20,000 g and 4°C to precipitate the 
RNA. The RNA pellet was washed with 75% ethanol, air-dried briefly and resuspended in 
H2O at a concentration of 0.5-2 µg/µl. 
2.5.2 Northern blotting 
To analyze small RNA species, total RNA samples or elution samples from RNA IP 
experiments (2.6.2) were mixed with 2X formamide loading dye and denatured at 90°C for 
3 min. The samples were separated on 8% or 12% 7M urea-polyacrylamide gels in 1X TBE 
and transferred to a Hybond-N membrane (GE Healthcare) for 2 h at 60 V and 4°C in the 
presence of 0.5X TBE. Alternatively, for northern blotting analysis of pre-ribosomal RNA 
processing, 5 µg total RNA were mixed with 5 volumes of glyoxal loading dye and incubated 
at 55°C for 1 h. The samples were separated for 16 h at 60 V on a 1.2% agarose gel in 1X 
BTPE. Prior to transfer, the gel was incubated for 20 min in 0.1 M NaOH followed by two 
washes of 15 min each in 0.5 M Tris-HCl pH 7.4 and 0.3 M NaCl, and a final equilibration 
step of 20 min in 6X SSC. The samples were then transferred to a Hybond-N membrane 
(GE Healthcare) by vacuum blotting for 2 h at 300 mbar in the presence of 6X SSC. After 
transfer, the RNA was crosslinked to the membrane at 254 nm with 240 mJ/cm2 in a 
Stratalinker UV Crosslinker (Stratagene). The membrane was pre-hybridized in SES1 buffer 
for 40 min at 37°C and 32P-labelled oligonucleotide probes were used to detect the RNA 
species of interest. 
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To generate labelled probes, 20 µl reactions containing 20 pmol DNA oligonucleotide (Table 
2.7), 20 µCi [g-32P]-ATP (PerkinElmer) and 10 U T4 Polynucleotide Kinase (Thermo Fisher) 
were set up and incubated at 37°C for 40 min. The labelled oligonucleotides were diluted in 
SES1 buffer and added to the membrane for overnight incubation at 37°C. The next day, 
the membrane was washed with 6X SSC and with 2X SSC + 0.1% SDS for 30 min each, 
and exposed to a phosphor screen (GE Healthcare). Detection of the radioactive signals 
was done with a Typhoon FLA 9500 scanner (GE Healthcare). 
2.5.3 Pulse-chase analysis of RNA 
HeLa cells were treated with siRNAs for 84 h as described in 2.3.3 and, prior to metabolic 
labelling, the cells were grown for 1 h at 37°C in phosphate-free DMEM. Labelling was 
carried out for 1 h at 37°C in phosphate-free DMEM supplemented with 10 µCi/ml [32P]-
orthophosphate (PerkinElmer). Afterwards, the labelling media was replaced with complete 
DMEM and the cells were harvested at specific time points for extraction of total RNA 
(2.5.1). The RNA samples were analyzed by agarose gel electrophoresis and northern 
blotting, followed by detection of the radioactive signals corresponding to the newly-
synthesized (pre)-rRNAs by phosphorimaging (2.5.2). In addition, the levels of actin mRNA 
were determined using a specific northern blotting probe (Table 2.7). 
2.5.4 Quantitative and gel-based reverse transcription PCR (RT-PCR) 
First-strand cDNA synthesis was performed using the SuperScript III Reverse Transcriptase 
kit (Thermo Fisher) according to manufacturer’s instructions. Two µg of template RNA were 
denatured for 5 min at 65°C in a volume of 13 µl with 10 nmol dNTP mix (Roche) and 50 
pmol anchored oligo(dT)24VN primer or 75 pmol random hexamer primer. The samples were 
briefly placed on ice and 7 µl of reverse transcription mix containing 4 µl 5X first-strand 
buffer, 1 µl 100 mM DTT, 1 µl RiboLock RNase Inhibitor (Thermo Fisher) and 1 µl 
SuperScript III Reverse Transcriptase were added. The reactions were incubated for 1 h at 
50°C and subsequently the reverse transcriptase was inactivated at 70°C for 15 min. The 
obtained cDNA was used for quantitative RT-PCR (qRT-PCR) or for PCR coupled to gel-
based analysis depending on the experiment. 
Quantitative RT-PCR was done using the LightCycler 480 SYBR Green I Master kit 
(Roche). Ten µl reactions containing 0.65X SYBR Green mix, 0.33 pmol forward and 
reverse primer (Supplementary Table S3) and 3 µl cDNA diluted as necessary (generally 
1:10 dilution) were pipetted in each well in triplicates. Samples were amplified in a 
LightCycler 480 machine (Roche) using the following program: 5 min pre-incubation at 95°C 
and 50 cycles of 10 sec denaturation at 95°C, 20 sec annealing at 58°C and 15 sec 
amplification at 72°C. Melting curve analysis was subsequently performed and involved 
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incubation for 10 sec at 95°C and for 1 min at 55°C followed by continuous acquisition of 
fluorescence until 97°C. The presence of a single melting peak indicated specific 
amplification of one product. Crossing point (Cp) values were determined with the second 
derivative maximum method and relative quantification was done based on the DDCt 
method. To account for differences in the input material, the results were normalized to the 
expression level of housekeeping genes (GAPDH or EMC7). All analysis steps were 
performed using the LightCycler 480 software. 
For alternative splicing analysis, PCR reactions were carried out as specified in Table 2.12 
using the primers listed in Supplementary Table S3. The samples (1/5 of the PCR reactions) 
were mixed with 6X DNA loading dye and separated on a 4% polyacrylamide gel in 1X TBE. 
The PCR products were stained with 0.5 µg/ml ethidium bromide for 10 min and visualized 
using a Typhoon FLA 9500 scanner (GE Healthcare). Quantification was done with 
ImageQuant TL 8.1 and the percentage spliced in (PSI) values were calculated as the ratio 
of the inclusion isoform relative to the sum of the inclusion and skipping products. The 
results were expressed as the mean of two biological replicates ± standard error of the 
mean (s.e.m), unless otherwise stated. 
Table 2.12. PCR parameters for alternative splicing analysis 
PCR reaction components (alternative splicing) 
5X buffer 5 μl 
dNTP mix (10 mM) 0.5 μl 
Forward primer (10 μM) 0.5 μl 
Reverse primer (10 μM) 0.5 μl 
cDNA template (1:2 dilution) 1 μl 
H2O 17.25 μl 
Phusion polymerase 0.25 μl 
PCR reaction conditions (alternative splicing) 
98°C (initial denaturation) 2 min x1 
98°C (denaturation) 30 sec 
x26-30 55°C (annealing) 40 sec 
72°C (elongation) 25 sec 
72°C (final elongation) 10 min x1 
 
2.5.5 Site-specific RNase H cleavage assay 
Total RNA (250 ng) was mixed with 10 pmol of 2′-O-methyl RNA-DNA chimeric 
oligonucleotides (Table 2.6) and denatured at 85°C for 3 min, followed by incubation at 
37°C for 10 min. The reactions were supplemented with 40 U RiboLock RNase Inhibitor 
(Thermo Fisher) and 5 U RNase H (NEB) in the presence of 1X RNase H buffer (NEB) and 
were incubated for 1 h at 37°C. Afterwards, the enzyme was inactivated with 4 volumes of 
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0.3 M sodium acetate pH 5.3 and 1 mM EDTA. The RNA was extracted with phenol-
chloroform-isoamyl alcohol (25:24:1) and precipitated overnight at -20°C with 3 volumes of 
100% ethanol and 1 µl glycogen. The samples were analyzed by urea-polyacrylamide gel 
electrophoresis and northern blotting as described in 2.5.2. 
 
2.6 Next-generation sequencing-based methods and data analysis  
2.6.1 RNA-seq sample preparation 
HEK293 cells were treated with the indicated siRNAs and total RNA was extracted using 
TRI Reagent (Sigma-Aldrich) as described in 2.5.1. Approximately 10 µg of RNA were 
incubated with 2 U TURBO DNase (Thermo Fisher) for 15 min at 37°C, in a reaction 
supplemented with 40 U RNasin Ribonuclease Inhibitor (Promega). The DNase-treated 
RNA was purified using the RNeasy Mini Kit (Qiagen) according to manufacturer’s 
instructions. Briefly, the reactions were brought to 100 µl with nuclease-free H2O (Qiagen), 
and 350 µl buffer RLT and 250 µl 100% ethanol were added. The samples were mixed well 
and the RNA was bound to the columns by centrifugation at 11,000 g for 15 sec. The 
columns were washed first with 500 µl RPE buffer and then with 500 µl of 80% ethanol. The 
residual ethanol was removed by centrifugation at 20,000 g for 5 min and the RNA was 
eluted in 14 µl nuclease-free H2O (Qiagen). Two µg RNA for each sample were used for 
rRNA depletion and library preparation with the Illumina TruSeq Stranded Total RNA Kit 
followed by 50 bp single-end sequencing on an Illumina HiSeq 4000 sequencer, which 
yielded approximately 20-50 million reads per sample. Library preparation and next-
generation sequencing were carried out by the Transcriptome and Genome Analysis 
Laboratory (University Medical Center Göttingen). 
2.6.2 Crosslinked RNA immunoprecipitation (RIP)-seq 
HEK293 stable cell lines expressing FLAG-tagged proteins were grown to confluency in 15 
cm plates (six plates for each sample) and prior to crosslinking protein expression was 
induced for 24 h with 1 µg/ml tetracycline. The cells were washed once with PBS and then 
crosslinked in the presence of 6 ml PBS at 254 nm with 400 mJ/cm2 in a Stratalinker UV 
Crosslinker (Stratagene). The crosslinked cells were collected by scraping and cells from 
three plates were pooled together, centrifuged at 800 g for 3 min and resuspended in 1 ml 
RIP buffer (20 mM HEPES-NaOH pH 7.5, 250 mM NaCl, 1 mM MgCl2, 0.5% Triton X-100, 
10% glycerol) containing cOmplete Mini Protease Inhibitor Cocktail (Roche) and 80 U 
RNasin Ribonuclease Inhibitor (Promega). The cells were lysed by sonication with a 
Branson Digital Sonifier at 25% amplitude in 3 cycles of 15 sec (0.3 sec on/0.7 sec off) with 
30 sec pause in between. The cell lysate was cleared by centrifugation for 15 min at 20,000 
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g and 4°C, and incubated with 75 µl slurry of pre-equilibrated anti-FLAG M2 Magnetic Beads 
(Sigma-Aldrich) for 2-3 h. The beads were then washed five times with RIP buffer and bound 
complexes were eluted for 2 h at 4°C with 250 µg/ml FLAG Peptide (Sigma-Aldrich) diluted 
in RIP buffer. Afterwards, the eluates were incubated with 2 U TURBO DNase (Thermo 
Fisher) for 20 min at 37°C in the presence of 40 U RNasin Ribonuclease Inhibitor 
(Promega). Eluates corresponding to the same sample were pooled together and treated 
with 275 µg/ml Proteinase K (Roche) for 2 h at 42°C in a reaction containing 1% SDS and 
0.5 mM EDTA. The released RNA was extracted with an equal volume of phenol-
chloroform-isoamyl alcohol (25:24:1) in the presence of 0.3 M sodium acetate pH 5.2. After 
centrifugation for 20 min at 20,000 g and 4°C, the upper phase was transferred to a new 
tube and the RNA was precipitated overnight at -20°C with 2.5 volumes 100% ethanol and 
1 µl glycogen. The RNA pellet was washed twice with 75% ethanol and resuspended in 
nuclease-free H2O (Qiagen). The RNA eluates were used for rRNA depletion and library 
preparation with the Illumina TruSeq Stranded Total RNA Kit. Sequencing of the libraries 
was done in single-end mode with a read length of 50 bp on an Illumina HiSeq 4000 
sequencer and generated approximately 50 million reads per sample. Library preparation 
and sequencing were performed by the Transcriptome and Genome Analysis Laboratory 
(University Medical Center Göttingen). Alternatively, the RNA eluates were analyzed by 
northern blotting as described in 2.5.2. 
2.6.3 Crosslinking and analysis of cDNA (CRAC) 
Stable cell lines expressing the FLAG tag or FLAG-tagged NKRF were induced for 24 h 
with 1 µg/ml tetracycline and approximately 1.2x108 cells (3x15 cm plates) per sample were 
used. When specified, the cells were treated for 6 h with 100 µM of the photoactivatable 
ribonucleoside 4-thiouridine (Sigma-Aldrich) prior to crosslinking. The protein-RNA 
crosslinking and anti-FLAG immunoprecipitation steps were performed as in 2.6.2 with the 
following modifications. Crosslinking at 254 nm (UV-CRAC) was done with 2400 mJ/cm2, 
while 360 mJ/cm2 were used for crosslinking at 365 nm in the presence of 4-thiouridine 
(photoactivatable ribonucleoside-enhanced-CRAC; PAR-CRAC). Cells were harvested by 
scraping in 1 ml of TNM150 buffer (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 1.5 mM MgCl2, 
0.1% NP-40, 5 mM 2-mercaptoethanol) and lysates were prepared as described above 
except that sonication was done at 40% amplitude. The cleared lysates were incubated with 
100 µl slurry of pre-equilibrated anti-FLAG M2 beads (Sigma-Aldrich) for 2-3 h at 4°C, 
followed by washes with TNM150 and TNM1000 (50 mM Tris-HCl pH 7.8, 1 M NaCl, 1.5 
mM MgCl2, 0.1% NP-40, 5 mM 2-mercaptoethanol). Elution was carried out overnight at 
4°C with 250 µg/ml FLAG Peptide (Sigma-Aldrich) diluted in TNM150.  
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Next, the eluates were treated with 0.1 U RNace-It Ribonuclease Cocktail (Agilent) for 30 
sec at 37°C. The samples were then supplemented with 6 M guanidine hydrochloride, 300 
mM NaCl and 10 mM imidazole, and incubated with 50 µl Ni-NTA beads (Qiagen) that had 
been pre-equilibrated with WB1 (50 mM Tris-HCl pH 7.8, 300 mM NaCl, 0.1% NP-40, 6 M 
guanidine hydrochloride, 10 mM imidazole, 5 mM 2-mercaptoethanol). After binding for 2 h 
at 4°C, the beads were washed with WB1 and PNK buffers (50 mM Tris-Hcl pH 7.8, 10 mM 
MgCl2, 0.5% NP-40, 5 mM 2-mercaptoethanol). The next steps involved dephosphorylation, 
ligation of 3′ and 5′ linkers and radioactive labelling by 5′ phosphorylation of the RNA. These 
reactions were carried out in the presence of 1X PNK buffer and 80 U RNasin Ribonuclease 
Inhibitor (Promega) as detailed below. Dephosphorylation was performed for 30 min at 37°C 
with 8 U TSAP Thermosensitive Alkaline Phosphatase (Promega) and afterwards the beads 
were washed with WB1 and PNK buffers. Ligation reactions containing 1 µM 3′ linker, 10% 
PEG8000 (Sigma-Aldrich) and 800 U T4 RNA Ligase 2, Deletion Mutant (Epicentre) were 
set up and incubated overnight at 16°C. The beads were washed as before and 
phosphorylation with 80 U T4 Polynucleotide Kinase (NEB) and 40 µCi [g-32P]-ATP 
(PerkinElmer) was done at 37°C for 40 min, followed by a 20 min incubation at 37°C with 
1.25 mM ATP-lithium salt (Roche). Next, ligation of the 5′ linker (1.25 µM) was carried out 
overnight at 16°C with 40 U T4 RNA Ligase 1 (NEB) and 1 mM ATP. The beads were 
washed with WB2 (50 mM Tris-HCl pH 7.8, 50 mM NaCl, 10 mM imidazole, 0.1% NP-40, 5 
mM 2-mercaptoethanol) and the crosslinked protein-RNA complexes were eluted with the 
same buffer containing 150 mM imidazole instead. The eluates were concentrated by 
trichloroacetic acid precipitation and denatured in 1X NuPAGE LDS Sample Buffer (Thermo 
Fisher) as described in 2.4.2. This was followed by separation on 4-12% NuPAGE Bis-Tris 
gels (Thermo Fisher) using MES buffer and western blotting transfer onto a Hybond-C 
membrane (GE Healtchare). The membrane was exposed to X-ray films to detect the 
radioactive signals and the regions containing crosslinked complexes were excised and 
incubated overnight at 42°C with WB2 supplemented with 1% SDS, 5 mM EDTA and 275 
µg/ml Proteinase K (Roche). The RNA was recovered by phenol-chloroform-isoamyl alcohol 
extraction as described in 2.6.2 and used for reverse transcription with SuperScript III 
Reverse Transcriptase (Thermo Fisher), which was performed as in 2.5.4 with a primer 
specific for the 3′ linker. 
PCR amplification of the resulting cDNA was done with the TaKaRa LA Taq DNA 
polymerase kit (Clontech) using the conditions shown in Table 2.13. The PCR products 
were separated on 3% MetaPhor agarose (Lonza) gels in 1X TBE and extracted using the 
MinElute Gel Extraction Kit (Qiagen) according to manufacturer’s recommendations. The 
concentration of the cDNA libraries was determined using a Qubit fluorometer (Thermo 
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Fisher) and next-generation sequencing was performed by the Transcriptome and Genome 
Analysis Laboratory (University Medical Center Göttingen) on a HiSeq 2500 system 
(Illumina). 
Table 2.13. PCR parameters for CRAC 
PCR reaction components (CRAC) 
10X buffer 5 μl 
dNTP mix (2.5 mM) 2.5 μl 
Forward primer (10 μM) 1 μl 
Reverse primer (10 μM) 1 μl 
cDNA template  1 μl 
H2O 39 μl 
TaKaRa LA Taq polymerase 0.5 μl 
PCR reaction conditions (CRAC) 
98°C (initial denaturation) 2 min x1 
98°C (denaturation) 30 sec 
x40 60°C (annealing) 40 sec 
68°C (elongation) 40 sec 
72°C (final elongation) 5 min x1 
 
2.6.4 Next-generation sequencing data analysis 
Raw sequencing data obtained from the RNA-seq and RIP-seq experiments were 
processed with Flexbar 2.7 (Dodt et al., 2012) to discard low-quality reads and to remove 
contaminating adapter sequences. In addition, the RNA-seq knockdown reads were 
trimmed to 45 nt and shorter reads were discarded to fit the requirements of the downstream 
analyses. After quality-control, the reads were mapped to the human GRCh38.p12 genome 
assembly using the STAR RNA-seq aligner (Dobin et al., 2013). For spliced alignments, 
only reads crossing annotated splice junctions were selected. The mapped reads were then 
analyzed with featureCounts (Liao et al., 2014) to obtain cumulated read counts for all 
annotated genes, which were expressed as counts per million (CPM) relative to the total 
number of mapped reads. For the RIP-seq samples, a highly variable accumulation of reads 
mapping antisense to annotated genomic features was observed, which were considered 
to be an artefact introduced during library preparation and were therefore excluded from the 
analysis. To determine changes in gene expression levels, a pseudocount of 0.5 was 
assigned to all genes to enable calculation of the log2 fold change between the sample of 
interest and the control. 
Alternative splicing analysis was done with MISO (Katz et al., 2010) based on a set of 
precomputed splicing events derived from annotated exon-intron boundaries, which are 
classified into cassette exon (CE), alternative 5′ and 3′ splice site (A5′SS and A3′SS), 
mutually exclusive exons (MXE) and retained intron (RI) events (Figure 3.11). Each splicing 
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event can lead to two outcomes that can be described in general as an inclusion and an 
exclusion isoform, and MISO calculates a percentage spliced in (PSI) value to denote the 
expression of the inclusion isoform. For an alternatively spliced exon, PSI is estimated 
based on the reads that map to that exon and to its junctions with the adjacent constitutive 
exons relative to the reads that span the junction between the two constitutive exons. 
Changes in alternative splicing were detected using a threshold of at least 20% difference 
in PSI values between the knockdown sample and the control, and a Bayes factor greater 
than or equal to 10, which is a measure of the likelihood that the event is indeed differentially 
expressed. For visualization of RNA-seq and RIP-seq data, the read coverage for specific 
genes was analyzed using Integrative Genomics Viewer (IGV; Robinson et al., 2011) and 
scatterplots and Venn diagrams were generated using packages available in RStudio. The 
analysis of CRAC sequencing data was done using a bioinformatics pipeline that had 
already been established in the lab. Briefly, raw sequencing reads were processed with 
Flexbar 2.7 (Dodt et al., 2012) and the pyCRAC software (Webb et al., 2014) to remove 
low-quality sequences, contaminating adapters and duplicated reads, and to discard reads 
shorter than 21 nt. The remaining reads were mapped with Bowtie (Langmead et al., 2009) 
to the GRCh37.75 human genome version and further analysis steps were done using tools 
from the pyCRAC software. The workflow for RNA-seq and RIP-seq data analysis was 
established in collaboration with Jens Kretschmer, who performed all the bioinformatics 
analysis steps described above. 
 
2.7 In vitro methods 
2.7.1 Recombinant protein expression and purification 
Recombinant protein expression plasmids (Table 2.4) were transformed in BL21 (DE3) 
CodonPlus-RIL cells or, in the case of the DHX15 constructs, in BL21 (DE3) pLysS (2.2.3). 
Single colonies were used to inoculate LB cultures, which were grown overnight at 37°C. 
The next day, 1 l cultures were initiated from the overnight cultures at a 1:1000 dilution and 
grown at 37°C until an O.D. of 0.6. Induction of protein expression was done either with 500 
mM IPTG for 3 h at 37°C for the G-patch domains or with 250 mM IPTG at 18°C overnight 
in the case of full-length DHX15, DHX16, GPKOW and NKRF. The cultures were harvested 
by centrifugation at 5000 g for 10 min and after a wash with PBS, the cell pellet was 
resuspended in lysis buffer and purification was carried out as described below. For the  
G-patch domains, 1 l of bacterial culture was used, while purification of full-length proteins 
required approximately 6-10 l of culture. All purification steps were done at 4°C. 
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Purification of full-length DHX15, DHX16, GPKOW and NKRF 
The cells were resuspended in 16 ml of lysis buffer (50 mM Tris-HCl pH 7.4, 600 mM NaCl, 
1 mM MgCl2, 0.5% Triton X-100, 10% glycerol, 25 mM imidazole, 2 mM 2-mercaptoethanol) 
per liter of culture and lysed with EmulsiFlex-C3 (Avestin) by three passes at 10,000 psi. 
The lysate was cleared by centrifugation at 50,000 g for 30 min and incubated with  
pre-equilibrated Ni-NTA beads (Qiagen) for 1.5 h. Approximately 125 µl of slurry were used 
per liter of culture. After binding, the beads were washed with 20 ml of wash buffer 1 (50 
mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2, 10% glycerol, 40 mM imidazole) followed 
by a high-salt wash with wash buffer 2 (same as wash buffer 1 but with 1 M NaCl instead) 
and a final washing step with wash buffer 1. The bound proteins were eluted with elution 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2, 10% glycerol, 250 mM 
imidazole) and the fractions were checked by SDS-PAGE. The fractions containing the 
highest amount of protein were pooled together and buffer exchange was done on PD-10 
columns (GE Healthcare) against a buffer with 50 mM Tris-HCl pH 7.4, 150 mM NaCl,  
1.5 mM MgCl2 and 10% glycerol.  
Purification of G-patch domains 
The cell pellets were resuspended in 18 ml of lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 1 mM MgCl2, 10% glycerol, 5 mM imidazole) and sonicated on ice using a Branson 
Digital Sonifier for 4 cycles at 45% amplitude with 0.5 sec on/0.5 sec off pulses and with 30 
sec pause between the cycles. The lysate was cleared by centrifugation at 20,000 g for 20 
min and bound to 1.5 ml Ni-NTA resin (Roche) for 1 h. The beads were then washed with 
10 ml wash buffer 1 (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2, 10 mM imidazole), 
10 ml wash buffer 2 (50 mM Tris-HCl pH 7.4, 1 M NaCl, 1 mM MgCl2, 10 mM imidazole) 
and again with 10 ml wash buffer 1. Elution was carried out with a buffer containing 50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2 and 250 mM imidazole. The fractions 
containing the highest amount of protein were pooled together and dialyzed against a buffer 
with 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2 and 10% glycerol using 
Spectra/Por Dialysis Tubing (Spectrum Labs) with a cutoff of 6-8 kDa. All recombinant 
proteins purified in this study were stored at -80°C and protein concentration was 
determined using Coomassie Plus (Bradford) assay (Thermo Fisher). 
2.7.2 Steady-state ATPase assay 
The ATPase activity was determined using an NADH-based enzymatic assay, in which the 
hydrolysis of ATP to ADP leads, in several steps, to the oxidation of NADH to NAD+ and to 
a concomitant decrease in absorbance at 340 nm (Kiianitsa et al., 2003). Reactions 
containing 45 mM Tris-HCl pH 7.4, 25 mM NaCl, 2.5 mM MgCl2, 300 µM NADH, 1 mM 
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phosphoenolpyruvate, 20 U/ml pyruvate kinase/lactic dehydrogenase, 4 mM ATP and 2 µM 
polyU32 RNA oligonucleotide (IDT) were set up, and recombinantly purified MBP-DHX15-
His10 or MBP-DHX16-His10 were added to a final concentration of 250 nM. The reactions 
were further supplemented with 1.5 µM ZZ-tagged G-patch domains as indicated. The 
experiments were carried out at 30°C and the absorbance at 340 nm was measured every 
min for 50 min using a BioTEK Synergy plate reader. The amount of ATP hydrolyzed, which 
is equimolar to the amount of NADH oxidized, was determined from the slope of the linear 
absorbance decrease and results from three experiments were expressed as mean ± s.e.m. 
2.7.3 Fluorescence anisotropy 
To determine RNA binding affinities, the anisotropy of an ATTO647N-labelled RNA 
substrate (Table 2.6) obtained from IDT was followed in the presence of increasing amounts 
of protein. Reactions contained 50 nM RNA and binding was analyzed in a buffer with 50 
mM Tris-HCl pH 7.4, 90 mM NaCl, 1 mM MgCl2 and 4% glycerol. For the DHX15 binding 
curves, the helicase was titrated from 0 to 600 nM and the reactions were supplemented 
when indicated with the purified ZZ-tagged G-patch domains or the ZZ tag only at a 
concentration of 1.2 µM for all data points. Alternatively, binding curves in which the  
G-patch domains of GPATCH1, GPATCH2, GPATCH8 and GPKOW were titrated from 0 
to 10 µM were generated in the same conditions as above. 
After mixing all the components, the samples were incubated for 2 min at 25°C before being 
transferred to a Quartz SUPRASIL 10x2 mm High Precision cuvette (Hellma-Analytics). The 
steady-state fluorescence anisotropy was measured in a FluoroMax-4 spectrofluorometer 
(Horiba) using the following settings: excitation wavelength - 644 nm, emission wavelength 
- 661 nm, excitation and emission slits - 8, integration time - 0.5 sec, temperature - 25°C. 
Measurements were performed with a target error of less than 2% up to a maximum of six 
trials. The averaged data from two or three biological replicates were plotted and fitted with 
Origin 8.2 using the equation below (eq.1) to obtain dissociation constant (Kd) values ± 
s.e.m. Please note that for reactions containing both DHX15 and G-patch cofactors, only 
the concentration of the helicase was taken into account for calculations due to the 
insignificant level of RNA binding displayed by the G-patch domains themselves. 
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2.7.4 Unwinding assay 
Unwinding experiments were performed using an RNA-DNA duplex as a substrate, which 
consisted of a 32P-labelled DNA oligonucleotide (GCTGATCATCTCTGTATTG) 
complementary to an in vitro transcribed RNA of 118 nt. For annealing, the RNA and DNA 
were mixed at a 1:1 molar ratio in annealing buffer (30 mM HEPES pH 7.5 and 100 mM 
potassium acetate) and heated at 95°C for 3 min, followed by incubation at 65°C for 5 min 
and cooling down to room temperature. Unwinding reactions consisted of 1 nM duplex and 
2.5 nM DHX15 with or without 2.5 nM NKRF, and were carried out in a buffer containing 50 
mM HEPES pH 7.5, 50 mM KCl, 0.5 mM MgCl2, 100 µg/ml BSA, 5% glycerol, 2 mM DTT 
and 20 U RiboLock RNase Inhibitor (Thermo Fisher). To ensure single-turnover conditions, 
the samples were supplemented with 50-fold excess of unlabelled complementary DNA 
oligonucleotide. The reactions were initiated with 2 mM ATP/MgCl2 and incubated for up to 
20 min at 30°C, followed by quenching with 4X quenching buffer (50 mM Tris-HCl pH 8.0, 
2.5% SDS, 50 mM EDTA, 25% glycerol). The samples were separated on 10% 
polyacrylamide gels in 0.5X TBE that were afterwards exposed to phosphor screens and 





3.1 Identification and characterization of G-patch protein-RNA helicase 
interactions 
3.1.1 Human G-patch proteins interact with a subset of DEAH/RHA RNA helicases 
RNA helicases have essential roles in the cell and their activity is tightly controlled by a 
variety of mechanisms, including through interactions with protein cofactors. The inventory 
of helicase cofactors identified so far includes several proteins that contain a G-patch 
domain. However, to date, a systematic analysis of the role of the human G-patch protein 
family as cofactors of RNA helicases is lacking. In order to identify the entire network of  
G-patch protein-RNA helicase interactions in human cells, we set out to study all proteins 
that are annotated as containing a G-patch domain in the UniProt database, excluding only 
those that belong to the endogenous retroviral elements family for which there is little 
evidence of expression (Hanke et al., 2016). First, the coding sequences of 22 human  
G-patch proteins were cloned into mammalian expression vectors (Table 2.3) and 
tetracycline-inducible stable cell lines for expressing these proteins with a FLAG tag were 
generated. Induction for 24 h followed by western blotting analysis with an anti-FLAG 
antibody confirmed synthesis of the FLAG-tagged proteins and, using a-Tubulin as a 
loading control, their relative expression levels could be compared (Figure 3.1). 
Figure 3.1. Confirmation of the expression of the FLAG-tagged variants of human G-patch proteins from 
inducible stable cell lines. HEK293 stable cell lines encoding the indicated human G-patch proteins were 
induced for 24 h with tetracycline and cell extracts were analyzed by SDS-PAGE and western blotting. The 
expression of the FLAG-tagged proteins was detected with an anti-FLAG antibody and a-Tubulin was used as 
a loading control. 
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These cell lines were then used together with control cells encoding only the FLAG tag in 
IP experiments with an anti-FLAG antibody, followed by identification and quantification of 
the co-precipitated proteins by LC-MS/MS analysis and spectral counting. The experiments 
were performed in the presence of RNase to avoid bridging of interactions by RNA and to 
retain only protein-protein interactions. The proteins identified by MS analysis of the IP 
eluates were ranked based on the total spectral counts, which are an indicator of protein 
abundance (Old et al., 2005) and their fold enrichment in the samples expressing  
FLAG-tagged G-patch proteins relative to the FLAG control was calculated. 
Table 3.1. MS analysis results of IP experiments with FLAG-tagged G-patch proteins. The fold enrichment 
for the indicated DEAH/RHA helicases was calculated based on the spectral counts measured in the samples 
expressing FLAG-tagged G-patch proteins relative to the FLAG tag control. The asterisk (*) marks the samples 








AGGF1 DHX15 4.8 
CHERP DHX15 5.6 
CMTR1* DHX15 42.9 
GPANK1 DHX15 7.8 
GPATCH1 DHX35 236 
GPATCH2 DHX15 21.9 
GPATCH3 DHX15 214.9 
GPATCH4 DHX15 9 
GPATCH8 DHX15 14.6 
GPATCH11 DHX15 46.8 
GPKOW DHX16 1720.5 
NKRF DHX15 9 
PINX1 DHX15 57 
RBM5 DHX15 11.9 
RBM6 DHX15 1.6 
RBM10 DHX15 13.6 
RBM17 DHX15 6.6 
SON DHX15 21.4 
SUGP1* - - 
SUGP2 DHX15 3.7 
TFIP11 DHX15 22 
ZGPAT DHX15 47 
 
Among the proteins that were co-precipitated with the G-patch protein baits, we focused 
our attention on RNA helicases that belong to the DEAH/RHA family, since this subset of 
helicases contain an OB-fold domain, which has previously been shown to be essential for 
the interaction with several G-patch cofactors (Robert-Paganin et al., 2015; Sloan and 
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Bohnsack, 2018). Interestingly, the MS data revealed that DHX15 was the top  
co-precipitated DEAH/RHA helicase for the majority (19/22) of G-patch proteins, being 
recovered between 1.6 and 215-fold more compared to its levels in the FLAG control (Table 
3.1). Thus, in addition to confirming the known interactions with CMTR1, GPATCH2, PINX1, 
RBM5, TFIP11 and ZGPAT, these results uncovered a plethora of previously unknown  
G-patch protein-DHX15 complexes, suggesting that DHX15 might be regulated by an 
extensive network of cofactors (Lin et al., 2009; Yoshimoto et al., 2009; Niu et al., 2012; 
Chen et al., 2014; Chen et al., 2017; Inesta-Vaquera et al., 2018). Apart from the  
DHX15-interacting G-patch proteins, we identified a novel interaction between GPATCH1 
and the RNA helicase DHX35, which have previously been detected together in 
spliceosomal and centrosomal complexes (Agafonov et al., 2011; Gupta et al., 2015). 
Furthermore, these data confirmed the known association of GPKOW with DHX16, which 
is conserved from yeast (Silverman et al., 2004; Zang et al., 2014). Lastly, in the case of 
SUGP1, no DEAH/RHA helicase was reproducibly enriched relative to the FLAG control in 
the two experiments performed. 
Table 3.2. MS analysis results of the FLAG-DHX15 IP. The spectral counts (SC) measured for the G-patch 
proteins that were enriched in the FLAG-DHX15 IP sample compared to the FLAG tag control are shown 







NKRF 613 94.3 
CMTR1 324.5 72.1 
TFIP11 176.5 58.8 
PINX1 165.5 165.5 
GPATCH8 116 116 
ZGPAT 88.5 16.1 
GPATCH3 40 40 
RBM6 35 1.8 
RBM17 28 28 
CHERP 27.5 1.9 
GPATCH11 19.5 19.5 
GPATCH2 16.5 16.5 
SUGP2 6.5 6.5 
 
To test some of the identified interactions in a reciprocal manner, IPs with lysates from cells 
expressing FLAG-tagged DHX15 were also carried out and analyzed by MS. Consistent 
with our previous findings, 13 G-patch proteins were enriched in the FLAG-DHX15 IP 
compared to the FLAG control, including known interactors as well as novel binding partners 
(Table 3.2). Interestingly, the mammalian-specific G-patch protein NKRF was the most 
highly enriched protein in the DHX15 IP eluate, indicating a strong association of the 
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helicase with this putative cofactor. Furthermore, RBM6 and SUGP2, which showed a weak 
binding to DHX15 in the reciprocal analysis, were also co-precipitated with the helicase, 
implying that they are indeed DHX15 interactors. Importantly, no interaction between 
GPKOW and FLAG-DHX15 was observed despite both proteins being well-established 
spliceosome components and the specificity of this method is further supported by the lack 
of GPATCH1 in the DHX15 pulldown.  
Next, to confirm the interactions identified by MS, IPs with the G-patch protein-expressing 
cell lines were performed and this time the eluates were analyzed by western blotting using 
antibodies against several RNA helicases. Strong binding of DHX16 to GPKOW-FLAG and 
of DHX35 to GPATCH1-FLAG was observed, suggesting that a significant proportion of 
these helicases is found in complex with their interacting G-patch protein in cells (Figure 
3.2). On the other hand, as our previous results indicated, DHX15 is distributed among a 
multitude of G-patch interactors and would probably interact to different extents with each 
of these proteins. In line with this, the anti-FLAG IP results showed that for all G-patch 
proteins except GPATCH1 and GPKOW, DHX15 was enriched in the eluates to variable 
levels compared to the FLAG tag only control. In addition to the 19 G-patch proteins that 
were already indicated by MS as DHX15-interactors, this included SUGP1, which showed 
a weak but reproducible binding to DHX15. Importantly, the RNA helicases DHX9 and 
DDX21 were not recovered in any of the IP samples, further supporting the specificity of the 
interactions detected.  
Figure 3.2. Human G-patch proteins interact specifically with DHX15, DHX16 or DHX35 in vivo. The 
expression of the FLAG tag or of FLAG-tagged G-patch proteins from HEK293 stable cell lines was induced for 
24 h with tetracycline. Cell lysates were used for immunoprecipitation with an anti-FLAG antibody and the  
co-precipitated proteins were detected by western blotting using antibodies against the indicated RNA helicases. 
Input samples representing 1% of the lysates for DHX15, DHX9 and DDX21, and 2% for DHX35 and DHX16 
were processed alongside the elution fractions. Two different exposures are shown for DHX15 (short and long).  
Overall, these results revealed that human G-patch proteins interact with a small subset of 
RNA helicases: DHX15 has a network of 20 G-patch proteins, while DHX35 and DHX16 
Results 
 52 
bind GPATCH1 and GPKOW respectively. Excitingly, 14 novel G-patch protein interactors 
were discovered for DHX15 in addition to the 6 cofactors that had been described by others 
either prior to or during this work. 
The identification of DHX35 as a binding partner of GPATCH1 suggested the existence of 
an additional RNA helicase regulated by G-patch cofactors apart from DHX15 and DHX16 
(Robert-Paganin et al., 2015). Several studies have shown that the interaction between  
G-patch proteins and RNA helicases involves the G-patch domain of the cofactor and the 
OB-fold region of the helicase (Walbott et al., 2010; Christian et al., 2014; Heininger et al., 
2016; Inesta-Vaquera et al., 2018). Therefore, to assess if GPATCH1 and DHX35 form a 
bona fide G-patch cofactor-RNA helicase complex, the requirement for these domains for 
their interaction was analyzed by deleting the N-terminal region of GPATCH1, which 
includes the G-patch domain (GPATCH1199-931), as well as the OB-fold domain of DHX35 
(DHX351-597). These truncated proteins were expressed with a FLAG tag from stable cell 
lines and used together with the wild-type proteins and with a FLAG only control in IP 
experiments. Western blotting analysis of the IP eluates showed that full-length GPATCH1 
and DHX35 interacted in a reciprocal manner, however, binding was strongly reduced when 
either the G-patch domain of the cofactor or the OB-fold of the helicase were lacking (Figure 
3.3). Thus, these results indicate that GPATCH1 and DHX35 constitute a novel G-patch 
cofactor-RNA helicase complex as their binding follows the same mode of interaction that 
has been described for other such complexes. 
Figure 3.3. GPATCH1 and DHX35 interact through conserved domains. (A) IP experiments with anti-FLAG 
beads were performed using extracts prepared from cells induced for 24 h with tetracycline to express the FLAG 
tag, FLAG-GPATCH1 or FLAG-GPATCH1199-931. The levels of DHX35 and of the bait proteins (FLAG) in the 
input (1%) and elution samples were detected by western blotting. (B) Stable cell lines expressing the FLAG 
tag and FLAG-tagged DHX35 and DHX351-597 were used as in (A) and the samples were analyzed with the 
indicated antibodies. 
3.1.2 The G-patch domain is sufficient in most cases for the regulation of the cognate 
RNA helicase 
The G-patch domain has been suggested to mediate protein-protein interactions and in 
specific cases protein-RNA interactions, and has previously been shown to be essential for 
activating RNA helicases in yeast and human cells (Lebaron et al., 2009; Niu et al., 2012). 
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To assess whether the G-patch protein-RNA helicase complexes identified by IPs involve 
direct protein-protein binding and to test the potential of the G-patch domains to regulate 
their cognate helicase, we studied ATP hydrolysis and RNA binding as parameters of RNA 
helicase activity in vitro, in the presence or absence of the putative G-patch cofactors. For 
this, the fragments corresponding to the 22 G-patch domains were recombinantly 
expressed and purified with a ZZ-His7 tag together with full-length MBP-DHX15-His10,  
MBP-DHX16-His10 and ZZ-GPKOW-His7 (Figure 3.4). 
Figure 3.4. Overview of the recombinantly purified G-patch domains and full-length GPKOW, DHX15 and 
DHX16. The G-patch domains (GP) of the indicated proteins were expressed in E. coli with a ZZ-His7 tag and 
purified on Ni-NTA. The resulting protein preparations were analyzed by SDS-PAGE and Coomassie staining 
(left panel). Similarly, full-length GPKOW containing a ZZ-His7 tag (GPKOWFL) and DHX15 and DHX16 carrying 
an MBP-His10 tag were purified on Ni-NTA, separated by SDS-PAGE and visualized by Coomassie staining 
(right panel). 
The steady-state ATP hydrolysis activity of the RNA helicase DHX15 was analyzed in the 
presence or absence of excess G-patch domains using an NADH-coupled enzymatic assay 
(Kiianitsa et al., 2003). Since RNA helicases are RNA-dependent ATPases, all samples 
were supplemented with in vitro synthesized polyU32 RNA. Compared to the activity of the 
helicase alone, addition of the G-patch domains to DHX15 led to an increase of ATP 
hydrolysis between 1.5 and 6.6-fold for 19 out of the 22 samples, indicating that these 
proteins act as cofactors of the helicase and have a stimulatory effect (Figure 3.5). 
Importantly, the G-patch domains of the non-DHX15 interactors, GPATCH1 and GPKOW, 
did not influence the activity of the helicase. 
In order to confirm the specificity of the effects observed, the ATPase activity of DHX16 with 
or without addition of the G-patch domains was also determined (Figure 3.5). In contrast to 
DHX15, ATP hydrolysis by DHX16 was not significantly stimulated by the presence of any 
of the G-patch domains compared to its activity in the absence of cofactor (maximum fold 
increase 1.3). The small changes observed are likely caused by unspecific binding of the 
G-patch domains to DHX16 due to their presence in excess. However, we failed to observe 
a clear stimulation of DHX16 by the G-patch domain of GPKOW (GPKOWGP) despite the 
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well-established interaction between these proteins. Similarly, addition of RBM6GP did not 
enhance the ATPase activity of DHX15, although these proteins interacted weakly in vivo.  
Figure 3.5. The G-patch domain is generally sufficient to stimulate the ATPase activity of the interacting 
RNA helicase. An NADH-coupled assay was used to measure ATP hydrolysis in reactions containing 250 nM 
of recombinantly purified DHX15 and DHX16 together with 2 µM RNA and the indicated G-patch domains (GP) 
at a concentration of 1.5 µM. The amount of ATP hydrolyzed in each sample was expressed relative to the 
samples containing only the RNA helicase and RNA (no cofactor) and results from three independent 
experiments are shown as mean ± s.e.m. 
This suggested that the G-patch domain is not always sufficient to regulate the activity of 
RNA helicases and that other regions of the G-patch protein might contribute to binding and 
activation of the helicase. Therefore, the ATP hydrolysis activity of DHX15 and DHX16 was 
also analyzed in the presence of full-length GPKOW (GPKOWFL). Upon addition of 
GPKOWFL to the reaction, a higher increase in ATPase activity was observed for DHX16 
compared to DHX15 relative to their basal activities, which have similar values (Figure 3.6). 
This supports the specificity of the interaction between GPKOW and DHX16 as well as the 
stimulatory role of the cofactor. Since full-length RBM6 could not be purified due to its large 
size, it remains to be determined whether this G-patch protein regulates the ATPase activity 
of DHX15 as well. 
Taken together, these results demonstrate that the interactions identified in vivo represent 
bona fide helicase-cofactor complexes and that the G-patch domain is sufficient in most 
cases to confer specificity for interaction with the cognate helicase and to regulate its 
activity. Furthermore, these data show that G-patch proteins have primarily a stimulatory 




3.1.3 The RNA binding affinity of DHX15 is enhanced by the G-patch domains of its 
cofactors 
In the functional cycle described for DEAH/RHA helicases, binding of the RNA substrate 
leads to conformational changes that favor ATP hydrolysis, thereby providing the basis for 
the RNA-dependent ATPase activity exhibited by these enzymes (He et al., 2017; Tauchert 
et al., 2017). To gain more insight into the mechanisms involved in the stimulation of the 
RNA helicase ATPase activity by G-patch proteins, the effect of the G-patch domains on 
the RNA binding affinity of DHX15 was determined in vitro by fluorescence anisotropy using 
an 11 nt RNA substrate labelled with ATTO647N. Binding curves were generated by titration 
of the helicase to the RNA substrate, with or without the addition of a constant concentration 
of the DHX15-interacting G-patch domains at all data points. In the absence of cofactor, 
DHX15 bound RNA with an estimated Kd of 1.07 µM (Figure 3.7). Upon addition of the  
G-patch domains, the RNA binding activity of DHX15 was stimulated in most cases, up to 
a Kd value of 70 nM, with the highest effects being observed in the presence of GPATCH2GP 
and CMTR1GP, consistent with the results of the ATPase assay (Figure 3.5). Importantly, 
no stimulation was observed when the purified ZZ tag was added to DHX15, demonstrating 
that the G-patch moiety is indeed responsible for the observed increase in RNA binding. 
On the other hand, the presence of the G-patch domains of GPATCH8, RBM6, SUGP1, 
SUGP2 and ZGPAT did not stimulate RNA binding by DHX15, which suggested, in line with 
earlier results (Figure 3.5), that these proteins might be weaker cofactors. Of note, neither 
of the DHX15-interacting G-patch domains showed any significant RNA binding at the 
selected concentration (Figure 3.7, first data point). Interestingly, however, in the course of 
these experiments we observed that GPKOWGP and GPATCH1GP, which interact with 
DHX16 and DHX35 respectively, had a considerably higher RNA affinity than the other  
G-patch domains. Titration of these G-patch domains with the RNA substrate revealed a 
Kd of 8.7 µM for GPKOWGP and of 26.2 µM for GPATCH1GP (Figure 3.8). These binding 
affinities were several orders of magnitude higher than the affinity of the other G-patch 
Figure 3.6. Full-length GPKOW stimulates the 
ATPase activity of DHX16. The ATPase activity of 
DHX15 and DHX16 (250 nM) in the presence of RNA 
(2 µM) was measured with or without the addition of 
1.5 µM full-length GPKOW (GPKOWFL) using an 
NADH-coupled assay. The level of ATP hydrolysis in 
the presence of GPKOW was calculated relative to the 
samples containing only DHX15 or DHX16 and was 
represented as mean ± s.e.m of three experiments. 
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domains, with GPATCH2GP and GPATCH8GP being shown here as representative 
examples.  
Figure 3.7. The RNA binding affinity of DHX15 is enhanced by the G-patch domains of its cofactors. The 
fluorescence anisotropy of an 11 nt ATTO647N-labelled RNA was determined in the presence of increasing 
amounts of DHX15 (0-0.6 µM) either without cofactor or with the addition of 1.2 µM of the indicated ZZ-tagged 
G-patch domains or the ZZ tag only. Data from two independent experiments were averaged and fitted in Origin 
8.2 to calculate Kd values ± s.e.m, which are shown alongside the binding curves.  
Taken together, these results demonstrate that most G-patch domains of the  
DHX15-interacting proteins can enhance the RNA binding affinity of the helicase, indicating 
that this might be the major mechanism contributing to the stimulation of its ATPase activity 
observed in the presence of cofactors. Furthermore, these data show that G-patch domains 
themselves can have significantly different RNA binding affinities, and in some cases, can 
mediate protein-RNA interactions in addition to protein-protein interactions. 
Figure 3.8. The G-patch domains of GPKOW and 
GPATCH1 bind RNA. An 11 nt RNA substrate 
labelled with ATTO647N was incubated with 
increasing concentrations (0-10 µM) of the indicated 
G-patch domains (GP) and the steady-state 
fluorescence anisotropy was measured. Results from 
three experiments were analyzed in Origin 8.2 to 
determine Kd values ± s.e.m. The obtained Kd values 
were 8.7 ± 1.3 µM for GPKOWGP and 26.2 ± 4.8 µM 
for GPATCH1GP, while the RNA affinities of 




3.2 Functional characterization of DHX15 and its G-patch cofactors 
3.2.1 The majority of human G-patch proteins are localized in the nucleoplasm 
Having identified and characterized the interactions that human G-patch proteins establish 
with their cognate RNA helicases, the next aim was to study their target pathways and 
cellular functions. First, immunofluorescence microscopy was used to investigate the 
localization of the FLAG-tagged G-patch proteins expressed from the HEK293 stable cell 
lines. Staining of cells with an anti-FLAG antibody, with antibodies against markers for 
different cellular structures (UTP14A - nucleoli, PCM1 - centrosome) and with DAPI for 
visualization of the nuclear material revealed that all G-patch proteins were localized in the 
nucleus with the exception of GPATCH1, which was found in the cytoplasm and at the 
centrosome (Figure 3.9). Interestingly, the presence of GPATCH1 at the centrosome in 
close proximity to PCM1 is in line with the previously described association of this protein 
with centrosomal complexes (Gupta et al., 2015). 
Within the nucleus, most G-patch proteins had a nucleoplasmic localization without any 
nucleolar staining, as demonstrated by the lack of colocalization with UTP14A. A more 
particular localization was observed for GPATCH8, which showed a punctate staining in the 
nucleoplasm. Similarly, SON was detected in specific foci that correspond to splicing 
speckles as has been reported in other studies (Huen et al., 2010; Ahn et al., 2011). 
Furthermore, in addition to its nucleoplasmic localization, ZGPAT was enriched in structures 
adjacent to nucleoli, which based on results from another study represent Cajal bodies 
(Chen et al., 2017). 
On the other hand, GPATCH2 and PINX1 showed both a nucleoplasmic and a nucleolar 
staining, while GPATCH4 and NKRF were strongly enriched in nucleoli. The localization of 
these proteins in nucleoli suggested that they might be involved in ribosome biogenesis, 
which is initiated at these sites. In line with this, it has been proposed that GPATCH2 and 
PINX1 are implicated in ribosome production similar to their yeast homologs Sqs1 and Pxr1 
(Chen et al., 2014; Robert-Paganin et al., 2015). Taken together, these results provide an 
overview of the subcellular localization of all human G-patch proteins and represent a 









Figure 3.9. Human G-patch proteins are localized almost exclusively in the nucleus. FLAG-tagged  
G-patch proteins were expressed from the HEK293 stable cell lines after induction with tetracycline for 24 h and 
their localization was followed by immunofluorescence microscopy using an antibody against the FLAG tag 
(green). Antibodies against the centrosomal protein PCM1 (only for the GPATCH1 sample) and the nucleolar 
marker UTP14A were used for counterstaining (red) and nuclei were visualized with DAPI (blue). Overlays of 







3.2.2 Genome-wide analyses reveal that DHX15 and most of its G-patch cofactors 
regulate alternative splicing 
The nucleoplasmic localization observed for the majority of human G-patch proteins 
suggested that they might impact RNA metabolism at an early stage in the gene expression 
pathway. Thus, in order to gain more insight into the function of G-patch proteins and RNA 
helicases, we investigated in a genome-wide manner changes in alternative splicing and 
gene expression upon their siRNA-mediated knockdown. Given the intriguing finding that 
DHX15 interacts with such a large number of G-patch proteins, our analyses focused on 
this helicase and its cofactors with the aim to understand this complex network of 
interactions and the interplay between its components. However, the G-patch proteins that 
are likely involved in ribosome biogenesis (GPATCH2, GPATCH4, NKRF, PINX1) as 
indicated by their nucleolar localization, were not included in the analysis since they were 
not expected to have a direct effect on the transcriptome. To enable comparison with the 
DHX15 cofactors, GPKOW, which interacts with DHX16, was also studied. Therefore, 
knockdowns for DHX15 and for 17 human G-patch protein genes together with a control 
knockdown against the firefly luciferase gene (non-target, NT) were established in HEK293 
cells using one siRNA for each, and the efficiency of the depletion was tested by qRT-PCR. 
This showed a decrease in the expression of the target mRNAs compared to the NT control 
ranging between 65% and 96% relative to the levels of the reference housekeeping gene 
(Figure 3.10). 
Figure 3.10. The expression levels of the G-patch protein-encoding genes are efficiently reduced by 
siRNA treatment. HEK293 cells were treated for 72 h with a non-target siRNA (siNT) or with siRNAs against 
the indicated genes and the levels of the target mRNAs were determined by qRT-PCR. The housekeeping 
genes GAPDH and EMC7 were used for normalization and for each sample the expression level of the targeted 
mRNA is shown relative to the siNT control. 
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Next, total RNA extracted from siRNA-treated cells was subjected to rRNA depletion and 
library preparation for RNA-seq analysis, and the obtained sequencing reads were mapped 
onto the human genome and analyzed for changes in alternative splicing and gene 
expression levels. Alternative splicing analysis was performed with the MISO software (Katz 
et al., 2010), which uses the genome annotation to derive all known splicing events and 
determines changes in the extent of these events between the knockdown samples and the 
control based on the difference in PSI values (see pages 43-44 for a detailed explanation). 
The most abundant type of alternative splicing is represented by cassette exons, which are 
exons that can be either included or skipped during the splicing process (Figure 3.11). The 
other alternative splicing events are classified into alternative 5′ and 3′ splice sites, mutually 
exclusive exons and retained intron. 
Figure 3.11. Classification of alternative splicing events. (A) Schematic representation of the five types of 
alternative splicing events. Modified from Park et al., 2013. (B) The number of annotated splicing events for 
each category of alternative splicing based on the GRCh38 human genome annotation as determined using the 
MISO software. 
Interestingly, the results of the MISO analysis, which are summarized in Table 3.3, showed 
that depletion of DHX15 and of all the G-patch proteins tested affected a multitude of 
splicing events belonging to all categories of alternative splicing. The highest numbers of 
differentially expressed splicing events were observed upon knockdown of SON (2450 
events), ZGPAT (2202 events), DHX15 (737 events), AGGF1 (460 events), TFIP11 (336 
events) and SUGP2 (325 events), indicating that these factors have important roles in 
splicing regulation. In some cases, multiple splicing changes were detected for the same 
gene and the number of target genes is also shown in Table 3.3. 
For all proteins analyzed, the majority of regulated events belonged to the CE category, 
consistent with this being the most abundant type of alternative splicing (Figure 3.11B). In 
general, DHX15 and G-patch proteins promoted both exon skipping and inclusion to similar 
levels, however, in some cases a stronger effect was observed for the former or the latter 
(Figure 3.12). For example, depletion of AGGF1 led to three times more exon skipping 
events than inclusion, while knockdown of RBM10 regulated four times more exon inclusion 
compared to skipping events. Despite the large number of differentially expressed cassette 
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exons that were detected, these represented a small fraction of all known CE events, with 
only about 2% of the total being affected by depletion of SON and ZGPAT. Interestingly, 
analysis of the other types of alternative splicing revealed a high level of intron retention 
following SON knockdown (12.5% of total RI events; Figure 3.11B; Table 3.3), which is in 
agreement with previous reports (Lu et al., 2013). Furthermore, depletion of ZGPAT 
preferentially regulated the choice between two adjacent alternative exons, impacting 6.5% 
of the total number of annotated MXE events. 
Table 3.3. Summary of the RNA-seq and alternative splicing analysis results. The number of differentially 
expressed alternative splicing events for the indicated samples relative to the control is shown for each category 
(CE - cassette exon, A5′SS and A3′SS - alternative 5′ and 3′ splice sites, MXE - mutually exclusive exons, RI - 
retained intron). The number of genes showing changes in alternative splicing and the percentage of unique 
events for each sample are also indicated. 













siAGGF1 223 40 53 63 81 460 (337) 46.3 
siCHERP 145 34 22 26 36 263 (205) 35.7 
siCMTR1 68 12 20 16 19 135 (122) 37.8 
siDHX15 427 38 90 61 121 737 (542) 41.7 
siGPANK1 92 20 15 37 28 192 (147) 35.4 
siGPATCH3 63 12 18 18 13 124 (107) 47.6 
siGPATCH8 103 23 30 44 27 227 (192) 11.0 
siGPATCH11 97 21 32 50 28 228 (192) 13.6 
siGPKOW 84 20 11 25 21 161 (137) 35.4 
siRBM5 52 7 15 14 6 94 (84) 42.6 
siRBM6 59 8 7 24 15 113 (92) 46.0 
siRBM10 70 14 16 18 11 129 (113) 38.8 
siRBM17 120 16 26 54 19 235 (180) 50.6 
siSON 935 162 301 168 884 2450 (1230) 69.7 
siSUGP1 89 18 35 34 25 201 (161) 41.8 
siSUGP2 193 25 18 51 38 325 (258) 35.7 
siTFIP11 180 35 28 53 40 336 (262) 44.6 
siZGPAT 1009 191 228 608 166 2202 (1341) 74.3 
  
Comparison of the differentially expressed splicing events revealed that for most proteins 
analyzed approximately 35-75% of the detected changes were unique for that sample, 
however, there was also overlap between the targets identified for G-patch proteins and for 
DHX15. For example, SON regulated 256 splicing events that overlapped with the DHX15 
targets, while ZGPAT and SUGP2 had 78 and 48 events in common with the helicase. 
Common events were also detected between DHX15 and GPKOW, suggesting that multiple 
factors and/or mechanisms might be responsible for alternative splicing regulation at the 
same sites. A notable result was obtained in the case of GPATCH8 and GPATCH11, for 
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which 80% of the splicing changes identified were identical, leading to 180 common target 
events and suggesting that G-patch proteins might also act synergistically or redundantly. 
Figure 3.12. Depletion of G-patch proteins and DHX15 affects both exon skipping and inclusion. Total 
RNA extracted from cells treated for 72 h with a non-target siRNA (NT) or with siRNAs against the indicated 
genes was analyzed by RNA-seq. Changes in alternative splicing between the samples and the NT control were 
determined using MISO and the differentially expressed cassette exon events were further divided into exon 
skipping (DPSI ³ 0.2) and inclusion (DPSI £ -0.2) events. 
To confirm their role in alternative splicing regulation, four G-patch proteins were examined 
in more detail and their effect on the splicing of a few targets was tested experimentally. 
The selected proteins included factors that had not been linked to splicing until now 
(AGGF1) and proteins previously associated with the spliceosome but whose functions or 
targets were not known (SUGP2, TFIP11 and ZGPAT). First, Sashimi plots were generated 
from the MISO analysis for one CE event for each of the four G-patch proteins in order to 
enable visualization of alternative splicing. The Sashimi plots, which display the number of 
reads spanning splice junctions and the read coverage for the alternative and constitutive 
exons alongside the calculated PSI values, clearly indicated that, compared to the NT 
control, depletion of AGGF1 and SUGP2 promoted exon inclusion for RHOT1 and THEM4 
respectively, while knockdown of TFIP11 and ZGPAT led to exon skipping in the case of 
SLIT2 and NF1 (Figure 3.13A-D). 
These changes were also analyzed experimentally by RT-PCR using primers that bind in 
the flanking constitutive exons, which would amplify different amplicon sizes depending on 
whether the alternative exon is included or skipped. For this, total RNA extracted from cells 
treated with a NT siRNA or with siRNAs against the genes of interest was reverse-
transcribed into cDNA, which was used as a template for PCR with primers designed as 
described above. The PCR products were separated on polyacrylamide gels, visualized by 
ethidium bromide staining and the PSI value for each sample was calculated as the ratio of 
the inclusion isoform relative to the total level of the inclusion and skipping isoforms. 
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Figure 3.13. Knockdown of G-patch proteins leads to changes in alternative splicing for specific genes. 
(A-D) RNA extracted from cells treated for 72 h with siRNAs against AGGF1 (A), SUGP2 (B), TFIP11 (C), 
ZGPAT (D) and with a non-target siRNA (siNT) was subjected to RNA-seq followed by alternative splicing 




analysis using MISO. Sashimi plots were generated for one splicing event/gene for each sample to display the 
read coverage as well as the number of reads spanning each splice junction. The alternative exon and the 
flanking constitutive exons are shown as rectangles, while the introns are represented as lines. The PSI (Y) 
values are shown on the right. (E-H) Knockdown samples were obtained as in (A-D) and the same splicing 
events for RHOT1 (E), THEM4 (F), SLIT2 (G) and NF1 (H) were analyzed by RT-PCR and PAGE. The position 
of the exon inclusion and skipping isoforms is marked on the right. The PSI values were determined as the ratio 
of the inclusion isoform relative to the level of both products and the mean ± s.e.m of two experiments is shown. 
The results in Figure 3.13E-H showed that knockdown of AGGF1, SUGP2, TFIP11 and 
ZGPAT induced changes in the splicing of their target genes compared to the NT control 
sample, thus confirming the observations from the RNA-seq data analysis. However, these 
effects were weaker than those determined computationally, which might be due to the 
semi-quantitative nature of the RT-PCR and PAGE methods. GPKOW was used as an 
additional control and its depletion did not affect the splicing of the selected cassette exons. 
Figure 3.14. Specific splicing events are regulated by both DHX15 and its G-patch cofactors. (A-D) Total 
RNA extracted from cells treated for 72 h with a non-target siRNA (NT) or with siRNAs against the indicated 
genes was analyzed by RT-PCR and PAGE to determine the splicing of an alternative exon for UPF3B (A), 
ACIN1 (B), SFXN2 (C) and FAM135A (D). The inclusion and skipping products are indicated on the right and 
the PSI values were calculated as the ratio of the inclusion isoform relative to the total level of both isoforms. 
Results are shown as mean ± s.e.m of two experiments. 
Next, splicing events that were common between these G-patch proteins and DHX15 were 
analyzed using the same approach and changes in the alternative splicing of the target 
genes were observed upon depletion of both the helicase and of its G-patch cofactors 
compared to the control. Knockdown of DHX15 and AGGF1 and of DHX15 and TFIP11 
promoted exon skipping for UPF3B and SFXN2 respectively and similarly, the level of exon 
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inclusion for ACIN1 and FAM135A was increased upon depletion of both the helicase and 
of SUGP2 or ZGPAT (Figure 3.14A-D). Again, knockdown of GPKOW did not show the 
same effects on the splicing of the genes analyzed. Thus, these results suggest that DHX15 
regulates alternative splicing at these sites together with its G-patch cofactors. 
The finding that such a large number of the G-patch protein cofactors of DHX15 are involved 
in alternative splicing raised the possibility that their action is coordinated. Interestingly, 
genes targeted by multiple G-patch proteins at the same splice sites or at different locations 
were also identified in our analysis. One example of such a gene is CD46, for which splicing 
of two alternative exons was found to be impacted by depletion of several G-patch proteins. 
More specifically, knockdown of AGGF1 and ZGPAT had an antagonistic effect on one 
cassette exon event, while depletion of RBM10, SON and SUGP2 promoted exon inclusion 
at a separate site (Figure 3.15A). These splicing changes were tested by RT-PCR, which 
confirmed that multiple G-patch proteins can target a gene at different splice sites and that 
they can regulate the same splicing event either cooperatively or antagonistically (Figure 
3.15B). 
Figure 3.15. Alternative splicing of the CD46 gene is regulated by multiple G-patch proteins. (A) 
Schematic representation of the structure of the CD46 gene with exons and introns depicted by rectangles and 
lines respectively. The two alternatively spliced exons targeted by several G-patch proteins are colored in red 
(E1 and E2) and the proteins whose depletion affects their splicing are shown above, with the arrows indicating 
the effects that they exert (¯ exon skipping, ­ exon inclusion). (B) The splicing of the two alternative exons 
depicted in (A) was analyzed by RT-PCR in cells depleted of the indicated G-patch proteins or in cells treated 
with a control siRNA (siNT). The products corresponding to the inclusion and skipping isoforms are indicated to 
the right of each panel and the PSI values were calculated as the ratio of the inclusion isoform relative to the 
total level of both isoforms. 
The DHX15 and G-patch protein knockdown RNA-seq samples were also analyzed for 
changes in gene expression levels in order to determine correlations with the alternatively 
spliced target genes or other effects on the transcriptome. For this, the normalized read 
count for each gene was expressed as counts per million and the fold change relative to 
Results 
 66 
the control sample was calculated. The output of the analysis showed that depletion of 
DHX15 and of the majority of G-patch proteins tested did not significantly impact gene 
expression, with only a small number of genes (<100) being upregulated or downregulated 
with a log2 fold change of more than 1.5 (Figure 3.16). Exceptions to this were GPATCH8, 
SON and ZGPAT for which 222, 813 and 937 genes were downregulated, and SON and 
ZGPAT for which 186 and 469 genes were upregulated using the same threshold. 
Comparison of the differentially expressed genes with the alternative splicing targets 
identified by MISO revealed that only few of the genes whose splicing was regulated by 
DHX15 and G-patch proteins also showed changes in expression levels. The highest 
overlap was observed in the case of the SON knockdown sample, for which 167 out of the 
1230 splicing targets had a decreased expression, while only one gene was expressed at 
a higher level. 
 
Taken together, the transcriptome analyses following knockdown of DHX15 and of its  
G-patch cofactors revealed that in most cases these proteins regulate alternative splicing 
without influencing gene expression levels. The identification of genes targeted by multiple 
G-patch proteins at the same splice sites or at different locations indicates that the action 
of these cofactors might be coordinated or redundant in some cases. Furthermore, the 
detection of splicing events regulated by both DHX15 and its G-patch cofactors suggests 
that they function together in this pathway. These data also propose novel factors involved 
in alternative splicing such as AGGF1 and provide an overview of the splicing targets for 
the analyzed proteins that represents a resource for more in-depth functional studies. 
Figure 3.16. Knockdown of DHX15 
and of most G-patch proteins does 
not lead to significant changes in 
gene expression levels. Total RNA 
extracted from cells treated with the 
indicated siRNAs was used for RNA-
seq analysis and the obtained reads 
were mapped onto the human 
genome. The read count for each 
gene was normalized to the total 
number of mapped reads and the 
log2 fold change was calculated in 
each knockdown sample relative to 
the control sample. Genes were 
considered differentially expressed if 
the log2 fold change values were  





3.2.3 DHX15 and its G-patch cofactors regulate splicing either directly or indirectly 
The finding that a large number of human G-patch proteins are involved in alternative 
splicing raised the question of whether they regulate the splicing of their target mRNAs by 
direct binding or in an indirect manner. To address this, the HEK293 stable cell lines 
expressing FLAG-tagged G-patch proteins were used in RNA IP experiments to identify 
binding to cellular RNAs. Cells were crosslinked in vivo with UV light of 254 nm, which 
introduced covalent bonds between proteins and RNA, and the tagged G-patch proteins 
were recovered using anti-FLAG beads. The co-precipitated RNA was extracted and 
analyzed by next-generation sequencing followed by mapping of the sequencing reads onto 
the human genome and their assignment to the corresponding genomic features. 
For this analysis, we focused on SUGP2 and ZGPAT, which were among the G-patch 
proteins with the highest number of regulated splicing events (Table 3.3). First, the reads 
mapping to protein-coding genes were examined and, interestingly, for SUGP2 more than 
2000 mRNAs were found enriched compared to the FLAG control with a log2 fold change 
greater than 1.5 (2.25-fold enrichment; Figure 3.17A). Approximately 40% of these target 
mRNAs were enriched at least four-fold and 6% accumulated more than six-fold. In contrast, 
for ZGPAT only about 20 mRNAs were enriched with a log2 fold change greater than 1.5 
relative to the control, suggesting that this protein does not crosslink to mRNAs (Figure 
3.17B).  
Figure 3.17. SUGP2 crosslinks to thousands of mRNAs. (A-B) Stable cell lines expressing SUGP2-FLAG 
or ZGPAT-FLAG and cells encoding the FLAG tag only were crosslinked at 254 nm and protein-RNA complexes 
were immunoprecipitated. The isolated RNA was analyzed by next-generation sequencing and the obtained 
reads were mapped to the corresponding genomic features. Scatterplots displaying the log2 values of the 
normalized read counts (counts per million, CPM) for protein-coding genes in these samples were generated. 
The mRNAs that were enriched with a log2 fold change ³ 1.5 in the SUGP2-FLAG (A) or ZGPAT-FLAG (B) 
sample compared to the FLAG control are colored in red.  
Closer inspection of the distribution of reads mapping to protein-coding genes in the SUGP2 
IP sample revealed a higher percentage of intronic reads compared to reads mapping to 
exons, which was different than the distribution observed for the FLAG control (Figure 
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3.18A). Representative views of the read coverage for three of the SUGP2 target genes 
(AMOT, APMAP and SF3B4) confirmed the accumulation of reads mapping to introns 
(Figure 3.18B). 
Figure 3.18. SUGP2 binds preferentially pre-mRNAs. (A) The reads mapping to protein-coding genes in the 
FLAG and SUGP2-FLAG RIP-seq samples were analyzed to obtain their distribution into exonic and intronic 
regions. (B) The normalized read coverage in the FLAG (black) and SUGP2-FLAG (red) samples for three 
representative genes (AMOT, APMAP and SF3B4) were illustrated using IGV. The exons and introns are 
depicted in blue as rectangles and lines respectively.  
Overall, these results strongly suggested that SUGP2 binds pre-mRNAs at an early stage 
during their processing, which would be consistent with a role in splicing regulation. 
Therefore, the mRNAs bound by SUGP2 in the RIP experiment were compared with the 
mRNAs whose splicing was affected by depletion of this G-patch protein and 38 common 
targets were found (Figure 3.19), including THEM4 for which the role of SUGP2 in its 
alternative splicing had been confirmed by RT-PCR (Figure 3.13F). These results indicate 
that SUGP2 might regulate alternative splicing by direct binding to pre-mRNAs and that the 
two complementary approaches, namely the RIP-seq and the knockdown coupled to  
RNA-seq analysis, could together reveal the full spectrum of RNA targets for SUGP2 and 
for other G-patch proteins. 
Figure 3.19. Overlap between the SUGP2 bound mRNAs and its 
alternative splicing targets. The protein-coding genes enriched in the 
SUGP2-FLAG RIP-seq analysis with a log2 fold change ³ 1.5 relative to 
the FLAG control (RIP targets) were compared with the genes whose 
splicing was affected by knockdown of SUGP2 based on the RNA-seq 
and MISO analysis (Splicing targets) and the overlap is shown. 
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Apart from mRNAs, binding to other RNA types was analyzed and, excitingly, for ZGPAT a 
30-fold increase in the number of reads mapping to scaRNAs was observed compared to 
the FLAG control (Figure 3.20A). These small RNA molecules guide the 2′-O-methylation 
and pseudouridylation of snRNAs that take place in Cajal bodies where ZGPAT was also 
detected by our localization experiments and by prior studies (Figure 3.9; Chen et al., 2017). 
Analogous to scaRNAs, snoRNAs direct the methylation and pseudouridylation of rRNAs 
in the nucleolus. However, a few snoRNAs are involved in the modification of U6 snRNA, 
which follows a different biogenesis pathway than the other spliceosomal snRNAs. 
Figure 3.20. ZGPAT crosslinks to multiple scaRNAs/snRNAs and depletion of DHX15 affects snRNA 
modification. (A) Stable cell lines expressing the FLAG tag or ZGPAT-FLAG were induced with tetracycline 
and crosslinked at 254 nm. The bait proteins were immunoprecipitated and the co-eluted RNA was extracted 
and analyzed by next-generation sequencing. The obtained reads were mapped onto the human genome and 
the normalized read count for scaRNA genes in the two samples is shown. (B) Samples were prepared as in 
(A) except that the isolated RNA was analyzed by northern blotting using the probes indicated on the right. Input 
samples representing 0.5% of the lysates were also included. (C) Total RNA extracted from cells treated with a 
non-target siRNA (siNT) or with siRNAs against ZGPAT and DHX15 was used for site-specific RNase H 
cleavage with oligonucleotides targeting the G11 and G25 residues of U2 snRNA as indicated on the left. The 
reactions were analyzed by northern blotting with a probe against the U2 snRNA and the position of the 
uncleaved and cleaved products is indicated on the right. 
Analysis of the RIP-seq read distribution for individual scaRNA genes revealed that multiple 
scaRNAs were significantly enriched in the ZGPAT eluate, with SCARNA2 accumulating 
approximately 80 times more compared to the control sample (Table 3.4). Interestingly, 
SCARNA2 guides the 2′-O-methylation of U2 snRNA G25 and C61 and is also processed 
into a shorter fragment (mgU2-61) that likewise directs methylation of U2 snRNA C61 and 
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also of U2 snRNA G11 (Lestrade and Weber, 2006). Other ZGPAT targets included 
scaRNAs involved in the methylation and/or pseudouridylation of U1, U2, U4 and U5 
snRNAs (Table 3.4), as well as the snoRNAs SNORA79B and SNORD10 that act on U6 
snRNA. 
Table 3.4. Overview of the scaRNAs and snRNAs enriched in the ZGPAT RIP-seq analysis. The 
normalized read count for scaRNA and snRNA genes expressed as counts per million (CPM) is shown for the 
ZGPAT-FLAG RIP-seq sample together with the log2 fold change relative to the FLAG control sample. 
scaRNA/snRNA CPM ZGPAT log2 CPM (ZGPAT/FLAG) 
SCARNA2 5298.8 6.3 
SCARNA12 1783.1 5.9 
SCARNA17 54.2 5.4 
SCARNA9 162.4 5.1 
SCARNA6 418.9 5.1 
SCARNA5 562.1 5.0 
SCARNA13 963.6 4.9 
SCARNA10 2425.7 4.8 
SCARNA7 752.6 4.0 
SCARNA21 43.3 3.5 
SCARNA22 37.7 2.1 
SCARNA4 3.9 1.9 
SCARNA8 2.5 1.2 
SCARNA14 0.8 1.1 
SCARNA11 1.2 1.1 
SCARNA3 1.2 0.9 
SCARNA21B 0.3 0.7 
SCARNA1 10.4 0.6 
SCARNA16 140.2 0.4 
SCARNA23 4.1 0.4 
SCARNA20 0.5 0.3 
SCARNA15 0.1 0.3 
SCARNA18B 0.1 0.0 
SCARNA18 0.6 -0.1 
U4 snRNA 10527 4 
U6 snRNA 254 3.9 
U1 snRNA 11473.4 0.6 
U2 snRNA 1667 0.2 
U5 snRNA 203.9 0.2 
 
In addition to scaRNAs and snoRNAs, an accumulation of U4 and U6 snRNAs was 
observed for the ZGPAT IP sample compared to the FLAG control, which is in agreement 
with results from another study (Chen et al., 2017). However, our data did not show binding 
of the G-patch protein to U5 snRNA as reported in the same study, suggesting that ZGPAT 
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does not directly contact U5 snRNA and that the previously described interaction was most 
likely indirect. 
To confirm the RNA interactions detected for ZGPAT, the RNA IP was repeated and this 
time the samples were analyzed by northern blotting using probes complementary to a few 
selected scaRNA and snRNA targets. The experiment was done with cells expressing only 
the FLAG tag or FLAG-tagged ZGPAT, DHX15 and RBM5, with the latter serving as an 
additional control for specificity. The results of the northern blotting analysis confirmed the 
binding of ZGPAT to multiple scaRNAs (SCARNA2 full-length and mgU2-61 fragment, 
SCARNA12, SCARNA5, SCARNA13 and SCARNA10) as well as to U4 and U6 snRNAs 
(Figure 3.20B). At the same time, the levels of U1, U2 and U5 snRNAs were not increased 
in the ZGPAT eluate relative to the FLAG control, indicating specific binding of the G-patch 
protein to its scaRNA and snRNA targets. For DHX15, despite its strong interaction with 
ZGPAT (Figure 3.2; Table 3.2), none of the analyzed scaRNAs were enriched in the elution 
fraction compared to the FLAG and RBM5 IP samples, suggesting that the helicase might 
be associated with these small RNAs indirectly or transiently and that only the G-patch 
protein contacts them directly. RBM5 did not interact with any of the scaRNAs and snRNAs 
tested except for U2 snRNA, which is in line with its detection in U2 snRNP-related 
spliceosomal complexes (Agafonov et al., 2011). 
The direct crosslinking of ZGPAT to U4 and U6 snRNAs is consistent with the identification 
of these components in a 35S splicing complex that also contains U5 snRNA, DHX15 and 
other splicing factors and that represents an intermediate in the assembly of the U4/U6.U5 
tri-snRNP (Chen et al., 2017). Interestingly, our data revealed that ZGPAT binds scaRNAs 
that guide modification of all spliceosomal snRNAs and not only of U4 and U6 snRNAs, 
indicating that this protein might have several independent functions in splicing. Therefore, 
given that its association with U4 and U6 has been described elsewhere and has been 
suggested to involve DHX15, the next aim was to understand the functional basis of the 
interactions that ZGPAT establishes with scaRNAs and to determine whether the helicase 
is implicated in this as well. 
To check if ZGPAT and DHX15 play a role in the scaRNA-guided modification of snRNAs, 
the modification status of U2 snRNA at two sites of 2′-O-methylation (G11 and G25) that 
are targeted by the SCARNA2 fragment mgU2-61 or by full-length SCARNA2 respectively 
was analyzed using a site-specific RNase H cleavage assay. In this method, RNase H is 
guided by a 2′-O-methyl RNA-DNA chimeric oligonucleotide and cleaves the snRNA-DNA 
duplex region at a specific residue unless the target base is 2′-O-methylated. Total RNA 
extracted from cells treated with NT siRNA or with siRNAs against ZGPAT or DHX15 was 
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incubated with or without RNase H in the presence of the chimeric oligonucleotides and the 
reaction products were analyzed by northern blotting using a probe to detect U2 snRNA. In 
the control samples treated with NT siRNA, U2 snRNA was not cleaved by RNase H (Figure 
3.20C), which is consistent with the almost complete 2′-O-methylation of the G11 and G25 
residues in normal conditions (Krogh et al., 2017). On the other hand, in the DHX15 
knockdown sample, U2 snRNA was cleaved at both G11 and G25, albeit weakly at the latter 
site, indicating a decrease in the methylation level of these residues. Considering that 
ZGPAT was found to crosslink to the scaRNAs responsible for these modifications, this 
suggested that DHX15 might have a direct role in the scaRNA-guided methylation of U2 
snRNA together with the G-patch protein. Contrary to this hypothesis, knockdown of ZGPAT 
did not affect the extent of 2′-O-methylation at the sites tested (Figure 3.20C). This might 
be explained by the less efficient knockdown of ZGPAT, implying that the residual protein 
is sufficient for carrying out this function (Figure 3.10). Alternatively, ZGPAT might not be 
required for snRNA modification, but instead might bind scaRNAs for another purpose, such 
as assisting in their biogenesis. Furthermore, it is also possible that the role of DHX15 in 
snRNA modification is not linked to scaRNAs and is instead mediated through the protein 
components of the 2′-O-methylation machinery (FBL, NOP56, NOP58, SNU13), but 
inspection of the RNA-seq data did not reveal any changes in the expression level or 
alternative splicing of these factors upon knockdown of DHX15. Taken together, these data 
show that ZGPAT interacts directly with multiple scaRNAs and suggest that this might be 
linked to the role of DHX15 in snRNA modification, which in turn could influence pre-mRNA 
splicing. 
3.2.4 DHX15 and the G-patch protein NKRF function together in ribosome biogenesis 
3.2.4.1 DHX15 and NKRF form a nucleolar complex with XRN2 
The results so far showed that DHX15 and a large number of its G-patch cofactors regulate 
splicing, either by probably binding directly to target mRNAs as in the case of SUGP2 or by 
influencing snRNA modification patterns as suggested for DHX15 possibly together with 
ZGPAT. Thus, DHX15 likely impacts splicing at multiple levels through its G-patch cofactors 
and acts as a master regulator of this process. In higher eukaryotes, the majority of RNA 
helicases are suggested to be multifunctional and to regulate different steps of gene 
expression in a coordinated manner (Jankowsky, 2011; Bourgeois et al., 2016). Therefore, 
we explored additional functions of DHX15 and, since four of its G-patch cofactors are 
localized in nucleoli (Figure 3.9), the attention was focused on ribosome biogenesis, which 
is initiated at these sites. IP experiments followed by MS analysis identified the nucleolar 
protein NKRF as the top interacting G-patch protein for FLAG-DHX15 based on the total 
spectral counts and the enrichment compared to the control (Table 3.2). Apart from NKRF, 
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another protein highly abundant in the DHX15 IP sample was the 5′-3′ exonuclease XRN2 
(124-fold enrichment relative to the FLAG control), which is involved in multiple aspects of 
RNA metabolism, including ribosome biogenesis (Miki and Grosshans, 2013). Interestingly, 
XRN2 was found to interact in mammals with proteins containing a DUF3469 domain (also 
called XRN-Two-Binding-Domain, XTBD) and sequence analysis revealed that the G-patch 
protein NKRF is among the three human XTBD-containing proteins (Miki et al., 2014; 
Richter et al., 2016). This indicated that NKRF might also bind XRN2, and given the strong 
association between NKRF and DHX15, we hypothesized that these interactions might be 
related. Therefore, to study whether DHX15, NKRF and XRN2 are present together in 
endogenous complexes, immunoprecipitation with an anti-NKRF antibody was performed 
and the co-precipitated proteins were analyzed by western blotting. This showed that 
together with NKRF, both DHX15 and XRN2 were recovered in the anti-NKRF IP eluate but 
not in the control sample (Figure 3.21A). At the same time, the nucleolar protein 
Nucleophosmin was not co-precipitated with NKRF, demonstrating the specificity of the 
interactions with DHX15 and XRN2. 
Figure 3.21. DHX15, NKRF and XRN2 are associated into a complex in vivo. (A) HeLa cells were used for 
immunoprecipitation with an anti-NKRF antibody and the eluates (IP) were analyzed by western blotting with 
the indicated antibodies. A control IP using beads lacking the antibody (Beads) and an input sample 
representing 1% of the lysate were also analyzed. (B) Extracts from HeLa cells that were either untreated (WT) 
or treated for 96 h with a control siRNA (siNT) or with siRNAs against the indicated targets were analyzed by 
western blotting to determine the levels of the proteins shown on the right. (C-D) HEK293 cells were treated 
with the indicated siRNAs for 96 h and the expression of FLAG-tagged XRN2 (C) or DHX15 (D) was induced in 
the last 24 h with tetracycline. Lysates prepared from these cells were used for anti-FLAG IPs and the co-
precipitated proteins were detected by western blotting using the indicated antibodies. Untreated cells (WT) 




To gain insight into how the DHX15-NKRF-XRN2 complex is organized, the 
interdependency of these interactions was examined by depleting each protein and 
analyzing the association between the other two factors. First, siRNA-mediated 
knockdowns of DHX15, NKRF and XRN2 were established and efficient depletion of the 
target proteins was confirmed by western blotting (Figure 3.21B). Stable cell lines encoding 
FLAG-tagged XRN2 or DHX15 were treated with these siRNAs or with a non-target siRNA, 
followed by induction of transgene expression and IP with an anti-FLAG antibody. The 
results of the western blotting analysis showed that FLAG-XRN2 interacted efficiently with 
both DHX15 and NKRF when treated with non-target siRNA, but upon depletion of NKRF, 
its interaction with DHX15 was strongly reduced (Figure 3.21C). In contrast, knockdown of 
DHX15 did not influence binding of FLAG-XRN2 to NKRF. Similarly, both NKRF and XRN2 
were recovered with FLAG-DHX15 in cells treated with siNT and depletion of NKRF affected 
the interaction between FLAG-DHX15 and XRN2 (Figure 3.21D). However, knockdown of 
XRN2 did not influence binding of FLAG-DHX15 to NKRF. In all cases, cells expressing the 
FLAG tag were used as a control and none of the analyzed proteins were co-precipitated 
with this sample. Overall, these results demonstrate that DHX15, NKRF and XRN2 
associate in a complex in vivo and that NKRF mediates the interaction between DHX15 and 
XRN2.  
Several studies have shown that the regulation of RNA helicases by G-patch proteins 
requires the G-patch domain of the cofactor and the OB-fold region of the helicase (Lebaron 
et al., 2009; Christian et al., 2014; Heininger et al., 2016; Inesta-Vaquera et al., 2018). In 
addition to its G-patch domain, NKRF contains a domain (XTBD) that has been described 
in other proteins to mediate binding to XRN2 (Miki et al., 2014; Richter et al., 2016). Based 
on these observations, the contribution of the different regions of NKRF and of the DHX15 
OB-fold domain for their interactions within the complex with XRN2 was analyzed. For 
NKRF, a truncated form lacking the XTBD (NKRF110-705) and a mutant protein containing six 
glycine to alanine substitutions in the G-patch domain (NKRFG1-6A) were generated, while 
for DHX15 the OB-fold domain was deleted to produce a truncated protein (DHX151-698). 
These constructs were expressed with a FLAG tag from HEK293 stable cell lines together 
with the wild-type proteins and the FLAG tag only control, and immunoprecipitation 
experiments were carried out. Western blotting analysis of the IP samples revealed, as 
expected, that wild-type FLAG-NKRF interacted with XRN2 and DHX15 (Figure 3.22A). 
Similarly, FLAG-NKRF110-705 bound both proteins, indicating that for NKRF the XTBD is not 
required for association with XRN2 as in other proteins. On the other hand, mutations in the 
G-patch domain of NKRF or deletion of the OB-fold domain of DHX15 led to a loss of the 
NKRF-DHX15 interaction, demonstrating that these proteins associate in a similar mode to 
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other G-patch protein-RNA helicase complexes (Figure 3.22A-B). In addition, while binding 
of NKRFG1-6A to XRN2 was only mildly affected, DHX151-698 was not able to interact with 
XRN2, supporting the model that NKRF is the core component of the complex with DHX15 
and XRN2.  
Figure 3.22. The NKRF-DHX15 interaction is mediated by the G-patch domain of NKRF and the OB-fold 
of the helicase. (A-B) HEK293 stable cell lines were induced for 24 h with tetracycline to express the indicated 
NKRF (A) and DHX15 (B) variants or the FLAG tag. Cell extracts were used in IP experiments with an anti-
FLAG antibody followed by western blotting detection of the co-precipitated proteins using the indicated 
antibodies. The panels in this figure were originally published in Memet et al., 2017. 
Having established that DHX15, NKRF and XRN2 associate in a complex in vivo, the next 
aim was to determine in which cellular compartment these interactions occur. All three 
factors have been identified in proteomic screens of isolated nucleoli and the localization 
studies for FLAG-tagged NKRF confirmed that the G-patch protein is present at these sites 
(Andersen et al., 2005; Figure 3.9). To assess if endogenous NKRF is also found in nucleoli 
and to check for the localization of DHX15 and XRN2, immunofluorescence microscopy 
was performed in HeLa cells using antibodies against these proteins together with an 
antibody against the rRNA methyltransferase NSUN5 as a nucleolar marker. The results in 
Figure 3.23A showed that DHX15, NKRF and XRN2 were present in nucleoli based on 
colocalization with NSUN5, suggesting that they interact at these sites. DHX15 and XRN2 
also displayed a nucleoplasmic staining consistent with their known functions in processes 
such as pre-mRNA splicing and RNA polymerase II transcription respectively. To assess if 
the DHX15-NKRF-XRN2 complex is assembled in the nucleolus, subcellular fractionation 
of cells expressing the FLAG tag or FLAG-DHX15 was performed to isolate nucleoli, whose 
purity was confirmed by western blotting using antibodies against a-Tubulin, PCNA and 
Fibrillarin as markers for the cytoplasm, nucleoplasm and nucleoli respectively (Figure 
3.23B). Lysates prepared from the purified nucleoli were used in anti-FLAG IP experiments, 
which showed that FLAG-DHX15 interacted with both NKRF and XRN2 in this subcellular 
compartment (Figure 3.23C). In contrast, the nucleolar protein Nucleophosmin was not  




Figure 3.23. DHX15, NKRF and XRN2 interact in the nucleolus and co-migrate with pre-ribosomal 
complexes. (A) HeLa cells were analyzed by immunofluorescence microscopy using antibodies against 
endogenous NKRF, DHX15 or XRN2 (Endog., green) and the nucleolar protein NSUN5 (red). Nuclei were 
visualized by DAPI staining (blue) and overlays of the three channels are shown (Merge). The scale bar 
represents 10 µm. (B) Subcellular fractionation of cells expressing the FLAG tag or FLAG-DHX15 was 
performed and samples corresponding to whole lysates (Total) and the nucleoplasmic (Nuc) and nucleolar (No) 
fractions were analyzed by western blotting using antibodies against a-Tubulin, PCNA and Fibrillarin as markers 
for the cytoplasm, nucleoplasm and nucleoli respectively. (C) Lysates prepared from nucleoli isolated as in (B) 
were used in IP experiments with an anti-FLAG antibody and the co-eluted proteins were analyzed by western 
blotting together with input samples representing 1% of the nucleolar lysates. (D) HeLa cell extracts were 
separated on sucrose gradients and the obtained fractions were analyzed by western blotting using antibodies 
against the indicated proteins. The absorbance at 260 nm was measured for each fraction to determine the 
position of the 40S and 60S ribosomal subunits and of the 80S monosome. This figure was originally published 
in Memet et al., 2017. 
The nucleolus represents the site at which ribosome production is initiated and contains a 
high concentration of pre-ribosomal complexes that are formed through the recruitment of 
ribosomal proteins and ribosome assembly factors to sites of rDNA transcription. Therefore, 
to check whether DHX15, NKRF and XRN2 associate with pre-ribosomes, whole cell 
extracts were separated on sucrose gradients and the distribution of these proteins in 
fractions of different sedimentation coefficients was followed by western blotting. The 
fractions containing the mature 40S small ribosomal subunit, the 60S large ribosomal 
subunit and the 80S ribosome were determined by measuring the RNA content (absorbance 
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at 260 nm, A260) and by the presence of the ribosomal proteins RPS3A and RPL15 (Figure 
3.23D). The position of the different pre-ribosomal complexes was established based on 
the migration patterns of previously described ribosome biogenesis factors: the 90S/early 
pre-40S components UTP14A and PWP2, and the pre-60S and late pre-40S factors PES1 
and WBSCR22 respectively (Dosil and Bustelo, 2004; Rohrmoser et al., 2007; Hu et al., 
2011; Ounap et al., 2013; Haag et al., 2015; Sloan et al., 2015). Analysis of the distribution 
of DHX15, NKRF and XRN2 in the sucrose gradient fractions showed that they co-migrated 
both in the top part of the gradient that contains free proteins and small complexes as well 
as in fractions containing (pre)-ribosomal particles (Figure 3.23D). Together with the 
nucleolar localization of these proteins, these results indicate that DHX15, NKRF and XRN2 
associate with pre-ribosomes during their maturation. 
3.2.4.2 NKRF crosslinks to the pre-rRNA transcript at several sites 
To decipher the function of the DHX15-NKRF-XRN2 complex, the RNA interactions that the 
core component NKRF forms in cells were studied, similar to the genome-wide analyses 
employed to identify the RNA targets of other G-patch proteins described in 3.2.2. However, 
due to its association with pre-ribosomes, a different approach was required for NKRF that 
would also enable the identification of its binding site(s) on (pre)-rRNA. Thus, the 
crosslinking and analysis of cDNA (CRAC) method was used, in which cells expressing 
FLAG-NKRF or the FLAG tag only were crosslinked with UV at 254 nm to introduce covalent 
bonds between proteins and their interacting RNAs (UV-CRAC). Alternatively, cells were 
treated for 6 h with the photoactivatable ribonucleoside 4-thiouridine, which when 
incorporated into RNA can be specifically crosslinked to proteins using UV light of 365 nm 
(PAR-CRAC; Hafner et al., 2010). After crosslinking, the FLAG-tagged proteins, which also 
contain a His6 tag in their sequence (Table 2.3), were recovered in a two-step purification 
using anti-FLAG and Ni-NTA beads. A partial RNase digestion step was performed to 
remove any RNAs that were not protected by the protein and the trimmed RNA was ligated 
to sequencing adapters, reverse-transcribed and amplified by PCR to generate a library for 
next-generation sequencing. Mapping of the sequencing reads onto the human genome 
showed an accumulation of reads corresponding to (pre)-ribosomal RNA in the FLAG-
NKRF sample compared to the FLAG control (36% compared to 13% for UV-CRAC and 
14% compared to 2% for PAR-CRAC of the total number of mapped reads; Figure 3.24A-
B). Visualization of the CRAC read coverage at the rDNA locus encoding the 47S pre-rRNA 
transcript revealed several binding sites for NKRF, in the spacer regions as well as within 
the 28S rRNA sequence (Figure 3.24C-D). 
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Figure 3.24. NKRF crosslinks to the pre-rRNA transcript in the spacer regions and within the 28S rRNA. 
(A-B) HEK293 stable cells expressing the FLAG tag or FLAG-NKRF were crosslinked at 254 nm (UV; A) or 
were treated with 4-thiouridine for 6 h and crosslinked at 365 nm (PAR; B). Protein-RNA complexes were 
isolated and the RNA fragments protected by the protein were extracted and used to generate a cDNA library 
for next-generation sequencing. The sequencing reads were mapped onto the human genome and the 
distribution of reads into the different classes of RNA is shown. (C-D) UV-CRAC (C) or PAR-CRAC (D) 
sequencing reads were analyzed as in (A-B) and the read coverage for the rDNA locus encoding the 47S  
pre-rRNA transcript is shown for the FLAG (gray) and FLAG-NKRF (red/blue) samples. A schematic 
representation of the 47S transcript with the mature rRNAs and the spacer regions drawn as rectangles and 
lines respectively is shown below each panel. (E-G) Magnified views of the read coverage corresponding to the 
5′ETS (E), ITS1 (F) and ITS2 (G) regions of the pre-rRNA with the cleavage sites marked below each panel. 
The lower panels show the number of reads containing deletions or substitutions (Mutations) in the UV-CRAC 




Closer examination of the reads mapping to pre-rRNA spacers showed NKRF crosslinking 
sites in the 5′ETS, ITS1 and ITS2 regions that mostly overlapped in the two methods used 
(Figure 3.24E-G). For UV-CRAC, these binding sites were supported by the detection of 
mutations at these loci, which are generally introduced at the reverse transcription step 
when a crosslinked nucleotide is encountered. Thus, these data imply that NKRF binds the 
pre-rRNA transcript at an early stage during its maturation and taken together with the 
association of DHX15, NKRF and XRN2 with pre-ribosomal particles suggest that this 
nucleolar complex might have a role in ribosome production. 
3.2.4.3 DHX15, NKRF and XRN2 are required for efficient pre-rRNA processing 
To gain further insight into the function of the complex involving DHX15, NKRF and XRN2, 
knockdowns of all three factors were performed and the processing of pre-rRNA was 
analyzed by northern blotting using probes hybridizing at specific sites to detect the different 
precursors of the mature rRNAs (Figure 3.25A). This showed that, compared to untreated 
cells (WT) or cells treated with NT siRNA, depletion of DHX15, NKRF and XRN2 led to an 
increase in the levels of the 47S and 30SL5′ intermediates, which accumulate when 
processing at site A′ in 5′ETS is impaired and is preceded by cleavage in ITS1 (Figure 
3.25B). Nevertheless, knockdown of these factors did not impact the production of mature 
ribosomal subunits as revealed by pulse-chase labelling and detection of newly-synthesized 
18S and 28S rRNA, as well as analysis of the steady-state levels of the mature rRNAs by 
methylene blue staining, indicating that only the order of the processing events is affected 
(Figure 3.25B; Figure 3.26). Consistent with these results, changes in the kinetics of the 
different pre-rRNA cleavage steps have been previously observed after knockdown of 
XRN2 and it has been suggested that the existence of several processing pathways might 
ensure that the production of the mature rRNAs is not blocked (Sloan et al., 2013). In 
addition, despite the fact that A′ cleavage is suggested to take place co-transcriptionally, 
the pulse-chase analysis did not show any significant changes in pre-rRNA transcription 
after knockdown of these factors (Figure 3.26; Lazdins et al., 1997). 
Depletion of NKRF and XRN2, but not of DHX15, also caused an accumulation of the 36S 
precursor, which forms when cleavage in ITS1 takes place at site E before site 2, and of 
the 12S intermediate, which is generated by processing of 32S and is the precursor to the 
5.8S mature rRNA (Figure 3.25B). This indicated that NKRF and XRN2 might have 
additional roles in pre-rRNA processing that are independent of the helicase. In line with 
this, knockdown of NKRF and XRN2 also led to an increase in the levels of the pre-rRNA 
spacer fragments corresponding to the 5′-A′ and A0-1 regions in 5′ETS, and the E-2 and 
4a-4 regions in ITS1 and ITS2 respectively, which are normally degraded by the 
exonuclease after being excised (Figure 3.25C; Wang and Pestov, 2011; Schillewaert et 
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al., 2012; Sloan et al., 2013; Sloan et al., 2014). Considering that NKRF was found to 
crosslink to these pre-rRNA spacers (Figure 3.24), these results imply that the G-patch 
protein is required for the function of XRN2 in their turnover. Taken together, these data 
suggest that DHX15, NKRF and XRN2 are required for efficient pre-rRNA cleavage at site 
A′ in the 5′ETS, while NKRF and XRN2 also function together in the degradation of  
pre-rRNA spacer sequences that are released during processing.  
Figure 3.25. DHX15, NKRF and XRN2 are required for pre-rRNA processing and turnover of by-products. 
(A) Schematic representation of the pre-rRNA processing pathway in human cells. The mature rRNAs are 
shown as rectangles and the spacer regions are drawn as lines. The cleavage sites are marked above the 47S 
transcript and the hybridization position of the probes indicated in the box is shown below. The aberrant 
intermediates that are not part of the normal processing pathway are colored in gray. (B) HeLa cells were either 
untreated (WT) or treated for 96 h with a control siRNA (siRNA) or with siRNAs against the indicated genes. 
Total RNA extracted from these cells was analyzed by northern blotting and the different pre-rRNA 
intermediates, which are marked on the left, were detected using the probes indicated on the right side. The 
28S and 18S mature rRNAs were visualized by methylene blue (MB) staining. (C) Samples were prepared as 
in (B) and the levels of the pre-rRNA fragments indicated on the left were analyzed by northern blotting using 




Figure 3.26. Knockdown of DHX15, NKRF or XRN2 does not affect pre-rRNA transcription and the 
production of mature rRNAs. HeLa cells were treated for 84 h with a non-target siRNA (siNT) or with siRNAs 
against NKRF, XRN2 or DHX15 and nascent RNAs were labelled with [32P]-orthophosphate. After labelling, 
cells were grown in unlabelled media and harvested at the indicated time points. Total RNA was extracted and 
analyzed by northern blotting followed by detection of the labelled nascent RNAs by phosphorimaging. In 
addition, actin mRNA, which served as a loading control, was detected using a specific probe and the steady-
state levels of the mature 28S and 18S rRNA were visualized by methylene blue staining (MB). This figure was 
originally published in Memet et al., 2017. 
3.2.4.4 NKRF regulates the function of XRN2 in the degradation of pre-rRNA 
processing by-products 
The common defect in the turnover of fragments excised during pre-rRNA processing 
observed in cells lacking either NKRF or XRN2 indicated that depletion of the G-patch 
protein impaired the activity of the 5′-3′ exonuclease at these sites. Interestingly, this 
function of XRN2 was previously found to be regulated by CARF, whose overexpression 
led to a relocalization of the exonuclease into the nucleoplasm and, consequently, to an 
accumulation of these pre-rRNA fragments (Sato et al., 2015). Similar to NKRF, CARF 
contains an XTBD and interacts with XRN2, raising the possibility that the nucleolar 
localization and function of the exonuclease in the turnover of pre-rRNA processing  
by-products is dynamically regulated through interactions with both NKRF and CARF (Miki 
et al., 2014; Richter et al., 2016). 
Therefore, to assess if NKRF also influences the localization of XRN2, the levels of the  
G-patch protein were depleted in cells stably expressing GFP-tagged XRN2 from a 
tetracycline-inducible promoter and the subcellular distribution of the exonuclease was 
followed by fluorescence microscopy. Compared to cells treated with NT siRNA in which 
GFP-XRN2 was detected in the nucleoplasm and nucleoli, knockdown of NKRF led to a 
strong reduction of the nucleolar fraction of XRN2, indicating that the G-patch protein is 
required for its recruitment to these sites (Figure 3.27A). In contrast, depletion of DHX15 
did not influence the localization of the exonuclease. To further demonstrate that in the 
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absence of NKRF, XRN2 is not able to associate with nucleolar pre-ribosomal particles, 
lysates prepared from cells treated with a control siRNA or with siRNAs against NKRF or 
DHX15 were separated on sucrose gradients and the distribution of the 5′-3′ exonuclease 
in the different fractions was determined by western blotting. In line with our previous 
findings, XRN2 was found to co-migrate with pre-ribosomal complexes in cells treated with 
NT siRNA and depletion of DHX15 did not influence the levels of XRN2 in these fractions 
(Figure 3.27B). In contrast, knockdown of NKRF led to a strong reduction of the amount of 
XRN2 associated with pre-ribosomal particles, demonstrating that NKRF is indeed required 
for the nucleolar recruitment of XRN2 and consequently for its activity in the turnover of  
pre-rRNA substrates.  
Figure 3.27. NKRF is required for the nucleolar localization of XRN2. (A) Stable cells encoding GFP-XRN2 
were treated for 96 h with the siRNAs indicated on the left and the expression of the transgene was induced in 
the last 24 h with tetracycline. The GFP-XRN2 signal was visualized directly (green), while the localization of 
the nucleolar protein UTP14A was detected using a specific antibody (red). Nuclei were visualized by DAPI 
staining (blue). Overlays of the three channels are shown on the right (Merge) and the scale bar represents  
10 µm. (B) Lysates prepared from HeLa cells treated with a non-target siRNAs or with siRNAs against NKRF 
or DHX15 were subjected to sucrose gradient centrifugation and the distribution of XRN2 in the different 
fractions was analyzed by western blotting. The position of the co-migrating ribosomal/pre-ribosomal complexes 
is indicated below the panel. The panels in this figure were originally published in Memet et al., 2017. 
3.2.4.5 NKRF stimulates the activity of DHX15 for efficient processing of the pre-rRNA 
transcript at a specific site 
After establishing that the common pre-rRNA processing defects observed after depletion 
of NKRF and XRN2 likely arise due to a failure to recruit the exonuclease to its nucleolar 
substrates, the next focus was to elucidate the molecular basis of the impaired A′ cleavage 
that was detected upon knockdown of DHX15, NKRF and XRN2 (Figure 3.25B). Our 
previous in vitro data showed that the G-patch domain of NKRF enhanced the activity of 
DHX15 both at the level of RNA binding and ATP hydrolysis (Figure 3.5; Figure 3.7). To 
gain more insight into the role of this G-patch protein as an RNA helicase cofactor, the 
effects of full-length NKRF on the ATPase and unwinding activities of DHX15 were also 
tested. After confirming that full-length recombinant MBP-NKRF-His10 was capable of 
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stimulating ATP hydrolysis by DHX15, these proteins were used in unwinding assays with 
a labelled RNA-DNA duplex as a substrate. Visualization of the unwinding reaction products 
by PAGE and phosphorimaging revealed that, while on its own the helicase was not able 
to disrupt the duplex, significant unwinding was detected when DHX15 and NKRF were 
incubated together with the substrate in the presence of ATP (Figure 3.28A). Therefore, 
these results indicate that the G-patch protein stimulates both the ATPase and unwinding 
activities of DHX15. 
Figure 3.28. The activity of DHX15 is stimulated by NKRF and is required for efficient pre-rRNA 
processing. (A) Unwinding assays with recombinant DHX15 and DHX15E261Q were performed in the presence 
or absence of NKRF and/or ATP using a radiolabelled RNA-DNA duplex. The reactions were stopped after 10 
min and 20 min and the double-stranded (ds) and single-stranded (ss) products were separated by PAGE and 
detected by phosphorimaging. A control sample in which the duplex was denatured at 95°C was also analyzed. 
(B) HEK293 cells encoding the FLAG tag, FLAG-DHX15 or FLAG-DHX15E261Q were treated with a non-target 
siRNA (siNT) or with a siRNA against DHX15 (siDHX15) and expression of the transgene was induced for 24 h 
with tetracycline. RNA and protein samples were analyzed by northern blotting (top) using the ETS1 probe and 
by western blotting (bottom) with antibodies against DHX15 and a-Tubulin. The panels in this figure were 
originally published in Memet et al., 2017. 
To assess if the catalytic activity of the RNA helicase is required for pre-rRNA processing 
at site A′, an in vivo complementation system was established that enables knockdown of 
endogenous DHX15 and expression of a FLAG-tagged transgene encoding either wild-type 
DHX15 or a mutant version containing a glutamate to glutamine substitution in the DEAH 
motif (DHX15E261Q) that is essential for ATP binding and hydrolysis. Analysis of the levels 
of DHX15 by western blotting and of pre-rRNA processing by northern blotting showed an 
accumulation of the 47S and 30SL5′ intermediates when endogenous DHX15 was depleted 
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and only the FLAG tag was expressed, compared to the control sample treated with NT 
siRNA (Figure 3.28B). Expression of FLAG-tagged DHX15 from a transgene rescued these 
defects, however, upon expression of DHX15E261Q to a similar level, the 47S and 30SL5′ 
precursors still accumulated. Unwinding assays with recombinant DHX15E261Q confirmed, 
as expected, that this protein is catalytically inactive and, moreover, anti-FLAG IP 
experiments showed that the mutant helicase was able to associate with NKRF and XRN2 
in vivo (Figure 3.28A and C). Together, these results indicate that the catalytic activity of 
DHX15, which is stimulated by the G-patch cofactor NKRF, is the main determinant for the 
function of the complex in pre-rRNA processing at site A′, suggesting that structural 





4.1 G-patch protein-RNA helicase interactions in human cells 
RNA helicases are ubiquitous enzymes that catalyze the NTP-dependent remodeling of 
RNA and RNA-protein complexes. Individually, most RNA helicases have the ability to 
perform more than one cellular activity and, altogether, they accomplish a wide range of 
functions and participate in every RNA-related process (Jankowsky, 2011). In recent years, 
a multitude of interacting proteins that modulate different aspects of the function of RNA 
helicases have been identified (Young and Karbstein, 2012; Sloan and Bohnsack, 2018). 
These helicase cofactors provide several layers of regulation that are necessary due to the 
characteristics of this family of enzymes. First, RNA helicases share a highly similar 
helicase core that lacks the ability to specifically recognize RNA substrates. Therefore, it 
has been suggested that in order to act on diverse substrates and carry out such broad 
activities, the specificity of RNA helicases for their RNA targets and/or functions is controlled 
through other mechanisms. Furthermore, several RNA helicases were shown to have a low 
activity in vitro and it was proposed that they are found in an auto-inhibited conformation in 
the cell, from which they would be released by the action of interacting proteins (Ozgur et 
al., 2015; Robert-Paganin et al., 2017). The default inactive state might be required to 
prevent unwanted cellular activities and enable the activation of RNA helicases at specific 
stages or subcellular locations. Similarly, the distinct activities of multifunctional RNA 
helicases could be regulated in a spatial and temporal manner by interactions with multiple 
cofactors. The requirement for helicase cofactors can be extended to other functions as 
well. For example, the MIF4G domain cofactor CWC22 chaperones the RNA helicase 
eIF4A-III to its target site by preventing unspecific RNA binding (Barbosa et al., 2012). At a 
subsequent stage, the interaction of eIF4A-III with other cofactors, namely MAGOH and 
Y14, inhibits the release of Pi after ATP hydrolysis and clamps the RNA helicase on the 
substrate RNA to promote the assembly of the exon-junction complex (Ballut et al., 2005; 
Nielsen et al., 2009). Thus, RNA helicases associate with protein cofactors that modulate 
their activity in diverse ways and increase the complexity of their function, which is 
necessary for the wide range of specific roles that these enzymes have in the cell. 
The inventory of RNA helicase cofactors described so far includes several yeast and human 
proteins that contain a G-patch domain. The potential role of G-patch proteins as a 
dedicated family of RNA helicase cofactors has recently become apparent after the 
characterization of a growing number of such helicase-cofactor complexes (Robert-Paganin 
et al., 2015; Sloan and Bohnsack, 2018). The G-patch domain was found to be essential 
for the regulation of RNA helicases, raising the possibility that every protein containing this 
motif might act as a helicase cofactor. Indeed, all five G-patch proteins identified in yeast 
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were shown to modulate the activity of an RNA helicase. However, much less was known 
about the role of human G-patch proteins as cofactors of RNA helicases. Interestingly, the 
human genome encodes 22 proteins that contain a G-patch domain compared to five 
proteins in yeast. This might be linked to the larger number of RNA helicases expressed in 
human cells as well as to the higher complexity needed for their regulation, as most 
helicases in higher eukaryotes are probably multifunctional and coordinate several cellular 
events. At the start of this project, only four human G-patch proteins were known to 
associate with an RNA helicase and three of these interactions were conserved from yeast 
(Lin et al., 2009; Yoshimoto et al., 2009; Niu et al., 2012; Chen et al., 2014). Two more  
G-patch cofactor-RNA helicase complexes have been described recently (Chen et al., 
2017; Inesta-Vaquera et al., 2018), but numerous additional human G-patch proteins 
remained to be characterized. 
In this work, we first sought to establish if all human G-patch proteins interact with an RNA 
helicase and determine the effects that they have on the activity of their helicase partner. 
Immunoprecipitation experiments of FLAG-tagged G-patch proteins expressed from 
HEK293 stable cell lines revealed that GPKOW and GPATCH1 associate with DHX16 and 
DHX35 respectively, whereas the remaining 20 G-patch proteins interact with DHX15. 
Thus, these results confirmed that every human G-patch protein can be found in complex 
with an RNA helicase. In addition, in vitro experiments validated the role as genuine 
helicase cofactors for 20 out of the 22 G-patch proteins based on their influence on the ATP 
hydrolysis and/or RNA binding activities of their cognate RNA helicase. On the other hand, 
the effects induced by GPATCH1 and RBM6 remain to be further characterized 
experimentally and are discussed in more detail in the next section. 
The intriguing finding that DHX15 might be regulated by approximately 20 cofactors raised 
the question of whether these interactions take place in every cell or if they are modulated 
by variable expression of G-patch proteins depending on the cell and tissue type or 
developmental stage. Despite the fact that our results are based on the exogenous 
expression of G-patch proteins, the reciprocal experiment with FLAG-tagged DHX15 
confirmed the interaction with 13 out of the 20 G-patch cofactors. This suggests that the 
majority of the identified G-patch protein-DHX15 complexes are present in normal 
conditions in HEK293 cells and are not a result of overexpression. The failure to identify the 
remaining G-patch proteins could be due to their low expression level or their weak 
association with the helicase, which might be below the detection sensitivity of the method. 
Interestingly, a complementary study using HA-tagged DHX15 transiently expressed in 
HeLa cells identified 11 G-patch proteins that were co-precipitated with the helicase, six of 
which overlapped with our data (Inesta-Vaquera et al., 2018). Together, these two studies 
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validated the interactions of DHX15 with approximately 18 G-patch proteins in a reciprocal 
manner and imply that the helicase might be differentially associated with its extensive 
network of cofactors depending on the cell type or conditions. The dynamic nature of the 
G-patch protein-DHX15 interactions is further supported by the tissue-dependent 
expression levels and the upregulation/downregulation in cancer cells that have been 
reported for multiple G-patch proteins (Laplante et al., 2000; Jianfeng et al., 2003; Sampath 
et al., 2003; Sampson and Hewitt, 2003; Lin et al., 2009; Xu et al., 2014; Wang et al., 2015). 
Furthermore, post-translational modifications have been detected for some G-patch 
proteins, but it remains to be determined if these can modulate the helicase-cofactor 
interaction (Aksaas et al., 2011; Liu et al., 2013; Rother et al., 2016). 
The OB-fold domain of RNA helicases was defined as the binding site for G-patch proteins 
based on protein-protein crosslinking experiments and interaction studies with truncated 
helicases (Silverman et al., 2004; Walbott et al., 2010; Christian et al., 2014; Inesta-Vaquera 
et al., 2018). Our results showed that deletion of the OB-fold region of DHX15 and DHX35 
strongly diminished their interactions with NKRF and GPATCH1, indicating a similar binding 
mode. These findings also imply that the interactions established by DHX15 with its G-patch 
cofactors are mutually exclusive and that the helicase associates with each cofactor in 
distinct subcomplexes that probably carry out separate functions. This model is supported 
by the finding that in yeast four G-patch cofactors can compete for binding to the 
multifunctional RNA helicase Prp43 in vitro. In addition, overexpression of certain Prp43 
cofactors in vivo led to a relocalization of the helicase and to its withdrawal from specific 
functions (Heininger et al., 2016). Thus, changes in the expression level and the dynamic 
interplay of cofactors might serve as a mechanism to regulate multifunctional RNA 
helicases. Since DHX15 is the human homologue of Prp43, the ability of these related 
helicases to interact with a multitude of G-patch proteins seems to be conserved, but the 
larger network of cofactors for DHX15 suggests that it performs more complex or additional 
functions compared to its yeast counterpart. The association of GPKOW with DHX16 is also 
conserved from yeast, where their homologues Spp2 and Prp2 function together in splicing 
(Silverman et al., 2004; Warkocki et al., 2015). On the other hand, DHX35 does not have a 
defined yeast homologue and its interaction with GPATCH1 is mammalian-specific, thus 
making this novel helicase-cofactor complex interesting to explore in future studies. 
Although the OB-fold of RNA helicases was identified as the binding platform for G-patch 
proteins, this domain is present in a large number of other proteins, where it is mostly 
involved in binding nucleic acids, but can also mediate interactions with proteins or other 
molecules (Arcus, 2002; Theobald et al., 2003). In RNA helicases, OB-folds are specific for 
the DEAH/RHA family and are always found in conjunction with a winged helix and a 
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ratchet-like domain. Together, these domains constitute the C-terminal auxiliary region, 
which contributes to RNA binding and is essential for the function and regulation of the 
helicase (He et al., 2010; Walbott et al., 2010). There are approximately 15 DEAH/RHA 
helicases in human cells that contain an OB-fold domain, but our data indicate that only 
three of them interact with G-patch proteins. It is currently unknown which features of 
DHX15, DHX16 and DHX35 enable these helicases to associate specifically with G-patch 
cofactors. However, homology modelling studies of the C-terminal domains of DHX8, 
DHX15, DHX16 and DHX38 revealed the existence of conserved regions, but also of 
divergent surface patches that were suggested to contribute to interactions with different 
proteins (Kudlinzki et al., 2012). In the absence of structural information of a G-patch 
cofactor-RNA helicase complex, the exact determinants of specificity for G-patch protein 
binding remain to be identified. Interestingly, for some RNA helicases that are not regulated 
by G-patch proteins, other functions have been described for the OB-fold domain apart from 
its common role in substrate binding and ensuring the overall architecture of helicases. For 
example, the OB-fold domain of DHX36 is implicated in the specific recognition of  
G-quadruplexes together with the N-terminal region of the helicase, while the OB-fold of 
DHX9 was suggested to modulate the splicing of proviral transcripts (Xing et al., 2014; Chen 
et al., 2018). 
Despite the fact that only three human DEAH/RHA helicases were found to interact with  
G-patch cofactors, it is likely that the remaining helicases are also regulated by accessory 
proteins. Consistent with this, the function of DHX37 and DHX9 was shown to be modulated 
by the cofactors UTP14A and NUP98 respectively (Capitanio et al., 2017; Choudhury et al., 
submitted). The modularity achieved by having protein cofactors that influence the activity 
of RNA helicases in trans would enable the independent regulation of both components and 
might be particularly well-suited for complex systems such as those in higher eukaryotes. 
In this way, post-translational modifications, changes in expression levels or interactions 
with competing proteins for both the helicase and cofactor can modulate the function of the 
complex, thus providing an additional layer of regulation. This might also be advantageous 
for the regulation of multifunctional RNA helicases, whose distinct functions could be 
accomplished by having dedicated cofactors for each activity. In line with this, the four  
G-patch cofactors of Prp43 were suggested to target the helicase to specific functions  
(Tanaka et al., 2007; Lebaron et al., 2009; Chen et al., 2014; Fourmann et al., 2016; 
Heininger et al., 2016). As a comparison, the prokaryotic RNA helicase DbpA and its other 
bacterial orthologues are recruited to their RNA substrate through interactions established 
by the C-terminal RRM domain (Diges and Uhlenbeck, 2001; Kossen et al., 2002). In this 
case, the helicase activity and the specificity for the target RNA are encoded in the same 
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polypeptide, which might reflect the fact that these enzymes have a single cellular function. 
However, helicase cofactors have also been described in bacteria and in viruses, indicating 
that the regulation of RNA helicases by accessory proteins is a widespread mechanism 
(Silverman et al., 2003; Redder et al., 2015). This might also be linked to the high level of 
conservation between RNA helicases across all domains of life (Fairman-Williams et al., 
2010). Whether or not every RNA helicase is regulated by a protein cofactor is currently not 
established. Nevertheless, other means of regulation have been described and given their 
characteristic features and their essential cellular functions, it is highly likely that the activity 
of RNA helicases is modulated at multiple levels. 
 
4.2 Mechanism of RNA helicase regulation by G-patch proteins 
Although the mechanistic details of the G-patch protein-mediated regulation of RNA 
helicases have not been elucidated, several common characteristics can be derived from 
the existing studies. G-patch proteins were shown so far to have an exclusively stimulatory 
role and to enhance the RNA binding affinity, the ATPase and/or unwinding activities of their 
interacting helicase. Furthermore, the G-patch domain was found to be essential for the 
regulation since no stimulation of activity was observed in its absence (Lebaron et al., 2009). 
This domain was also suggested to be sufficient for modulating the helicase activity, 
although most studies used slightly longer fragments than the G-patch motif only (Christian 
et al., 2014; Heininger et al., 2016). 
Here, ATPase assays of DHX15 and DHX16 in the presence of the G-patch domains 
confirmed that this region is sufficient in most cases to stimulate the activity of the helicase 
partner. Despite the weak effects induced by some cofactors, the increase in ATPase 
activity was observed only for the specific helicase, indicating that the G-patch domain alone 
is also able to distinguish the cognate RNA helicase. On the other hand, the G-patch domain 
of GPKOW did not enhance the activity of DHX16, despite a mild stimulation being observed 
in the presence of the full-length cofactor. This is consistent with the finding that, in some 
cases, other regions of G-patch proteins contribute to binding to the helicase, suggesting 
that for GPKOW sequences outside of the G-patch domain are also involved in the 
interaction with DHX16 (Lebaron et al., 2009). The G-patch domain of RBM6 did not 
stimulate the ATPase activity of DHX15 either, but instead caused a mild reduction. In the 
absence of experiments with the full-length protein, it is not clear what effects this cofactor 
induces. Similarly, no in vitro data is available for the GPATCH1-DHX35 interaction. 
Therefore, even though our results showed that 20 out of the 22 human G-patch cofactors 
enhanced the ATPase activity of their interacting helicase, it is not yet known if G-patch 
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proteins function exclusively as activators. Considering that the MIF4G domain cofactors of 
DEAD-box helicases were shown to have both stimulatory and inhibitory effects, it is 
possible that G-patch proteins could influence the activity of their helicase partner in other 
ways as well (Ozgur et al., 2015; Sloan and Bohnsack, 2018). The mild decrease of the 
DHX15 ATPase activity induced by the G-patch domain of RBM6 suggests that this cofactor 
might act as an inhibitor. In the cellular environment, this putative inhibitory role of RBM6 
could be manifested in a similar way to the function of the MIF4G cofactor CWC22, which 
holds the RNA helicase eIF4A-III in an inactive conformation to prevent unspecific RNA 
binding (Barbosa et al., 2012; Buchwald et al., 2013). Alternatively, RBM6 could also act as 
a placeholder that blocks the interaction of DHX15 with other G-patch cofactors, 
sequestering the helicase in a non-productive state. 
The results described above were based on ATP hydrolysis assays performed in the 
presence of RNA. Since RNA helicases are RNA-dependent NTPases, the higher ATPase 
activity observed upon addition of the G-patch cofactors could be due to an increased 
binding of the helicase to the RNA substrate. This is supported by anisotropy measurements 
that showed most G-patch domains can also enhance the RNA affinity of DHX15. In 
addition, other G-patch cofactors were previously found to stimulate both RNA binding and 
ATP hydrolysis by their helicase (Christian et al., 2014; Heininger et al., 2016). However, 
this mechanism cannot exclusively account for the stimulation of ATP hydrolysis because 
not all G-patch domains increased the RNA binding affinity of DHX15 despite their effects 
on its ATPase activity. Consistent with this, Spp2 was found to enhance the ATPase activity 
of Prp2, but not its affinity for the RNA substrate (Warkocki et al., 2015). It is also possible 
that the effects induced by these cofactors on the helicase RNA affinity are weak and below 
the detection limit. 
Several studies have shown that G-patch proteins can also stimulate the ATPase activity of 
the helicase in the absence of the RNA substrate (Lebaron et al., 2009; Chen et al., 2014; 
Christian et al., 2014). In the cellular context, this mechanism might not be significant since 
RNA helicases need to couple ATP hydrolysis to mechanical work on the RNA substrate. 
Based on the available information, a model can be proposed in which binding of the  
G-patch domain to the OB-fold domain of the RNA helicase leads to conformational 
changes both in the C-terminal region and in the helicase core. This enhances binding of 
the RNA substrate in some cases and also brings the helicase in a conformation that is 
more favorable for ATP hydrolysis. In turn, the bound RNA triggers further rearrangements 
that stimulate ATP hydrolysis, which then leads to translocation along the substrate (He et 
al., 2017; Tauchert et al., 2017). Thus, the cooperative action of the RNA and the G-patch 
protein is required for the remodeling function. Indeed, Spp2 was shown to be essential for 
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coupling the ATPase and remodeling activities of Prp2 (Warkocki et al., 2015). A similar 
role was suggested for Pxr1, which was proposed to act by disrupting stacking interactions 
between the nucleotide base and specific residues located in the two helicase domains 
(Robert-Paganin et al., 2017). Other G-patch cofactors were shown to stimulate the ATPase 
and unwinding activities of their interacting helicase, including NKRF in the present study, 
providing further support that G-patch proteins are essential for both functions (Lebaron et 
al., 2009; Chen et al., 2017; Inesta-Vaquera et al., 2018). 
It is currently not known if the G-patch domain can contact the RNA directly or if it enhances 
RNA binding by the helicase indirectly by promoting conformational changes. Our 
anisotropy studies showed that the DHX15-interacting G-patch domains don’t bind RNA on 
their own. Other G-patch cofactors were found to lack the ability to bind RNA, while Spp382 
was suggested to contact RNA only in complex with the helicase (Christian et al., 2014; 
Warkocki et al., 2015; Heininger et al., 2016). On the other hand, some virus-encoded  
G-patch domains were shown to associate with RNA with different substrate specificities 
(Svec et al., 2004). Our results also revealed that the G-patch domains of GPKOW and 
GPATCH1 bind RNA with Kd values of 8.7 µM and 26.2 µM respectively, providing one of 
the first quantitative reports of binding affinities for isolated G-patch domains. Strikingly, 
there is a clear separation between the DHX15-interacting G-patch domains, which don’t 
bind RNA, and those belonging to GPKOW and GPATCH1, which are cofactors of DHX16 
and DHX35 and are able to associate with RNA. This might indicate distinct mechanisms 
for the regulation of these three DEAH/RHA helicases by G-patch cofactors, with the 
contribution of the G-patch domain to RNA binding depending on the identity of the helicase-
cofactor complex. The G-patch domain is often found in combination with canonical RNA-
binding domains such as the RRM or the R3H domains (Aravind and Koonin, 1999; Figure 
1.4A). Thus, some G-patch proteins can bind the RNA substrate through these additional 
domains. Similar to the C-terminal tail of certain DEAD-box helicases that anchors the 
helicase core to the substrate, it is possible that these RNA-binding domains help to 
strengthen the interaction of the G-patch cofactor-helicase complex with the target RNA by 
binding to adjacent regions.  
The results of the ATPase and anisotropy assays also uncovered a putative hierarchy of 
the G-patch cofactors of DHX15 based on the strength of their effect, with GPATCH2 and 
CMTR1 being strong cofactors and proteins such as GPATCH3, SUGP2 or ZGPAT having 
weak effects. However, only the G-patch domains were used in these experiments and it is 
possible that the full-length cofactors might show different effects. Furthermore, in the 
cellular environment, other factors, such as the expression levels of G-patch proteins, their 
Discussion 
 92 
subcellular localization or the presence of competing proteins are likely to influence the 
interaction of each helicase-cofactor complex. 
It is currently unknown which residues of the G-patch domain are directly involved in the 
binding and regulation of RNA helicases, and consequently, the features that would make 
a cofactor stronger or weaker are elusive. The consensus sequence that was originally 
defined for the G-patch domain includes five glycine residues at conserved positions, an 
aromatic amino acid following the first glycine residue and a few conserved hydrophobic 
amino acids. However, these residues are not found in all G-patch proteins, for example, 
yeast Spp2 containing only two of the five conserved glycines (Aravind and Koonin, 1999; 
Robert-Paganin et al., 2015). Several mutational studies have attempted to define the 
amino acids of the G-patch domain that are essential for RNA helicase binding. For 
example, in the case of RBM5, mutation of conserved glycine residues in different 
combinations reduced the interaction with DHX15 (Niu et al., 2012). In this work, a similar 
result was obtained for NKRF, for which substituting six conserved glycine residues with 
alanine abolished binding to DHX15. Other studies have shown that several conserved 
leucine residues in the G-patch domain of specific proteins are also important for the 
interaction with RNA helicases (Tanaka et al., 2007; Inesta-Vaquera et al., 2018). 
Intriguingly, the first four glycine residues of the consensus sequence are highly conserved 
in human G-patch proteins, but the fifth glycine is less conserved and at this position all the 
DHX15 cofactors have a glycine residue, whereas the non-DHX15 interactors contain an 
arginine (for GPATCH1) or a glutamine (for GPKOW) (Figure 1.4B). Further experimental 
work is required to determine if the amino acid at this position is important for discriminating 
between different RNA helicases. Small differences at the level of the primary sequence 
have already been suggested to enable MIF4G domains to distinguish their cognate DEAD-
box helicases due to a few steric clashes or unfavorable electrostatic interactions and a 
similar mechanism is possible for G-patch proteins (Buchwald et al., 2013; Ozgur et al., 
2015). 
Interestingly, MIF4G cofactors that influence the activity of more than one helicase have 
been identified. For example, Gle1 activates the RNA helicase Dbp5 in the mRNA export 
pathway and also inhibits the function of Ded1 in translation, but it remains to be determined 
if the MIF4G domain is the regulatory module in both cases (Bolger and Wente, 2011; 
Montpetit et al., 2011). Although our data did not find any evidence for G-patch proteins 
acting as cofactors of multiple RNA helicases, this possibility cannot be excluded and 





4.3 Regulation of alternative splicing by DHX15 and G-patch proteins 
Alternative splicing is a key step of gene expression regulation that involves the differential 
usage of splice sites within a primary transcript derived from a single gene locus to produce 
multiple transcript variants. Almost every human gene undergoes alternative splicing, which 
generates diverse transcripts and protein isoforms that are essential determinants of cell 
identity and function (Lee and Rio, 2015). Alternative splicing relies on regulatory cis 
elements that are located either in introns or in exons and can be functionally classified into 
splicing enhancers and silencers. These regulatory elements are bound by trans-acting 
factors, including SR proteins and hnRNP proteins, that promote or inhibit splicing through 
various mechanisms, such as the recruitment of spliceosome complexes or steric hindrance 
of splice sites. Both the cis elements and the trans-acting factors can exhibit dual roles that 
are dependent on the sequence context. In addition, other features modulate the choice of 
splice sites, including pre-mRNA secondary structures or multiple proteins binding to the 
same regulatory elements (Wang and Burge, 2008; Chen and Manley, 2009; Fu and Ares, 
2014). Overall, the combination of these positive and negative effects determines splice site 
selection, but the underlying mechanisms are not yet elucidated. 
The majority of alternative splicing events are a result of exon skipping or inclusion, intron 
retention, the usage of alternative 5′ and 3′ splice sites or the choice between mutually 
exclusive exons. These patterns of alternative splicing occur independently or in different 
combinations, thus producing a multitude of diverse transcripts (Wang et al., 2015b). 
Alternative splicing can be investigated in a global manner using methods such as  
RNA-seq or, the more recently developed, long-read sequencing. Most commonly, 
alternative splicing analysis based on RNA-seq data is performed using libraries of known 
splicing events derived from annotated genomes. However, methods that enable the 
identification of novel splice junctions have also been developed to overcome the limitations 
of incompletely annotated or unannotated reference genomes (Conesa et al., 2016). 
In this study, changes in alternative splicing patterns at annotated splice sites were 
examined using RNA-seq in cells lacking either DHX15 or G-patch proteins. The results 
revealed differentially expressed splicing events upon knockdown of each of the 18 factors 
tested, with some proteins regulating only a small number of events (~100) and others, such 
as SON and ZGPAT, influencing thousands of sites. The changes in alternative splicing 
were not linked to altered gene expression levels, indicating that these proteins regulate 
splice site selection without affecting the transcription or stability of the target mRNAs. 
Several G-patch proteins have been previously implicated in splicing, including CHERP, 
RBM5, RBM6, RBM10, RBM17 and SON, which were suggested to regulate the alternative 
splicing of specific genes (Ahn et al., 2011; Bechara et al., 2013; Lu et al., 2013; De Maio 
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et al., 2018). A function in alternative splicing was also proposed for ZGPAT based on 
experiments with a generic splicing reporter (Chen et al., 2017). In addition, TFIP11 was 
found to participate with DHX15 in the disassembly of intron lariat spliceosomes, but a role 
in alternative splicing has not been addressed so far for these factors (Yoshimoto et al., 
2009). Some G-patch proteins, including CHERP and RBM17, have been reproducibly 
detected in purified spliceosomal complexes, indicating that they are core components of 
the spliceosome. Other G-patch proteins, such as RBM5 and SUGP2, were suggested to 
be loosely associated with the spliceosome and to act only at specific stages (Bessonov et 
al., 2008; Wahl et al., 2009; Agafonov et al., 2011). Our results indicate that a large number 
of G-patch proteins function as regulators of alternative splicing, implying that the failure to 
detect factors such as AGGF1, GPANK1 and others in spliceosomal preparations could 
similarly reflect a transient association with the splicing machinery. Proteins that interact 
weakly with the spliceosome might be well-suited for alternative splicing regulation, which 
requires rapid responses to changes in cellular conditions (Agafonov et al., 2011). 
Interestingly, it was shown that the core spliceosome components also modulate the 
alternative splicing of subsets of genes and do not influence constitutive splicing, which is 
consistent with our findings (Saltzman et al., 2011; Papasaikas et al., 2015). Apart from the 
core and non-core components of the spliceosome machinery, splice site selection can also 
be regulated by chromatin-related factors and RNA-processing proteins, suggesting that 
diverse factors can participate in alternative splicing (Papasaikas et al., 2015). 
One of the best studied G-patch proteins in splicing is SON, whose depletion was shown to 
lead predominantly to intron retention or exon skipping in specific transcripts, which is in 
accordance with our results (Ahn et al., 2011; Lu et al., 2013). Comparison of the  
SON-regulated genes detected in this study with the changes in alternative splicing reported 
in human embryonic stem cells after SON knockdown revealed approximately 40% overlap 
between the datasets, thus validating our analysis and indicating that the G-patch protein 
has general as well as cell type-specific substrates (Lu et al., 2013). SON was found to bind 
directly to some of its target pre-mRNAs and was proposed to regulate splicing by recruiting 
SR proteins and other factors through its N-terminal repetitive domains (Hickey et al., 2014; 
Lu et al., 2014). Interestingly, the G-patch domain of SON is required for the splicing 
function, implying that the G-patch protein might also recruit DHX15 to these target sites 
(Ahn et al., 2011). Consistent with a common function of SON and DHX15 in alternative 
splicing, our analysis identified 256 splicing events that were regulated by both proteins. 
Common splicing events between DHX15 and its other G-patch cofactors were also found, 
raising the possibility that DHX15 acts as a master regulator of alternative splicing through 
its network of cofactors. 
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In yeast, eight conserved RNA helicases participate in splicing and perform essential 
structural remodeling events during the assembly and catalytic activation of the 
spliceosome. Some of these helicases also ensure the accuracy of the process by 
proofreading the pre-mRNA-snRNA interactions (Cordin and Beggs, 2013). Apart from 
these conserved RNA helicases, additional helicases have been linked to splicing in human 
cells and it was suggested that they regulate alternative splicing or mediate other  
ATP-dependent remodeling steps required for spliceosome function (De et al., 2015; Lee 
et al., 2018). The only activity described for DHX15 in splicing until now was the 
disassembly of intron lariat spliceosomes (Yoshimoto et al., 2009). This function is 
conserved from yeast, where its homologue Prp43 was shown in addition to discard 
aberrant spliceosomes (Tanaka et al., 2007; Koodathingal et al., 2010). Interestingly, the 
role of Prp43 in the disassembly of late-stage and aberrant spliceosomes is tightly controlled 
by the G-patch protein Spp382 and by Ntr2, and in the absence of these factors the helicase 
can act unspecifically on properly assembled spliceosomal complexes at different stages of 
maturation (Fourmann et al., 2016). In human cells, this putative function of the helicase as 
a general disassembly factor could be regulated through interactions with its G-patch 
cofactors and enable DHX15 to participate at multiple steps of splicing. A recent study has 
shown that proofreading of splice sites by the yeast helicases Prp16 and Prp22 at the 
catalytic stages of splicing disengages weak substrates and allows the spliceosome to 
search for alternative splice sites (Semlow et al., 2016). These results provide a framework 
for alternative splicing regulation by DEAH/RHA helicases, suggesting that the proofreading 
function of yeast RNA helicases could have evolved in higher eukaryotes as a mechanism 
to control the choice of splice sites. Thus, DHX15 might preferentially disassemble 
spliceosome complexes at particular locations or stages and, in this way, lead to splicing at 
alternative sites. On the other hand, it is also possible that DHX15 regulates alternative 
splicing by resolving secondary structures in specific pre-mRNAs, as has been suggested 
for DDX5 (Lee et al., 2018). 
The findings that DHX15 and the analyzed G-patch proteins regulate alternative splicing 
and that the G-patch cofactors stimulate the activity of DHX15 strongly suggest that these 
helicase-cofactor complexes function together in this pathway. However, in addition to 
splicing events that were common between DHX15 and its G-patch cofactors, unique 
targets for each sample were also identified. Therefore, further experiments are required to 
understand if the role of G-patch proteins in alternative splicing is mediated exclusively 
through their interacting helicase. A possible explanation for the low overlap between the 
splicing changes induced by DHX15 and its cofactors is functional redundancy or synergism 
between G-patch proteins. In line with this, the RNA-seq analysis also revealed overlapping 
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splicing substrates between G-patch proteins. Furthermore, a recent study found that 
CHERP and RBM17 have common alternative splicing targets and proposed that these  
G-patch proteins function together in this pathway (De Maio et al., 2018). Although our data 
did not confirm these observations, a high overlap between GPATCH8 and GPATCH11 
was detected instead (~80%), indicating that other G-patch proteins could also act in a 
coordinated manner. The regulation of the same splice sites by multiple G-patch proteins 
suggests that the action of these cofactors might be redundant and serve as a backup 
mechanism. This is supported by the fact that RNA helicases probably interact in a mutually 
exclusive manner with their G-patch cofactors (Heininger et al., 2016). Alternatively,  
G-patch proteins could regulate the activity of the helicase synergistically through unknown 
mechanisms or could act independently of the helicase. Nevertheless, it is likely that the 
function of G-patch proteins is coordinated, as evidenced by the fact that in some cases 
they can influence each other’s expression levels (Loiselle et al., 2017; Sun et al., 2017; De 
Maio et al., 2018). 
RBM5, RBM6 and RBM10 were also found to crosslink to some of their target pre-mRNAs, 
similar to SON, suggesting that they have a direct role in alternative splicing regulation 
(Bechara et al., 2013). Our results revealed that SUGP2 binds directly to a large number of 
pre-mRNAs as well. Some of these targets showed changes in alternative splicing upon 
knockdown of the G-patch protein, supporting a direct function for SUGP2 in modulating 
splice site selection. Additional experiments are needed to determine the binding sites of 
SUGP2 on its target substrates, which would help uncover the mechanisms of alternative 
splicing regulation by this G-patch protein. At the same time, the other G-patch proteins 
identified in this study as novel regulators of alternative splicing require further investigation 
to confirm their function and assess if they have a direct or an indirect role in this process. 
It is possible that the G-patch proteins that interact directly with their RNA targets bind 
adjacent to the RNA helicase docking site and strengthen its interaction with the substrate 
in addition to stimulating its activity. This is supported by the fact that the yeast helicase 
Prp43 can crosslink to pre-mRNAs independent of its cofactor Spp382 (Fourmann et al., 
2016). In the case of G-patch proteins that don’t bind RNA on their own but still have a direct 
role in splice site selection, interactions with other proteins could mediate their recruitment 
to the target substrates as has been suggested, for example, for Spp2 (Warkocki et al., 
2015). 
On the other hand, the regulation of alternative splicing by G-patch proteins could take place 
through indirect mechanisms that are independent of their participation in the splicing 
reaction. In support of this, our data showed that ZGPAT does not crosslink to mRNAs, 
despite the numerous changes in alternative splicing observed after its knockdown, and 
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instead binds specific scaRNAs. These small non-coding RNAs associate with proteins into 
scaRNPs and generally guide the 2′-O-methylation and pseudouridylation of snRNAs by 
base-pairing to the target site. These two modification types alter the properties of the RNA, 
for example, by increasing its stability or influencing base-pairing and stacking interactions. 
Most 2′-O-methylations and pseudouridylations in snRNAs are found in functionally 
important regions that are involved in essential RNA-RNA and protein-RNA interactions 
(Karijolich and Yu, 2010; Bohnsack and Sloan, 2018). Consistent with this, some 
modifications were already shown to be required for snRNA function, although most 
modifications still await characterization. For example, several modifications at the 5′ end 
of U2 snRNA were found to be essential for the formation of early spliceosomal complexes 
and, consequently, for efficient splicing (Donmez et al., 2004). 
The mechanisms involved in the scaRNA-mediated modification of snRNAs are largely 
unknown, but considering that some RNA helicases were shown to modulate  
snoRNA-rRNA interactions, it is possible that these enzymes could have a similar role in 
scaRNA function. Therefore, the finding that ZGPAT crosslinks to scaRNAs, together with 
its role as a cofactor of DHX15, imply that this helicase-cofactor complex might be required 
for snRNA modification guided by scaRNAs. Analysis of the methylation status at the G11 
and G25 residues in U2 snRNA revealed that knockdown of DHX15 decreased the 
modification level at these sites, whereas depletion of ZGPAT did not show any effects. 
Despite the fact that DHX15 does not interact directly with scaRNAs, it seems likely that its 
role in snRNA modification is mediated through scaRNAs and that ZGPAT establishes the 
functional connection between these components. This model is supported by the fact that 
knockdown of DHX15 does not affect the expression level or alternative splicing of the 
protein components of the scaRNP methylation machinery. Therefore, based on these 
results, it is possible that DHX15 and ZGPAT function together in the scaRNA-guided 
modification of snRNAs. Considering that the G-patch protein crosslinks to specific 
scaRNAs, DHX15 and ZGPAT probably influence snRNA modification only at certain sites, 
but this aspect needs to be further assessed. 
Although it was recently shown that snRNAs are generally fully methylated at the known 
sites of modification across different tissues (Krogh et al., 2017), several findings have 
highlighted the potential of variations in the snRNA modification status to fine-tune the 
function of the spliceosome. In yeast, apart from the constitutive modifications, a few 
pseudouridine residues in U2 and U6 snRNAs were found to be induced in stress conditions 
or in different growth phases, and one of these novel pseudouridines decreased splicing 
efficiency (Wu et al., 2011; Basak and Query, 2014; Karijolich et al., 2015). In addition, 
substoichiometric snRNA 2′-O-methylation levels were detected at several sites during T 
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cell activation and the U4 snRNA C8 residue was not methylated in a specific cancer cell 
line as opposed to its status in normal conditions (Krogh et al., 2017). These examples of 
heterogeneity in snRNA modification suggest the possible existence of specialized 
spliceosomes, which might serve as a means to regulate alternative splicing similar to how 
specialized ribosomes were proposed to preferentially translate specific mRNA subsets 
(Krogh et al., 2017; Shi et al., 2017). Although direct evidence that variable levels of snRNA 
modifications influence alternative splicing is currently lacking, this hypothesis was also 
suggested based on the observation that decreased expression of specific scaRNAs 
correlates with changes in alternative splicing that contribute to cardiac disease (Patil et al., 
2015; Nagasawa et al., 2018). Therefore, it is possible that DHX15 and ZGPAT modulate 
alternative splicing through their putative function in snRNA modification. Considering that 
78 alternative splicing events were found to be regulated by both DHX15 and ZGPAT in our 
RNA-seq analysis, these target mRNAs could represent a starting point for confirming this 
model. Additional experiments will help decipher the exact function of DHX15 and ZGPAT 
in snRNA modification and alternative splicing regulation. 
 
4.4 The function of DHX15 and NKRF in ribosome biogenesis 
Eukaryotic ribosome biogenesis is a highly complex process involving hundreds of 
assembly factors that are required for the sequential maturation of rRNA precursors and 
their association with ribosomal proteins. In human cells, three of the four mature rRNAs 
are co-transcribed into a single precursor, the 47S pre-rRNA transcript, in which the 
sequences of the 18S, 5.8S and 28S rRNAs are separated and flanked by spacer regions 
(5′ETS, ITS1, ITS2 and 3′ETS). Processing of this initial transcript to release the mature 
rRNAs takes place through a series of endonucleolytic cleavage events at specific sites in 
the spacer regions that are coupled in most cases with exonucleolytic digestion. The 
pathway of ribosome production is generally conserved across eukaryotes, but several 
characteristics, such as the presence of additional cleavage sites and the larger number of 
assembly factors, demonstrate the increased complexity of this process in human cells 
compared to yeast (Henras et al., 2015; Aubert et al., 2018). The function of most ribosome 
assembly factors remains to be determined. 
In this study, novel interactions between the RNA helicase DHX15, the G-patch protein 
NKRF and the 5′-3′ exonuclease XRN2 were identified and the functions of these proteins 
in ribosome biogenesis were characterized. DHX15, NKRF and XRN2 were found to  
co-migrate with pre-ribosomal particles in sucrose gradients and to associate into a 
nucleolar subcomplex that is required for efficient pre-rRNA processing at site A′ in 5′ETS. 
The A′ cleavage event is specific for metazoans and, although it generally takes place early 
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in the pre-rRNA maturation pathway, it was found to not be a pre-requisite for downstream 
processing and can also occur at later stages or be skipped altogether (Sloan et al., 2014). 
This is consistent with our findings that depletion of these three factors does not affect the 
production of the mature ribosomal subunits despite the impaired A′ cleavage. Although the 
role of this additional processing event in metazoans is not known, the reduced cleavage at 
the A′ site upon knockdown of DHX15, NKRF and XRN2 leads to an accumulation of the 
47S and 30SL5′ precursors. Interestingly, in MCF7 cells, the levels of 30SL5′ pre-rRNA are 
inherently higher than in other cell lines (Sloan et al., 2014). Furthermore, alternative 
processing pathways that generate different intermediates exist at several stages of pre-
rRNA maturation and variations in the kinetics of these co-existing pathways that arise 
depending on the cell type or physiological conditions lead to changes in the ratios of the 
precursors. These different patterns of pre-rRNA processing were suggested to modulate 
the function of the ribosome, for example, by inducing distinct rRNA modification profiles 
depending on the precursors generated (Lafontaine, 2015; Aubert et al., 2018). Thus, even 
though the knockdown of DHX15, NKRF and XRN2 does not affect the production of the 
mature ribosomal subunits, it is possible that the increased levels of the 47S and 30SL5′ 
intermediates leads to subtle differences in rRNA modification that contribute to ribosome 
heterogeneity. This hypothesis is supported by the fact that 2′-O-methylation and 
pseudouridylation, which are the most abundant types of rRNA modification, occur at early 
stages of ribosome biogenesis, similar to A′ cleavage. Furthermore, sites with 
substoichiometric methylation levels as well as differences in the rRNA modification pattern 
between cell lines were recently discovered (Krogh et al., 2016). 
The nucleolar interactions between DHX15, NKRF and XRN2 and the common A′ 
processing defect observed upon their knockdown strongly suggests that these proteins 
function together at this site. Consistent with this, our results showed that NKRF acts as a 
cofactor of DHX15 and stimulates its RNA binding affinity, ATPase and unwinding activities, 
and this catalytic activity of the helicase is necessary for proper A′ cleavage. On the other 
hand, the presence of XRN2 in this complex might serve as a quality control mechanism to 
enable the degradation of aberrant pre-rRNAs, similar to the function described for its 
mouse homologue (Wang and Pestov, 2011). The finding that the catalytic activity of DHX15 
is required for efficient A′ cleavage suggests that the helicase might perform a structural 
remodeling event that facilitates processing, for example, by enabling the access of the 
currently unidentified endonuclease to its target site. This function would resemble the role 
proposed for its yeast homologue Prp43 in promoting the cleavage of 20S pre-rRNA by the 
endonuclease Nob1 (Pertschy et al., 2009). Alternatively, the action of DHX15 could lead 
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to the release or association of other proteins, such as factors that were previously 
implicated in A′ cleavage (Sloan et al., 2014). 
The involvement of DHX15 in A′ cleavage represents the first function reported for this 
human helicase in ribosome biogenesis. As this processing step is specific for metazoans, 
this activity is not performed by its yeast homologue Prp43, for which other roles in this 
pathway have been described instead. Prp43 was suggested to participate in the 
biogenesis of both ribosomal subunits by promoting the final step of 18S rRNA maturation 
and mediating the association or release of snoRNAs during the assembly of the large 
ribosomal subunit (Bohnsack et al., 2009; Pertschy et al., 2009). These distinct activities of 
Prp43 in ribosome biogenesis are likely regulated by the G-patch cofactors Sqs1 and Pxr1 
(Pertschy et al., 2009; Robert-Paganin et al., 2017). Thus, apart from its role in ensuring 
efficient A′ cleavage together with NKRF and XRN2, it is possible that DHX15 performs 
additional functions in this pathway with other G-patch cofactors, similar to Prp43. 
Consistent with this, our results showed that the G-patch proteins GPATCH2, GPATCH4 
and PINX1 stimulate the activity of DHX15 and are localized in nucleoli, implying that they 
might be involved in ribosome biogenesis. Since PINX1 was found to substitute the function 
of its yeast homologue Pxr1 in ribosome maturation, it likely performs a similar role in human 
cells (Chen et al., 2014; Robert-Paganin et al., 2017). 
Apart from the common function of DHX15, NKRF and XRN2 in A′ cleavage, our data also 
revealed that knockdown of NKRF and XRN2 leads to the accumulation of several  
pre-rRNA fragments that are excised during processing and are normally targeted for 
degradation. The involvement of XRN2 in the turnover of these processing by-products has 
been previously described and our results further show that the similar defects induced by 
depletion of NKRF arise due to its role in recruiting the exonuclease to the nucleolus and to 
its pre-rRNA substrates (Wang and Pestov, 2011; Schillewaert et al., 2012; Sloan et al., 
2013; Sloan et al., 2014). In addition, an increase in the levels of the 36S and 12S 
precursors was observed upon knockdown of NKRF and XRN2, which is probably a 
feedback effect caused by the failure to recycle the ribosome assembly factors bound to 
the excised pre-rRNA fragments. The common function of NKRF and XRN2 in pre-rRNA 
processing and turnover was also reported in a separate study, which found in addition that 
NKRF is upregulated during the heat shock response and restores nucleolar homeostasis 
by recruiting XRN2 to this subcellular location (Coccia et al., 2017). 
Interestingly, it was shown that the function and localization of XRN2 are also modulated 
by the nucleoplasmic protein CARF, whose overexpression leads to an accumulation of 
XRN2 in the nucleoplasm and to similar pre-rRNA processing defects as those caused by 
depletion of NKRF or XRN2 (Sato et al., 2015). Similar to NKRF, CARF contains a 
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conserved domain that was suggested to mediate the interaction with XRN2 (XTBD; Richter 
et al., 2016). Although our results indicate that NKRF binds XRN2 in a different mode than 
CARF, taken together, these findings imply that the distribution of XRN2 between its 
nucleolar and nucleoplasmic functions is controlled by the interplay between NKRF and 
CARF. In contrast to its yeast homologue Rat1, whose exonuclease activity is stimulated 
by the cofactor Rai1, the regulation of XRN2 by XTBD-containing proteins does not seem 
to directly influence its enzymatic activity, which is probably due to the different binding 
mode compared to the yeast proteins (Miki et al., 2014; Sato et al., 2015; Richter et al., 
2016). 
Taken together, our results identify the G-patch protein NKRF as a key factor in ribosome 
biogenesis that mediates the assembly of a subcomplex containing DHX15 and XRN2 for 
facilitating A′ cleavage of the pre-rRNA transcript and also functions together with XRN2 in 
the turnover of pre-rRNA fragments excised during processing. 
 
4.5 Conclusions and perspectives 
In this study, a systematic analysis of the human G-patch protein family was performed with 
the aim to establish these proteins as cofactors of RNA helicases and to gain insight into 
the function and regulation of the G-patch cofactor-RNA helicase complexes. Our 
interaction studies and in vitro experiments showed that every human G-patch protein 
associates with an RNA helicase, and in most cases, they stimulate the RNA binding and/or 
ATPase activity of the helicase. The G-patch domain was found to be generally sufficient 
for the regulation. Overall, we could confirm the role as bona fide cofactors for 20 out of the 
22 G-patch proteins, while for the remaining proteins additional experiments are required to 
uncover their effects on the helicase partner. Our results also revealed that only three 
human DEAH/RHA helicases interact with G-patch proteins: DHX16 and DHX35 have one 
cofactor each, while DHX15 associates with a network of 20 G-patch cofactors. It remains 
to be determined which characteristics enable these three RNA helicases to interact with 
G-patch proteins and what residues of the G-patch domain are essential for distinguishing 
and regulating the cognate helicase. Furthermore, the intriguing finding that DHX15 has 
such a large number of cofactors suggests that these interactions might be dynamically 
modulated and this hypothesis could be tested in different cell types or physiological 
conditions. 
Our genome-wide analyses indicated that DHX15 and most G-patch proteins regulate the 
alternative splicing of subsets of genes. Based on the identification of common targets for 
DHX15 and its G-patch cofactors, we propose that these complexes function together in 
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this pathway. Similarly, the detection of overlapping splicing targets between different  
G-patch proteins suggests that their action might be coordinated. The function of DHX15 
and of several G-patch proteins in alternative splicing was tested and confirmed, thus 
revealing novel regulators of this pathway. Our results also showed that SUGP2 crosslinks 
to pre-mRNAs, implying that this G-patch protein has a direct role in modulating splice site 
selection. On the other hand, ZGPAT was found to bind scaRNAs and DHX15 was shown 
to influence the scaRNA-guided modification of snRNAs at specific sites. Considering the 
role of ZGPAT as a cofactor of DHX15, this might suggest that these proteins are involved 
together in snRNA modification and, in this way, modulate alternative splicing. Further 
studies are needed to validate the function of the other G-patch proteins in alternative 
splicing and to understand the mechanisms through which they act. 
In addition to its involvement in alternative splicing, DHX15 has a role in ribosome 
biogenesis together with its G-patch cofactor NKRF and the exonuclease XRN2. These 
proteins form a nucleolar subcomplex that is required for efficient cleavage of the pre-rRNA 
transcript at a specific site. The finding that the catalytic activity of DHX15 is needed for this 
processing step suggests that the helicase performs a structural remodeling event at this 
site. In addition, NKRF mediates the recruitment of XRN2 to the nucleolus and is therefore 
required for the function of the exonuclease in the degradation of pre-rRNA fragments 
excised during processing. Taken together, the data presented in this study indicate that 
DHX15 participates in both alternative splicing and ribosome biogenesis together with its 
G-patch cofactors. Future experiments will help elucidate if there is cross-regulation 
between these functions as has been shown for other multifunctional RNA helicases. 
In conclusion, our findings validate G-patch proteins as a specific family of RNA helicase 
cofactors and expand the knowledge of the mode of regulation of RNA helicases by these 
proteins. The functional characterization of DHX15 and its G-patch cofactors revealed roles 
in alternative splicing and ribosome biogenesis that represent a starting point for more  
in-depth studies. Elucidating the function of each of these helicase-cofactor complexes 
would enable targeting specific activities of the helicase without affecting the others. 
Therefore, this study provides essential insights into the function of RNA helicases and their 
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